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ABSTRACT
Mechanisms responsible for resistance to B-Iactam antibiotics
were investigated in clinical isolates of Bacteroides spp., the most
common anaerobic Gram negative pathogen. Among 108 isolates of
Bacteroides spp. obtained from clinical material in Nottingham, 69
(64%) were identified as Bacteroides fragilis. Approximately one-fifth of
the Bacteroides spp. produced elevated levels of B-Iactamases, and
many of these strains showed increased resistance to ~-Iactam
antibiotics usually regarded as ~-Iactamase stable.
Four ~-Iactamase types were identified: Type one was
represented by zinc dependent rnetallo-p-lactamases that hydrolysed
cefoxitin, latamoxef and imipenem. Type two displayed intermediate to
high specific activity in tests with nitrocefin as substrate and hydrolysed
cefoxitin and latamoxef, but not imipenem. Type three exhibited
intermediate levels of specific activity and caused reduced susceptibility
to cefoxitin, latamoxef and imipenem, although they hydrolysed these
antibiotics inefficiently. Type four probably represented enhanced
production of the B-Iactamases characteristic of most bacteroides
strains. Organisms producing this enzyme normally remained
susceptible to cefoxitin, latamoxef and imipenem, and the enzyme was
fully susceptible to ~-Iactamase inhibitors, including clavulanic acid.
Several strains were detected that exhibited reduced
susceptibility to imipenem that was not related to metallo-B-Iactamases
production. In contrast, one strain that produced a metano-p-tactamase
remained fully sensitive to imipenem as judged by conventional titration.
Investigation of isolates producing metallo-b-Iactamase and several
similar ones encountered in an earlier study showed a correlation
between the degree of resistance to imipenem and specific
imipenemase activity.
In an attempt to elucidate reduced susceptibilty to imipenem
that was not related to metailo-p-lactamase production, cell envelope
properties and penicillin-binding proteins (PBPs) of selected strains
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were investigated. Studies of outer membrane proteins and
lipopolysaccharide compositiqn of B.tragi/is strains unexpectedly
showed that metallo-B-Iactamase producers displayed unusual cell
envelope profiles. Those strains that showed reduced susceptibility that
was not associated with B-Iactamase appeared to be normal, although
two of these strains displayed abnormally high crypticity values.
Between three and six PBPs were visualised in tests with 3H-
benzylpenicillin. PBPs 1 to 3 were present in all strains, but were
observed in imipenem-resistant strains only when tests were carried out
in the presence of f3-lactamase inhibitors. Competitive binding
experiments indicated that imipenem showed affinity for the high
molecular weight PBPs of sensitive B.tragi/is. The low molecular weight
PBPs 4 to 6 were detected intermittently and only in certain strains,
notably those that exhibited reduced susceptibility to imipenem. PBP 6
was found only in strains showing non-enzymic resistance.
The results suggest that several different types of resistance to
f3-lactam antibiotics are circulating in clinical isolates of Bacteroides
spp. in Nottingham: firstly, strains that produce a metallo-tHactamase
that hydrolyses 'f3-lactamase-stable' compounds, including imipenem;
secondly, strains producing enzymes that hydrolyse cefoxitin and
latamoxef, but not imipenem; thirdly, strains that possess a permeability
barrier that affects imipenem as well as other B-Iactam antibiotics;
fourthly, strains with altered penicillin-binding proteins; and fifthly strains
that produce raised amounts of 'normal' f3-lactamase. The latter strains
slowly hydrolyse imlpenem and other f3-lactamcompounds and this may
be a factor in the reduced susceptibility to these agents.
Clinical isolates that possess these resistance mechanisms
may appear susceptible according to conventional break-point criteria
in vitro. Never the less, they exhibit considerably reduced susceptibility
to B-Iactam agents and the therapeutic implications of this need
investigating. At present such strains represent a relatively small
proportion of clinical isolates of Bacteroides spp., but the prevalence of
resistance needs to be carefully monitored.
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CHAPTER 1
INTRODUCTION
1:1 General Introduction
Improvements in laboratory techniques for the isolation,
cultivation and identification of anaerobic bacteria has heightened
awareness of the role of obligate anaerobes in general, and
Bacteroides species in particular, in a wide variety of infections.
Many of the anaerobic bacteria isolated from an infected site are
considered to be opportunistic pathogens and are often part of a
mixed infection (McGowan and Gorbach, 1981).
In the UK, the two main groups of antimicrobial agents
employed to combat these infections are the 13-lactamantibiotics and
the nitro-imidazoles, particularly metronidazole. Metronidazole is
effective against virtually all obligate anaerobes but not against the
other bacteria which may be present in polymicrobial infections. 13-
Lactam antibiotics are active against a wide range of bacterial
species, including many anaerobic species, but resistance among the
bacteroides is relatively common (Phillips et al., 1981). I3-Lactamase
stable 13-lactam antibiotics have improved activity against
Bacteroides species, but problems of resistance are still apparent
(Betriu et al., 1992; Phillips et al., 1992).
In this study, an investigation of the resistance of Bacteroides
species to 13-lactam antibiotics was carried out, with detailed
examination of bacteroides 13-lactamases.Mechanisms of resistance
to carbapenems among B.fragi/is isolates were explored with
consideration of carbapenemase activity, permeability barriers and
penicillin binding proteins.
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1:2 Classification and characterisation of the genus
Bacteroides
Until recently the genus Bacteroides was represented by a
heterogeneous group of Gram negative, obligately anaerobic, non
sporing bacilli which, together with the genera Fusobacterium and
Leptotrichia, belonged to the family Bacteroidaceae. The species of
bacteroides were divided into 5 main groups: the fragilis group; the
melaninogenicus-oralis group; an asaccharolytic group; rumen
species; and 'others' (Duerden, 1990). However, lack of good criteria
for defining the genus, including the unacceptably wide range of DNA
base composition of G+C (28-61 mol per cent), led to a large
accumulation of more than 50 heterogeneous species (Holderman et
al., 1984).
To resolve this unsatisfactory position, Shah and Collins
(1989) made proposals restricting the genus Bacteroides to
saccharolytic, non-pigmented species whose DNA base composition
is within the range G+C 40-48 mol per cent and which are
biochemically and chemically related to the type species Bacteroides
tragilis. By these criteria, the genus Bacteroides is now comprised of
only 10 species, including B.tragi/is, B.distasonis, B.ovatus,
B.thetaiotaomicron and B.vulgatus, all members of the previously
named 'fragilis group'. These species produce acetate and succinate
as major metabolic end products, have enzymes of the pentose
phosphate pathway such as glucose-6-phosphate dehydrogenase
(G-6-PDH) and 6-phosphogluconate dehydrogenase (6-PGDH), and
contain a mixture of long chain fatty acids with predominantly straight
chain saturated, anteiso-methyl branched and iso-methyl branched
acids. The growth of these species is stimulated by bile.
The moderately saccharolytic species represented by the
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melaninogenicus-oralis group have been reclassified in a new genus,
..
Prevotella (Shah and Collins, 1990). These species differ from the
B.fragilis group in that they are sensitive to bile and lack the enzymes
G-6-PDH and 6-PGDH. They have a DNA G+C composition between
40 and 50 mol per cent, are largely indigenous to the oral cavity and
produce mainly acetic and succinic acids in a glucose medium. The
16 members of the Prevotella genus include species previously
named B.bivius, B.buccae, B.bucca/is, B. disiens and B.ora/is, and
the pigmented species B.me/aninogenicus and B.intermedius which
produce both protohaem and protoporphyrin pigments.
The asaccharolytic pigmented species, B.asaccharo/yticus,
B.gingivalis and B.endodontalis, comprise another tight cluster that
differs so significantly from the new genera Bacteroides and
Prevotella that they have been reclassified in a new genus,
Porphyromonas (Shah and Collins, 1988). These species produce
major amounts of protohaem on blood agar plates, lack G-6-PDH and
6-PGDH, produce high levels of butyric acid and possess
predominantly isomethyl branched long chain fatty acids.
The taxonomic position for many other species, such as
B.ureolyticus, B.forsythus and B.gracilis, remains uncertain. The
taxonomic revision of clinically important species previously included
in the genus Bacteroides is summarised in Table 1.1.
1:3 Clinical importance and pathogenicity of
Bacteroides species
The pathogenic potential of anaerobic Gram negative, non-
sporing, anaerobic bacilli has been recognised since the late
nineteenth century (Veillon and Zuber, 1897). Many early reports
7
Table 1.1 Current taxonomic status of clinically important
species previously included in the genus Bacteroides.
Group/Species Current genus name
Saccharolytic group
(B.fragi/is group) Bacteroides
B.fragilis, B.eaeeae, B.distasonis.
B.eggerthii, B.merdae, B.ovatus, B.$tercoris
B. thetaiotaomicron, B.uniformis, B. vulgatus
Moderately saccharolytic group
(B.oralis-B.me/aninogenicus group) Prevotella
B.me/aninogenicus, B.bivius, B.buccae,
B.buccalis, B.corporis, B.dentico/a, B.disiens,
B.heparino/yticus, B.intermedius, B./oescheii,
B.oralis,. B.oris, B.ou/orum, B.ruminicola,
B.veroretts, B.zoog/eoformans
Pigmented asaccharolytic group Porphyromonas
B.asaccharolyticus, B.gingivalis,
B.endodontalis
Others (uncertain taxonomic
B./ev;;, e.mececee
B.ureo/yticus
B.graci/is
B.capiJIosus
B.sp/anchnieus
B. forsyth us
status)
Possibly Porphyromonas
Campy/obaeter or Wolinella
Possibly Wolinella
Probably new genus
Probably new genus
Probably new genus
From Shah and Gharbia (1991)
8
described low isolation rates of anaerobes. Dack (1940) isolated non-
sporing anaerobes from less than 4% of specimens from patients in a
surgical unit and Stokes (1958) found anaerobes in 10% of over 4000
specimens in which bacteria were present. These figures probably
underestimate the incidence of anaerobic infections because of the
poor anaerobic techniques used at that time. The impact of good
anaerobic culturing methods was highlighted by Leigh (1974) who
showed that the isolation rate of Bacteroides species from wound
infections after abdominal surgery rose from 17% to 81% as a result
of improved anaerobic techniques during a period when the rate of
postoperative infection was constant.
Bacteroides species are an important cause of purulent
infections at body sites adjacent to colonized mucosal surfaces.
Holland et al. (1977) found 70% of the anaerobes isolated from
clinical samples, excluding those from stool, urine, sputum and blood,
were identified as Bacteroides species. The B.tragi/is group account
for most of the 'bacteroides' (old nomenclature) isolated from infected
sites, with B.fragilis the predominant species (Duerden, 1980a).
The most common bacteroides infections are intraabdominal
abscesses, peritonitis and wound infections associated with the
appendix or large intestine (Leigh, 1974). Finegold (1977) stated that
Bacteroides species of the fragilis group were associated with 86%
of intraabdominal infections. Bacteroides species are also principal
pathogens of the female genital tract and are present in two thirds of
the cases of pelviCabscesses (Gorbach and Bartlett, 1974; Thadapalli
et a/., 1973). Anaerobic pleuropulmonary infections include lung
abscesses, necrotizing pneumonia and empyema and B.tragi/is is
isolated in 15% of these cases (Bartlett and Finegold, 1974). Gram
negative anaerobic bacilli are the commonest cause of brain
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abscesses, B.tragilis being most frequently implicated in those
secondary to otitis media (Ingham et a/., 1977b). B.tragilis can also
be isolated from skin and soft-tissue infections, and is a major
pathogen in cases of diabetic foot ulcer (Louie et a/., 1976).
Bacteraemia is commonly associated with B.tragilis infections, but
endocarditis due to Bacteroides species is rare.
Certain underlying conditions, such as impairment of the blood
supply, disruption of the mucosal barriers or tissue destruction can
predispose to anaerobic infection. A preceding infection by an
anaerobic or facultative organism may also predispose a site to
invasion by the indigenous anaerobic flora. Anaerobic bacteria
involved in infections are usually derived from the normal flora of the
skin, oral cavity, nasopharynx, large intestine or female genital tract.
The infecting flora is complex, and therefore infections are usually
polymicrobial and often pyogenic (McGowan and Gorbach, 1981).
In these endogenous infections, the bacterial species present
do not reflect the composition of the normal flora at the site of infection
(Duerden, 1980a,b). Infections with B.tragi/is usually originate from
the lower gastrointestinal tract. The numerically dominant
Bacteroides species in the normal colonic flora are B.distasonis.
B.vulgatus and B.thetaiotaomicron, whereas B.tragi/is accounts for
only 5% of the colonic microflora (McGowan and Gorbach, 1981).
B.tragilis, however, is more commonly associated with intra-
abdominal and soft tissue infections than are the other BacterOides
species. Also, B.tragi/is is responsible for a large proportion of
serious bacteroides infections, such as bacteraemia, wound
infections, intraperitoneal abscesses and peritonitis (Polk and Kasper,
1977; Duerden, 1980a).
These observations suggest that B.tragilis has unique
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virulence properties. Kasper (1976) showed the presence of capsules
in a.tragi/is by electron microscopy. These polysaccharide capsules
are an important factor for virulence and abscess formation in
experimental animals (Onderdonk et al., 1977, 1984; Brook, 1987).
The capsule has been shown to be associated with resistance to
phagocytosis and intracellular killing by polymorphonuclear
leucocytes, suppression of macrophage phagocytosis, and
adherence to peritoneal surfaces (Reid and Patrick, 1984; Radloff et
al., 1986; Onderdonk et al., 1978). Adhesion of Gram negative
bacteria to mucosal surfaces is generally associated with fimbriae.
Van Doorn et al. (1987) isolated fimbriae from a strain of B.tragilis
and Pruzzo et al. (1989) found a correlation between fimbriation and
haemagglutination. Iron repressible outer membrane proteins have
been demonstrated in B.fragilis, which may be important in the
uptake of essential iron from the host (Otto et al., 1990). a.tragi/is
produces extracellular or membrane-associated enzymes, including
lipases, proteases and nucleases, which may cause the tissue
damage and necrosis accompanying bacteroides infections (Rudek
and Haque, 1976). The B.tragi/is group is also able to tolerate
exposure to oxygen, which is thought to be a prerequisite to virulence
of anaerobes, by the production of superoxide dismutase and
catalase (Tally et al., 1977; Gregory et al., 1977).
Furthermore, B.tragi/is has been shown to protect facultatively
anaerobic bacteria against phagocytosis and intracellular killing by
reducing the opsonic capacity of serum or removal of essential serum
components (Ingham et al., 1977a, 1981; Jones and Gemmell,
1982). Therefore, apart from being an important pathogen, a.tragilis
may also be a potentiator of infections caused by other organisms.
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1:4 Treatment of infections due to Bacteroides species
Apart from antimicrobial therapy, surgical intervention, which
includes drainage of abscesses and excision of necrotic tissue, is of
great importance in the treatment of anaerobic infections. In some
infections surgical therapy may be all that is required (Finegold,
1989). A single dose of a suitable antibiotic just before this surgical
drainage has been reported to prevent bacteraemia and accelerate
healing (Blick et al., 1980).
When antibiotics are used to combat infections solely due to
bacteroides or other anaerobes, metronidazole is the drug of choice.
Metronidazole has very low toxicity and is consistently bactericidal for
anaerobes. However, most infections involving Bacteroides species
are polymicrobial and antibiotic therapy must be directed at both the
anaerobic and aerobic components. In these situations,
metronidazole is commonly used in combination with an anti - aerobe
antibiotic, normally a cephalosporin or an aminoglycoside.
Another possible option in the treatment of infections due to
bacteroides and aerobic pathogens is the use of single broad
spectrum compounds. These would be simpler to administer and may
be financially preferable. Candidates for such antibiotics include the
cephamycins, carbapenems, latamoxef, and the combinations of
penicillins with ~-Iactamase inhibitors. Cephamycins have been
widely used, but are intrinsically less active than the carbapenems or
the combination products. Latamoxef is generally well tolerated with a
plasma elimination half-life of 2.5 hours and reasonably good
penetration into serous fluids, but is associated with
hypoprothrombinaemia in some patients (Lambert and O'Grady,
1992; Sanders and Aldridge, 1992). It is no longer marketed in the
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UK.
The f3-lactamases produced by Bacteroides species within an
abscess cavity or infected tissue can protect other organisms in a
mixed infection from the activity of susceptible f3-lactam antibiotics.
Brook and Yokum (1983) showed that the resistance of group A f3-
haemolytic streptococci to penicillin increased by 8,SOO-foldwhen
they were mixed with cultures of B.fragi/is. Also, Soriano et al.
(1989) demonstrated the ability of a B-Iactamase-producing strain of
B.fragi/is to shield E.coli from cefotaxime in peritoneal infections in
rats.
Of the other antibiotics, clindamycin, although effective in vitro
and in vivo, has lost its popularity because of an association with
pseudomembranous colitis. Chloramphenicol, despite its broad
antibacterial spectrum and good penetration into body fluids and
tissues, is restricted to use in serious infections because of its
potential for bone marrow toxicity.
Anaerobes, in particular Bacteroides species, play an
important role in post - operative infections after abdominal surgery.
To combat this, various prophylactic antibiotic regimens have been
used. Metronidazole alone, or in combination with a cephalosporin or
an aminoglycoside, has proved effective (Greenwood et aI, 1991).
Studies have also assessed the broad spectrum B-Iactam antibiotics,
which are active against bacteroides, as prophylactic agents and
found them to be as efficient as metronidazole alone (Panichi et al.,
1982).
1:5 B-Iactam antibiotics: their characterisation,
classification and spectrum of activity
f3-Lactam antibiotics are a large and therapeutically important
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group of compounds which ~a~e in common the structural feature of a
f3-lactam ring. They can be divided, according to their chemical
structure, into three broad categories: the penicillins or penams; the
cephalosporins or cephems, with related cephamycins, oxa-cephems
and carbacephems; and others including carbapenems,
monobactams and the clavams and sulphones that are used as f3-
lactamase inhibitors.
Penicillins are N-acylated derivatives of 6-aminopenicillanic
acid, comprising a f3-lactam ring fused with a saturated 5-membered
sulphur-containing thiazolidine ring. In cephalosporins, a six-
membered dihydrothiazine ring containing sulphur and a double
bond replaces the thiazolidine ring to give 7-aminocephalosporanic
acid. The closely related cephamycins, for example cefoxitin, have an
a-methoxy group substituted at the 7-position, and in oxacephems,
such as latamoxef, the sulphur is replaced by oxygen. Substitution of
the sulphur of cephalosporins with a carbon atom gives the
corresponding carbacephem analogue, such as loracarbef. The
remaining f3-lactam compounds have a variety of ring structures or
side chains attached to the f3-lactam ring. Carbapenems, such as
imipenem, differ in possessing a double bond in the thiazolidine ring
and the substitution of CH2 for sulphur. The only notable member of
the clavams is clavulanic acid, the structure of which differs from
penams by the substitution of oxygen for sulphur. The monobactams,
such as aztreonam, are monocyclic; Le. the f3-lactam ring is not
associated with a fused ring system. Sulbactam is an example of a
penicillanic acid sulphone. The basic nuclear structures of the f3-
lactam family of antibiotics are given in Fig. 1.1.
The first member of this large group of compounds was
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Fig. 1.1 Basic nuclear structures of ~-Iactam antibiotics currently
available (examples in parentheses)
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From Greenwood (1989) and Lees et al. (1993)
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benzylpenicillin (penicillin G), which is produced by the mould
Penicillium chrysogenum. Benzylpenicillin contains a
phenylacetamido side chain at the 6-position of the fused ring system
(Fig 1.2). It is active particularly against Gram positive organisms and
Gram negative cocci. Streptococci, f3-lactamase negative
Staphylococcus aureus and Neisseria spp. are highly susceptible.
The first improvements were made by inducing the producer organism
to incorporate variant side chains into the peniCillin molecule. By these
means, phenoxymethylpenicillin (penicillin V) was produced; this
exhibits enhanced acid stability and oral absorption without much loss
of antibacterial activity. In the late 1950s, removal of the side chain of
the benzylpenicillin nucleus was achieved by enzymatic cleavage,
opening up the possibility of the development of semi-synthetic
penicillins (Batchelor et al., 1959). As a result, the antistaphylococcal
penicillins, including methicillin and cloxacillin, were produced. These
are resistant to breakdown by staphylococcal f3-lactamases but display
reduced antibacterial activity. In 1961, the spectrum of benzylpenicillin
was extended to Gram negative bacilli by the addition of an amino
group to the side-chain to form ampicillin which is not, however, f3-
lactamase stable (Rolinson and Stevens, 1961). A further modification
in the spectrum of ampicillin was achieved by mecillinam, produced by
introducing an amidino side chain linkage at the 6-position of the
penicillanic acid nucleus (Lund and Tybring, 1972). A further change in
spectrum to include antipseudomonal activity, is demonstrated by
carbenlclltln, in which a carboxyl group is substituted for the amino
group of ampicillin (Knudsen et al., 1967). This was improved by the
thienyl variant of carbenicillin, ticarcillin (Neu and Winshell, 1970), and
by a group of N-acyl substituted ureido derivatives of ampicillin (the
acylureidopenicillins) which include azlocillin, mezlocillin and
16
Fig. 1.2 The structures of benzylpenicillin and cephalosporin C
showing the fused ring systems. and side chains
side - chain
~ -Iactarn ring thiazolidinering
benzyl penicillin
side chain 1
f3 -Iectem ring dihydrothiazinerinq
cephalosporin C
FromGreenwood(1989)
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piperacillin (Drusano et al., 1984). A 6-a-methoxy derivative of
ticarcillin, temocillin, has been developed with properties strikingly
different to its parent. Temocillin is highly resistant to a wide range of ~-
lactamases but virtually inactive against Pseudomonas aeruginosa
(Jules and Neu, 1982). The major groups of penicillins, with examples,
are given in Fig. 1.3.
The cephalosporins constitute a large and expanding group of
compounds based on cephalosporin C, a fermentation product of a
Cephalosporium mould (Fig. 1.2), first described by Newton and
Abraham (1955). All cephalosporins are derivatives of 7-
aminocephalosporanic acid which is obtained from cephalosporin C
by chemical means. This molecule can be modified at the C-3 and 7
amino position enabling a large number of derivatives to be
produced. In general, alterations at the C-3 position affects
pharmacokinetic behaviour and metabolic stability, and changes at
the C-7 position affect anti-bacterial activity and ~-Iactamase stability.
The cephalosporins are broad-spectrum compounds, although major
differences in their individual spectra of activity exists.
The most commonly used classification of the cephalosporins
is the division into three groups or 'generations' based on
antibacterial activity and resistance to (3-lactamases. 'First
generation' compounds were those initially developed and consist of
parenteral and oral compounds of moderate antimicrobial activity
which are resistant to (3-lactamases from staphylococci but are
unstable to many of those from enterobacteria. Examples of this group
are cephalothin (Griffith and Black, 1964) and cephalexin (Wick,
1967). In the late 1970s, 'second generation' cephalosporins were
developed which are a group of parenteral compounds, such as
cefuroxime (O'Caliaghan et al., 1976) and the cephamycins,
18
Fig. 1.3 The main groups of penicillins (other than
benzylpenicillin) with examples
1) Oral compounds resembling benzylpenicillin
Phenoxymethylpenicillin
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4) Penicillins active against Pseudomonas aeruglnosa
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CooNa
5) f3-lactamase resistant penicillins
Temoclllin ~CHCONH~~C~tz.j- J-~-CCH'
From Lambert and O'Grady(1992)
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cefotetan and cefoxitin (Kosmidis et al., 1973) (Fig.1.4); they exhibit
moderate antibiotic activity but show greater resistance to a wide
range of 13-lactamases. More recently, the 'third generation' of
parenteral and oral cephalosporins have been developed which
combine almost complete stability to most 13-lactamaseswith potent
antimicrobial activity. The first to be introduced was cefotaxime
(Hamilton-Miller et al., 1978); other examples are ceftazidime,
ceftriaxone and ceftizoxime. Latamoxef, a 7-methoxy-oxacephem, is
also a member of this group (Otsuka, 1981) (Fig. 1.4). The 'third
generation' cephalosporins also include compounds, such as
cefoperazone and cefsulodin, which are parenteral antibiotics with
moderate to poor activity against enterobacteria. They are active
against P.aeruginosa and stable to many 13-lactamase types (King
et al., 1980). The chemical structure of examples from each
generation of cephalosporins is shown in Fig. 1.5.
Some semi-synthetic cephalosporins previously mentioned,
such as cefoxitin and latamoxef, and certain isoxazolyl penicillins, for
example cloxacillin, have the ability to inhibit the activity of a narrow
range of 13-lactamases. There are other 13-lactamantibiotics, with
structures fundamentally different from those of penicillins and
cephalosporins, which have potent inhibitory activity against a wide
range of 13-lactamases.These include clavulanic acid, a clavam or
oxapenam, and sulbactam, a penicillanic acid sulphone (Fig. 1.6).
Both these compounds are irreversible 13-lactamase inhibitors, or
'suicide' inactivators, the enzyme and inhibitor initially interacting
competitively and then progressively uniting into a complex in which
both are inactivated (Bush and Sykes, 1983). Clavulanic acid and
sulbactam possess generally poor antibacterial activity but they have
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Fig. 1.4 The chemical structure of cefoxitin and latamoxef
Cefoxitin
Latamoxef
Q-tcCH.aCONH .........-,
~CH.aOCONH,
COOH
FromLambertandO'Grady (1992)
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Fig. 1.5 The chemical structure of examples from the three
generations of cephalosporins
1 s t Cephalothin
0- ss c~oNHn"'l
ryc~ococl1,
COOH
2nd Cefuroxime
3 r d Cefotaxime
From Lambert and O'Grady (1992)
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Fig. 1.6 The chemical structure of clavulanic acid and
sulbactam
Clavulanic acid
Sulbactam
~~C~J-~---l_CH,
o N coca
From LambertandO'Grady (1992)
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favourable pharmocokinetic properties enabling them to be used as
~-Iactamase inhibitors in combination with antimicrobially active, ~-
lactamase susceptible, ~-Iactam antibiotics. Clavulanic acid is
combined with amoxycillin to give the formulation co-amoxiclav or
with ticarcillin. Sulbactam is linked through the carboxyl groups with
ampicillin as sultamicillin, and is also available in an unlinked
combination with ampicillin (Lambert and O'Grady, 1992). Also,
tazobactam, a triazolymethyl penicillanic acid sulphone ~-Iactamase
inhibitor which acts on a variety of clinically important ~-Iactamases,
has been described. It has been shown to markedly enhance the
bactericidal activity of piperacillin (Higashitani et al., 1990). Payne
et al. (1994) recently reported on the comparative activities of
clavulanic acid, sulbactam and tazobactam against clinically
important j3-lactamases. Clavulanic acid and tazobactam were shown
to be more active than sulbactam against conventional-spectrum and
extended spectrum j3-lactamases.There were no differences between
the overall activities of tazobactam and clavulanic acid against these
enzymes, although differences in their inhibition profiles were
observed.
The only carbapenem presently available commercially,
imipenem (N-formimidoyl-thienamycin) (Fig. 1.7), is also a 13-
lactamase inhibitor but more importantly has the additional property of
potent activity against a wide range of Gram positive and Gram
negative aerobes and anaerobes (Kropp et al., 1985). Although
imipenem is stable to most ~-Iactamases, it is readily hydrolysed by a
dehydropeptidase located in the kidney and is therefore administered
with a dehydropeptidase inhibitor, cilastatin (Orusano, 1986). Two
other carbapenems have been recently developed, meropenem (Fig.
1.7) and biapenem. These have antibacterial spectra similar to that of
24
Fig. 1.7 The chemical structure of imipenem, meropenem and
aztreonam
imipenem
meropenem
aztreonam
From Edwards et al. (1989) and Lambert and O'Grady (1992)
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imipenem but are resistant to hydrolysis by human renal
dehydropeptidase (Edwards et al., 1989; Neu et al., 1989; Sader
and Jones, 1993; Aldridge et ai, 1994).
The monobactams, such as aztreonam, are monocyclic ~-
lactam-1-sulphonic acids having a ~-Iactam ring but no fused ring
system (Fig. 1.7). In contrast to imipenem, aztreonam shows little
activity against Gram positive organisms and strict anaerobes, but
potent activity against Gram negative bacteria including
P.aeruginosa (Livermore and Williams, 1981). Aztreonam is not
capable of ~-Iactamase inhibition but is stable to the plasmid-
mediated ~-Iactamases of most Gram negative bacteria (Bush et al.,
1982)
The final group of ~-Iactam agents is the carbacephem class, a
notable example of which is loracarbef; a semi-synthetic, orally
absorbed antibiotic. This compound has been shown to have broad
antibacterial activity with improved ~-Iactamase stability compared to
that of some orally administered cephalosporins (Pelosi and Fontana,
1988).
1:6 In-vitro susceptibility of Bacteroides species to ~-
lactams and other antibiotics
Bacteroides species are almost invariably insusceptible to
benzylpenicillin, with minimum inhibitory concentrations (MICs)
usually exceeding 16 mgtl (Duerden, 1990). This contrasts with most
other clinically important anaerobic bacteria including Prevotella
spp. and Porphyromonas spp. which are normally very susceptible to
benzylpenicillin. The other penicillins and the cephalosporins
(excluding the related cephamycins and oxa-cephems) also generally
show low activity towards Bacteroides species (Sutter and Finegold,
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1976; Rolfe and Finegold, 1981; Clarke and Zemcov, 1983) .
. .
However, bacteroides are more susceptible to some of the
acylureidopenicillins, such as piperacillin and azlocillin, with typical
MICs for B.fragi/is of 8 mgll (Cuchural et al., 1990). The rate of
resistance to piperacillin in the USA has been reported between 8%
and 16%, depending on the geographical source of the isolates
(Cuchural et al., 1988a).
Full sensitivity to benzylpenicillin and other f3-lactam agents
can normally be restored by the addition of f3-lactamase inhibitors.
Clavulanic acid renders most Bacteroides species susceptible. In
one study the MIC50 (minimum concentration required to inhibit at
least 50% of the strains) of amoxycillin against B.tragilis strains was
reduced from 32 mgll to 0.25 mg/I, although there was little effect on
the susceptibility of B.distasonis (Lamothe et al., 1984). Similarly,
sulbactam is capable of restoring the activity of f3-lactam antibiotics
against Bacteroides species. For example, the MIC50 of ampicillin
for clinical isolates was shown by Wexler et al. (1985) to be reduced
from 64 mg/J to 2 mg/l in the presence of sulbactam. Acar et al.
(1993) described piperacillin-resistant strains of B.tragi/is which were
susceptible to the piperacillin/tazobactam combination, the MICs of
piperacillin being reduced from 128 mg/l to 0.25 mgll.
The cephamycins, cefoxitin and cefotetan, are more active than
conventional cephalosporins against Bacteroides species, with
MIC50 of 8 mg/l (Cuchural et al., 1990). Low-level resistance to
cefoxitin (MIC 32 mgll) was recognised in bacteroides immediately
after the introduction of this drug in the late 1970s (Olsson-Liljequist
et al., 1980), while high-level resistance (MIC ~64 mg/l) was first
documented in 1983 (Cuchural et al., 1983). Resistance, however, is
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uncommon; in a recent European study 3% of Bacteroides species
were found to be resistant to cefoxitin and 4% of B.fragi/is strains
resistant to cefotetan, at a break point of 32 mgll (Phillips et al.,
1992). Bacteroides species are also susceptible to the oxa-cephem,
latamoxef, with a greater in-vitro activity compared to cefoxitin as
shown by the MIC50 of 4 mgll (Cuchural et al., 1990). The activity of
the more recently developed cephamycin, cefminox, against species
of Bacteroides is comparable to that of latamoxef and superior to that
of cefoxitin (Watanabe et al., 1985). In general, B.fragi/is and
B.vulgatus are more susceptible to these antibiotics than B.ovatus,
B.distasonis or B.thetaiotaomicron (Jenkins et al., 1982; Betriu et
aI, 1990).
Potent activity is displayed by the carbapenems against
Bacteroides species, with MICSOs of imipenem and meropenem of
0.06 mgll and 0.12 mgll respectively (Brown et al., 1981; Martin et
al., 1982; Edwards et al., 1989). Imipenem resistance is low, with
less than 4% of bacteroides strains reported as insusceptible (Eley
and Greenwood, 1986a; Betriu et al., 1992; Phillips et al., 1992;
Goldstein et al., 1993). The carbapenems, together with the
clavulanate potentiated penicillins, are the most active ~-Iactam
compounds against Bacteroides species (Breuil et ai, 1989; Betriu
et al., 1992; Dubreuil et al., 1992). As described in section 1:5, these
~Iactam antibiotics also possess a good spectrum of activity against
aerobic bacteria.
Of the non-jf-lactarn antibiotics, the nitroimidazoles have good
activity against obligate anaerobic bacteria, with an MICSO of
metronidazole for Bacteroides species of 0.5 mgll (Cuchural et al.,
1990; Mastrantonio et al., 1994). Resistance of Bacteroides species
to metronidazole is rarely reported and may sometimes be due to
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inadequate anaerobiosis (Phillips et al., 1981; Brogan et al., 1989).
Metronidazole, tinidazole and other 5-nitro imidazole compounds
share similar activities which do not extend to facultative anaerobes
or aerobes (Reynolds et al., 1975).
The lincosomide, clindamycin (and to a lesser extent its parent
compound lincomycin) is highly active against Bacteroides species
(M1C50 <0.06 mg/l) and many other anaerobes (Appelbaum and
Chatterton, 1978; Cuchural et al., 1990). These antibiotics also
possess good activity against staphylococci and streptococci. An
increasing problem of clindamycin resistance in Bacteroides species
hast however, been reported in the U.S.A., Spain and France
(Cuchural et al., 1981; Reig et al., 1984; Breuil et al., 1989).
Chloramphenicol and the related thiamphenicol have a broad
antibacterial spectrum with good activity against anaerobic bacteria.
B.tragilis is modestly susceptible to chloramphenicol, with MICs
between 1 mgtl and 8 mg/l (Phillips et al., 1992). Resistance in
B.tragilis is rare, and is due to acetylation of the antibiotic or reduced
permeability (Lambert and O'Grady, 1992).
The usefulness of the macrolides, in particular erythromycin, in
anaerobic infections is questionable because of the in-vitro
resistance, especially among B.tragiJis strains. Assessment of the
clinical potential of macrolides is difficult from in-vitro data because of
the effect of variables in the test system, such as pH, on bacterial
susceptibility (Greenwood et al.,1991).
Aminoglycosides, glycopeptides and quinolones show low or
unreliable activity against many bacteroides strains at concentrations
achievable therapeutically. The tetracyclines exhibit useful activity,
but are associated with high rates of resistance against Bacteroides
spp.; the MIC of tetracycline for over 60% of clinical isolates was
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found to exceed 4 mgll, in .a.recent European study (Phillips et al.,
1992). These agents are, therefore, not regarded as useful agents for
use in infections associated with Bacteroides species.
There is variation in sensitivity amongst the species of
bacteroides. B.fragilis tends to be more susceptible than the other
species to ~-Iactam antibiotics and clindamycin (Jacobus et al.,
1989; Phillips et al., 1992). The in-vitro activities of selected
antibiotics against Bacteroides species are displayed in Table 1.2.
1:7 Penetration of the antibiotic into the bacterial cell
The ability of an antibiotic to reach its site of action is a
prerequisite for drug action. In Gram negative bacteria, the outer
membrane presents a physical barrier to the penetration of antibiotics
into the periplasmic space. Proteins typically make up almost half of
the dry weight of an outer membrane and, with the exception of the
peptidoglycan-bound and free forms of lipoprotein, are individually
named as Omp proteins, after the genes that encoded them. The
outer surface of the membrane is largely occupied by
lipopolysaccharide, while phospholipid makes up the inner surface
(Hancock and Paxton, 1988).
The penetration of ~-Iactam antibiotics through the outer
membrane of Escherichia coli has been shown to occur through
aqueous channels formed by porin proteins, such as Omp C, Omp F
and Pho E (Harder et al., 1981). These proteins are normally
arranged as trimers with each monomeric unit, of molecular weight
between 28 kOa and 48 kOa, contributing a channel. The three
seperate openings of the Omp C and Omp F channels on the outer
surface of the outer membrane merge into a single channel near the
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Table 1.2 In vitro activity of selected antibiotics against
Bacteroides species
MIC (mg/l)
Antibiotic Range MICso MICgO
---------------------------------------------
Imipenem <0.06-8 0.06 1
Amoxycillin-clavulanate 0.5-8 1 2
Ticarciliin-clavuJanate <0.06->128 1 16
Latamoxef <0.12->128 4 128
Cefoxitin 0.5-128 8 16
Cefotetan 0.5->128 8 128
Ceftizoxime <0.25->128 8 128
Cefotaxime 0.5->128 32 >128
Cefoperazone 0.5->128 32 >128
Ceftazidime 2->128 >128 >128
Piperacillin 0.5->128 8 >128
Benzylpenicillin 0.5-~128 16 64
Clindamycin <0.06->256 <0.06 2
Tetracycline 0.125-64 16 32
Chloramphenicol 0.5-8 4 8
Metronidazole <0.25-8 0.5 1
FromCuchuralet al. (1990)and Mastrantonioet al. (1994)
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mid-point of the membrane in contrast to the non-branching
transmembrane channels formed by Pho E protein molecules. The
porins allow diffusion across the membrane of small hydrophilic
compounds within a limited size range (generally up to 600 daltons)
governed by the size of the channel. Most porins do not demonstrate
chemical selectivity for different substances, but they can be either
cation or anion selective. The cation selective Omp F channel in
E.coli favours diffusion of zwitterionic over anionic antibiotics,
whereas for the anion selective Pho E channel this situation is
reversed. The relative proportions of these proteins in the outer
membrane, and the proportion of them that form active pores, vary
with the growth conditions (Hancock, 1987; Hancock and Poxton,
1988).
The outer membrane protein composition of Bacteroides
species is more complex than that of E.coli (Diedrich and Martin,
1981; Kotarski and Salyers, 1984), and until recently no specific porin
molecules in bacteroides had been identified. However, Wexler et al.
(1992), using various sugars in a liposome assay, reported pore-
forming ability of a fraction isolated from the outer membrane of a
B.distasonis strain which was identified as a heat-modifiable protein.
The rank order of the ability of selected f3-lactam antibiotics to
permeate the outer membrane of B.tragi/is was reported by Cuchural
et al. (1988b) with cephaloridine the most rapid followed by
imipenem, cefotaxime, cefoxitin, cephalothin and latamoxef. They
also investigated factors influencing permeability and found results
similar to those described by Yoshimura and Nikaido (1985) for
E.co/i, in which increases in negative charge and molecular weight
are associated with decreased antibiotic uptake. However, unlike the
situation in E.coli, increased drug hydrophobicity was associated
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with increased uptake by B.fragiJis. It has been proposed that the
different effects of hydrophobicity on permeability are due to
dissimilarities in the outer membrane lipopolysaccharide composition.
The contribution of lipopolysaccharide to the barrier effect of the outer
membrane of E.coli has been highlighted by Hiruma et al. (1984).
1:8 Mode 01 action of ~-Iactam antibiotics
The ~-Iactam antibiotics act by selectively interfering with the
cross linking reaction which gives rigidity to the bacterial
peptidoglycan within the cell wall. In Gram negative bacilli, bacterial
death is secondary to this event as continued growth leads to osmotic
rupture of cells which are not protected by an intact wall (Greenwood
and O'Grady, 1972; Lambert and O'Grady, 1992).
The mechanism of this inhibition was highlighted by Spratt
(1975) who observed that bacterial cell membranes contain several
proteins that are able to bind penicillin and other ~-Iactam antibiotics.
These proteins, known as Penicillin Binding Proteins or PBPs,
covalently bind ~-Iactam agents, and are involved in enzymatic
activity in peptidoglycan synthesis.
For E.coli. the species most extensively studied, seven PBPs
have been identified, 1a, 1b, 2, 3, 4, 5 and 6, numbered in
descending order of molecular weight. PBPs 1a, 1b, 2 and 3
represent transpeptidase enzymes which are involved in the different
forms of cross linkage of glycopeptide polymers essential for growth,
septation and division. PBP 1a and 1b are associated with cell
elongation. and inhibition of these enzymes results in spheropfast
formation and rapid lysis. The shape of the bacterial cell is maintained
by PBP 2, selective inhibition of this enzyme causing osmotically
stable ovoid and round forms. PBP 3 is required for septum formation
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at division and inhibition of this PBP results in the production of
filamentous forms. Inhibition of any or all of these essential binding
proteins results in cell death preceded by the characteristic
morphological change (Spratt, 1977a). The other PBPs 4, 5 and 6 are
carboxypeptidases which may control the extent of cross linkage in
the cell wall. They appear to be non-essential and unconnected with
the antibacterial effect of t}-Iactams (Amanuma and Strom inger,
1980).
The t}-Iactam antibiotics vary with regard to their relative
affinities for the essential binding proteins 1, 2 and 3 of E.coli K-12.
Few act primarily through PBPs 1a and 1b, although, at low
concentrations, cephaloridine binds preferentially to PBP 1a (Curtis
et al., 1979). Some t}-Iactam agents, including cephalexin,
cephradine, temocillin and aztreonam, bind only to PBP 3. When
present in sufficient concentrations, however, most other t}-Iactam
antibiotics also bind to other sites including PBPs 1a, 1band 2
(Lambert and O'Grady, 1992). Imipenem and meropenem bind
preferentially to PBP 2, but they also bind to PBP 1. Meropenem,
unlike imipenem, also has high affinity for PBP 3 (Kitzis et al., 1989).
In contrast, mecillinam binds exclusively to PBP 2 (Spratt, 1977b).
The PBPs of Bacteroides species have not been studied so
extensively as those of E.coli and these findings often appeared
conflicting and inconclusive. Botta et al. (1983) and
Georgopapadakou et al. (1983) investigated the PBP profile of
B.fragilis strains and consistently observed three PBPs with
molecular weights between 76 kDa and 53 kDa, and 100 kDa and 68
kDa respectively, although additional PBPs of 78 kDa and 32 kDa
were occasionally detected by Georgopapadakou et al.. Four
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species of bacteroides were examined by Piddock and Wise (1986)
who found five PBPs in B.fragilis, B.thetaiotaomicron and B.ovatus,
and six PBPs in B.vulgatus. All species studied possessed three
major high molecular weight PBPs, 1, 2 and 3 between 58 kOa and
82 kOa. PBP 1 could be divided into two components, 1a and 1b, for
all the species tested except for a.tragil/s which had a third
component 1c. In addition, with the exception of a.tragi/is, all species
examined possessed low molecular weight PBPs below 50 kOa.
Yotsuji et al. (1988) also reported that B.tragilis had five high
molecular weight PBPs, between 94 kOa and 72 kOa. More recently
Wexler and Halebian (1990) investigated the PBPs of nine
Bacteroides species and found that each species had a distinctive
PBP pattern, although variations within species was seen. Generally,
five PBPs were visualised, ranging in molecular weight from 90 kOa
to 40 kOa, with one or more bands in the PBP 1 region and PBP 2
appearing fainter than the other PBP bands.
The PBPs of Bacteroides species differ from those of Ecoli in
terms of affinity for ~-Iactam antibiotics and in the morphological
consequences of inhibition of these proteins. The primary target in
bacteroides for most ~-Iactam antibiotics is PBP 2 which is involved in
septation and corresponds to PBP 3 of Ecoli. The PBP 1 complex is
usually the secondary target site and is associated with cell
elongation corresponding to PBP 1 of Ecoli. Compounds such as
imipenem and meropenem bind initially to PBP 3, causing round
cells, and then to PBP 2. PBP 3 in bacteroides, therefore, is
equivalent to PBP 2 in Ecoli and is involved in cell shape. Imipenem
also binds to PBP 1 at concentrations correlating with the MIC.
(Georgopapadakou et al., 1983; Piddock and Wise, 1986).
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1: 9 Mechanisms of resistance to ~-Iactam antibiotics
In order to inhibit Gram negative bacteria, f3-lactam antibiotics
must be able to penetrate the outer membrane, pass through the
periplasmic space, and arrive with undiminished potency at the PBPs
in the cytoplasmic membrane. Covalent binding with the PBPs has
then to occur for the lethal affect to take place. Mechanisms of
resistance which interfere with this chain of events are: inactivation of
the antibiotic; blockage of transport of the agent into the cell; and
alteration of target sites.
1: 10 Inactivation of the antibiotic by enzymic attack
The most common mechanism of resistance to f3-lactam
antibiotics is degradation of these compounds by the bacterial
enzymes amidases, esterases and, most importantly, f3-lactamases.
The sites of enzymic attack in penicillins and cephalosporins are
shown in Figs. 1.8 and 1.9.
Amidases attack penicillins by cleaving the CO-NH bond at the
6-amino position of the f3-lactam ring resulting in 6-aminopenicillanic
acid which retains some antibacterial activity. The corresponding
cephalosporin amidase also exists. These enzymes are not thought to
play an important role in f3-lactamresistance in vivo.
Deacetylation of cephalosporins containing an acetoxymethyl
group side chain at the 3 position of the dihydrothiazine ring, for
example cefotaxime, can take place as a result of esterase activity in
the mammalian liver and kidney. The end products of this reaction
exhibit reduced antibacterial activity, as in the case of
desacetylcefotaxime. The role of esterases in cephalosporin
resistance in vivo is not clear.
The most important type of resistance to f3-lactamantibiotics in
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Fig. 1.8 Sites f.0 enzymic attack in penicillins
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Fig. 1.9 Sites of enzymic attack in cephalosporins
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clinical medicine is that due to ~-Iactamase enzymes. These enzymes
hydrolyse the ~-Iactam ring 'and render the antibiotic inactive. ~-
Lactamases hydrolyse penicillins to form the corresponding
penicilloic acid. Cephalosporins are hydrolysed to produce a
cephalosporoic acid which survives only transiently before
breakdown into smaller fragments (Sykes and Matthew, 1976).
1: 11 Classification of ~-Iactamases
The ~-Iactamases of Gram positive and Gram negative bacteria
differ fundamentally. Gram positive organisms produce only a few
types of inducible exoenzymes which inactivate most penicillins,
except for the isoxazolylpenicillins, methicillin and nafcillin, and are
much less active against most cephalosporins (Greenwood, 1986).
In contrast, ~-Iactamases of Gram negative bacteria are a large
heterogeneous group with diverse physico-chemical properties which
are soluble enzymes largely located in the periplasmic space. Jack
and Richmond (1970) presented the first comprehensive classification
scheme of ~-Iactamases from Gram negative organisms. The
parameters used for characterising these enzymes were substrate
profiles, inhibition by p-chloromercuribenzoate (pCMB) and
cloxacillin, the neutralisation by an antiserum prepared against ~-
lactamase from E.coli with a TEM plasmid, and their electrophoretic
mobility in starch gel at pH 8. This system was modified by Richmond
and Sykes (1973) mainly by adding other ~-Iactam antibiotics,
carbenicillin and cephalexin, to the substrate profiles and by including
data on molecular weight. By these criteria, ~-Iactamases were
differentiated into five main classes, I to V. This scheme was then
expanded by Sykes and Matthew (1976) by including pi values
derived from isoelectric focusing and emphasizing the genetic
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location of these enzymes (Table 1.3).
The newer methodologies of amino acid and nucleotide
sequencing, together with enzymatic analysis, have been used to
distinguish three evolutionary classes of ~-Iactamases (Ambler,
1980). Class A ~-Iactamases have a serine residue at their active site,
have molecular weights of around 29 kOa, show significant amino
acid sequence homology and preferentially hydrolyse penicillins. The
common plasmid-encoded TEM-1 and TEM-2 enzymes are included
in this group. The class B ~-Iactamases are metallo-enzymes with
molecular weights of about 23 kOa, which require a metal co-factor
and attack cephalosporins. Class C enzymes are high molecular
weight proteins, approximately 39 kOa, which incorporate the
chromosomal mediated cephalosporinases refered to as class I in the
Richmond and Sykes classification scheme. They also have serine at
their active site, but have no sequence homology with class A ~-
lactamases.
More recently, Bush (1989a) has put forward an extended
classification scheme for ~-Jactamases. The criteria used for this
scheme was based on recommendations made by Bush and Sykes
(1986) which include substrate and inhibitor profiles, physical data,
inducibility characteristics and genetic location. By these means nine
types of ~-Iactamases are defined, 1, 2a, 2b, 2b' ,2c, 2d, 2e, 3 and 4
(Table 1.4). Group 1 are cephalosporinases which are not inhibited
by clavulanic acid and are almost always chromosomal in origin.
Their molecular weights are generally over 30 kOa and their
isoelectric points are basic. Group 2a are penicillinases inhibited by
clavulanic acid which include those from Gram positive organisms. t3-
Lactamases from group 2b exhibit broad spectrum activity,
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Table 1.3. Summary of the classification of f3-lactamases
from aerobic Gram negative bacteria
Substrate Genetic Genetic Inhibited by Found in
Class characteristics location control cloxacillin pcmb*
cephalosporins chromosome inducibleJ
constitutive
+ * *
III # penicillinsJ plasmid constitutive
cephalosporins
+
E.coll
Proteus spp.
Enterobacter spp.
Citrobacter spp.
Pseudomonas spp.
Serratia spp.
E.coll
P.mirabilis
many
Enterobacteriaceae
Pseudomonas spp.
H.influenzae
N.gonorrhoeae
+ Klebsiella spp.
Enterobacter spp.
II penicillins chromosome constitutive +
IV penicillinsJ chromosome constitutive
cephalosporins
V penicillins
including
methicillin and
isoxazolylpenicillins
plasmid constitutive - Pseudomonas spp.
-----------------~-----------------------------------------
* pcmb = p-chloromercuribenzoate
** = not inhibited by clavulanic acid
# = group III includes the TEM enzymes
Based on Richmond and Sykes (1973)
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Table 1.4 General classification scheme for bacterial
B-Iactamases
inhibited by
Group Subtitle Prefered substrate CfiJ. EDTA Representative enzyme(s)
---------------------------------------------------------
1 CEP·N Cephalosporins No No Chromosomal enzymes from
Gram-negative bacteria
2a PEN·Y Penicillins Yes No aram-pcetnve
penicillinases
2b BDS-Y Cephalosporins, Yes No TEM-1, TEM-2, SHV-1
penicillins
2b' EBS-Y Cephalosporins, Yes No TEM-3, TEM-5, SHV-2,
penicillins, cefotaxime SHV-3
2c CAR·Y Penicillins, Yes No PSE-1, PSE-3, PSE-4
carbenicillin
2d CLX·Y Penicillins, yesb No OXA-1, PSE-2
cloxacillin
2e CEP-Y Cephalosporins Yes No Proteus vulgaris
3 MET-N Variable No Yes Bacillus cereus II,
Pseudomonas maltophilla L1
4 PEN·N Penicillins No ?c Pseudomonas cepacla
-----------------------------------
a 10 JlM clavulanic acid
b Inhibition by clavulanic acid may occur at higher concentrations for some
members of the group
c Variable
From Bush (1989a)
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hydrolysing both penicillins and cephalosporins, but are inhibited by
clavulanic acid. They tend to "have mole_cularweights lower than 30
kOa and include TEM-1and TEM-2 enzymes. Group 2b' includes ~-
lactamases capable of hydrolysing the extended-broad spectrum ~-
lactam antibiotics such as cefotaxime and aztreonam, and are
inhibited by clavulanic acid (Bush, 1989b). Groups 2c and 2d are ~-
lactamases which hydrolyse carbenicillin or cloxacillin respectively
and are generally inhibited by clavulanic acid. Group 2e are
cephalosporinases separate from group 1 which are inhibited by low
concentrations of clavulanic acid. The metallo-enzymes are
represented by group 3, which are inhibited by EDTA with activity
restored by divalent cations (commonly Zn2+), and are not inhibited
by clavulanic acid. Finally, group 4 contains unusual penicillinases
which are not inhibited by clavulanic acid (Bush, 1989c).
1: 12 ~-Lactamases of Bacteroides species
Garrod (1955) was the first to report the penicillin-destroying
activity of B.fragilis, showing that two out of 31 strains examined were
able to destroy penicillin in solution. In 1968, Pinkus et al.
documented the production of ~-Iactamases by 14 penicillin-resistant
strains in a collection of 29 isolates of B.fragi/is. The first
characterisation of a ~-Iactamase produced by a strain of B.fragilis
exhibiting high level ampiCillin resistance was provided by Anderson
and Sykes (1973). They showed that the enzyme was a
cephalosporinase rather than a peniCillinase, that it was not inducible
and that its production correlated with high level resistance to ~-
lactam antibiotics. Olsson et al. (1977) reported that most
bacteroides strains (87%) produced small amounts of a constitutive ~-
lactamase, and 6% of strains produced elevated amounts of 13-
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Jactamase which correlated with high resistance to f3-Jactam
antibiotics. In 1988, Aldridge· et al. identified 97% of 246 B.fragilis
isolates from the USA that produced f3-lactamases of some type. A
more recent survey in the USA has shown that at least 90% of all
B.fragilis group strains produce f3-Jactamaseand that 25% produce
high levels (Cornick et al., 1990). The increasing frequency of
isolation of high-Jevel f3-lactamase-producing strains suggest a trend
towards high-level f3-Jactamaseproduction in Bacteroides species.
The production of f3-lactamases by Bacteroides species has
been shown in some strains to be highly dependent on growth phase:
enzyme production increases sharply during the logarithmic phase of
growth to reach a maximum in the pre-stationary phase before
declining again during the stationary phase (Olsson et al., 1976;
Edwards and Greenwood, 1990). Results from studies of the location
of f3-lactamase in B.tragi/is indicate that the enzymes are largely cell
associated, within the periplasmic space, and can be released by
osmotic shock (Britz and Witkinson, 1978).
Futher characterisation of the common f3-lactamases from
B.tragi/is have shown them to have a molecular weight of 30 kOa to
40 kOa, and to be inhibited by cloxacillin, pCMB and clavuJanic acid
(Olsson et al., 1976; Wise, 1977; Britz and Wilkinson,' 1978).
Cefoxitin, latamoxef and imipenem are typically resistant to hydrolysis
by these enzymes (Brown et al., 1981). Timewell et al. (1981)
reported on the f3-lactamases from B.tragi/is , B.thetaiotaomicron,
B.vulgatus and B.unitormis and found species differences in terms
of substrate profile and pi values which ranged between 4.9 for
B.tragi/is and 4.25 for B.thetaiotaomicron. They did, however. share
the general characteristics previously described.
These properties differ from those of f3-lactamasesfrom aerobic
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bacteria. Bacteroides ~-Iactamases do, however, bear some
..
resemblance to the enzymes of Richmond and Sykes class I, except
in terms of inhibition by pCMB and clavulanic acid (Timewell et al.,
1981). An additional class (VI) of the Richmond and Sykes scheme
was put forward by Neu (1986) to accommodate ~-Iactamases from
Bacteroides species. Typical ~-Iactamases produced by B.fragi/is
strains have been placed in group 2e of the Bush classification
scheme (Britz and Wilkinson, 1978; Yotsuji et al., 1983; Bush,
1989c). Recently, Rogers et al. (1993) characterised the
cephalosporinase gene cepA from B.tragi/is with high specific
activity and showed that these typical ~-Iactamases formed a distinct
subgroup of Ambler class A enzymes.
A wide variety of ~-Iactamases from bacteroides which are not
typical of those commonly encountered have been reported. Also,
although most of the genes for ~-Iactamases in the bacteroides are
located on the chromosome, plasmid mediated enzymes have been
identified. Sato et al. (1982) described a ~-Iactamase produced by a
B.tragi/is strain which was a potent penicillinase, had weak
cephalosporinase activity, was inhibited by pCMB and had an
isoelectric point of 6.9. In this case, ~-Iactamase production was found
to be transferable and this was considered to be plasmid mediated.
This enzyme has been designated a member of group 2d of the Bush
classification scheme (Bush, 1989c). Cefoxitin resistance transfer has
been reported in a strain of B.thetaiotaomicron, although the
mechanism of the resistance for this isolate was not determined
(Rashtchian et al., 1982). Cuchural et al. (1983) also described
atypical ~-Iactamases from strains of B.tragi/is which were able to
inactivate cefoxitin and were resistant to clavulanic acid. One of these
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strains, TAL 4170, was later shown to transfer ~-Iactamase-mediated
cefoxitin resistance to cl 'susceptlbte B.fragiJis recipient by
conjugation (Cuchural et al., 1986a). Another cephalosporin-
hydrolysing B.fragi/is tJ-lactamase which was not inhibited by
clavulanic acid has been reported and assigned to group 1 of the
Bush classification scheme (Sato etal., 1980; Bush, 1989b).
A 'new class' of tJ-lactamase from B.fragi/is, which inactivated
a wide range of ~-Iactam substrates usually considered stable to
hydrolysis including cephamycins and carbapenems, was reported by
Cuchural et al. (1986b). These enzymes were inhibited by the ion
chelator ethylenediaminetetraacetic acid (EDTA), and zinc ions
completely reversed this inhibition. Clavulanic acid did not inhibit ~-
lactamase activity. A metallo-p-lactamase with similar properties from
a B.fragi/is strain was reported by Bandoh et al. (1991). This
enzyme also hydrolysed carbapenems and cephamycins and was not
susceptible to clavulanic acid. Inactivation of the enzyme by EDTA
was completely reversed by the addition of zinc ions. A tJ-lactamase
described by Ajiki et al. (1991) required zinc as a co-factor and
hydrolysed imipenem and broad-spectrum cephem antibiotics of the
cefotaxime type. These compounds were more rapidly hydrolysed
than penicillin G.,The most stable ~-Iactam antibiotics tested were
cephamycins. It was concluded that this metallo-p-lactarnase
belonged to the same category of enzymes reported by Cuchural et
al. (1986b). More recently, Hedberg et al. (1992) also characterised
an imipenem hydrolysing rnetallo-p-lactamase from a B.fragi/is
strain. The substrate profile of this enzyme differed from that
described by Bandoh et al. (1991), while other characteristics such
as inhibition profiles and physical properties were similar. All these
enzymes caused substantial resistance to imipenem (MICs ~100
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mgtl), had pi values in the range from 4.5 to 5.2 and molecular
weights between 25 kOa and 33 kOa when determined by sodium
dodecylsulphate polyacrylamide gel electrophoresis. These metallo-
B-Iactamases belong to Ambler's molecular class B and the functional
Bush group 3 (Yang et al., 1992). Earlier, Yotsuji et al. (1983)
reported a potent B-Iactamase produced by a B.fragilis strain which
had a similar substrate profile to that described by Cuchural et al.
(1986b), being capable of hydrolysis of cephamycin derivatives and
imipenem, and not susceptible to clavulanic acid. However, EDTA
inhibition was not mentioned in their report. Similarly, Eley and
Greenwood (1986a,b) described three clinical isolates of B.tragi/is
which produced B-Iactamases capable of rapid hydrolysis of
imipenem and were resistant to clavulanic acid. The affect of EDTA on
the activity of these enzymes was not examined. The carbapenemase
producing isolates of B.tragi/is examined by Yotsuji et al. (1983) and
Eley and Greenwood (1986a,b) showed low to intermediate levels of
resistance to imipenem (MICs 0.25 mg/l to 32 mg/l).
Direct sequencing or probing has confirmed the presence of
highly homologous metallo-B-Iactamase ccrA and ctiA genes in 11
clinical isolates of B.tragi/is from USA, UK and France (Rasmussen
et al., 1990; Thompson and Malamy, 1990; Rasmussen et al., 1991;
Podglajen et al., 1992a). By DNA sequencing analysis, Rasmussen
et al. (1992) revealed that metallo-B-Iactamases produced by three
B.tragilis strains with different MICs (16-fold range for imipenem)
differed at five amino-acid residues. These three enzymes were
overexpressed, purified and their kinetic values for a variety of B-
lactam antibiotics determined. By these means, it was found that the
five amino-acid substitutions only modestly affected the hydrolysing
activity of these B-Iactamases. Podglajen et al. (1990) described the
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selection of imipenem resistance, associated with zinc B-Iactamases,
in B.fragi/is isolates which initially appeared moderately susceptible
to imipenem. By use of a DNA probe they have subsequently shown
that 2.2% of the 550 B.tragi/is clinical isolates studied carried the zinc
carbapenemase gene (cfiA). Two-thirds of these ctiA genes were
described as silent, being associated with non highly resistant strains
for which the MICs of imipenem were ~2 mgll (Podglajen et a/.,
1992b). It was concluded that differences in susceptibilities were
governed by the level of expression of these metallo-p-lactarnase
genes.
Until recently, transfer of metallo-B-Iactamase of bacteroides
had not been observed. Genes coding for B.tragi/is rnetatlo-p-
lactamases have been shown by Thompson and Malamy (1990) to be
present on the chromosome. However, in 1992, 8andoh et al.
reported on a strain of B.fragi/is containing a metallo-p-lactamase
gene on a small plasmid tranferable by conjugation. This situation
greatly increases the potential for spread of the enzyme.
Imipenem resistance (MIC 16 mgll) in a B.distasonis isolate
was attributed by Hurlburt et al. (1990) to the production of an
unusual imipenem inactivating serlne-p-lactamase together with
impermeability. This enzyme, with a molecular mass of 160 kDa, was
inhibited by clavutanic acid and sulbactam, but not EDTA.
Further attempts have been made to classify the wide variety of
B-Iactamases encountered in bacteroides strains. Eley and
Greenwood (1986b) examined the characteristics of type culture
strains of Bacteroides species and bacteroides strains known to
hydrolyse cefoxitin, latamoxef or imipenem. They defined three broad
groups of t}-Iactamases based on antibiotic degradation and inhibitor
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profiles: those enzymes that do not inactivate cefoxitin, latamoxef and
imipenem and were susceptible j3-lactamase inhibitors; those that
hydrolyse cefoxitin and latamoxef but not imipenem and were less
susceptible to inhibitors; and those that inactivated all three antibiotics
and were not inhibited by j3-lactamase inhibitors. In another study,
Eley and Greenwood (1986a) characterised the j3-lactamases
produced in raised amounts by clinical isolates of bacteroides. These
enzymes were divided into three groups using the additional criterion
of specific cephalosporinase activity (/J moles nitrocefin degraded per
min per mg protein): those of low specific activity which were
susceptible to j3-lactamase inhibitors; enzymes of intermediate
specific activity which hydolysed cefoxitin, latamoxef and sometimes
imipenem and were insusceptible to inhibitors; and those of high
specific activity which were susceptible to j3-lactamase inhibitors but
incapable of inactivation of 13-lactamasestable 13-lactamantibiotics.
1:13 Reduction of penetration the antibiotic
The role of porins in the outer membrane permeation of 13-
lactam antibiotics has been extensively studied in Gram negative
aerobic bacteria (Nikaido, 1989). Sawai et al. (1982) found
diminished uptake. of cephazolin in porin-deficient mutant strains of
Proteus mirabilis and Enterobacter cloacae. Mitsuyama et al.
(1987) examined porins from cefoxitin-resistant mutants of Proteus,
Morganella and Providencia species and established their role in
the permeation of j3-lactam antibiotics. Similarly, Godfrey and Bryan
(1987) found diminished permeation of 13-lactam antibiotics in a
mutant of P.aeruginosa with a structurally modified porin.
The role of permeability barriers in j3-lactam antibiotic
resistance in Bacteroides species has been observed indirectly.
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Results from crypticity measurements (the ratio of 13-lactamaseactivity
of broken cells to the activity of intact eelts), with cephaloridine as
substrate, have indicated that limited outer membrane permeability to
13-lactamantibiotics contributed to resistance in certain strains of
B.tragiJis (Olsson et al., 1979). Dornbusch et al. (1980) examined
strains of B.tragiJis with decreased sensitivity to cefoxitin and found
no correlation between 13-lactamaseproduction and resistance to
cephamycins. They postulated that changes in the cell wall, causing
decreased penetration of the antibiotic, could be a resistance factor.
Crosby and Gump (1982) used EDTA to increase the permeability of
the cell wall in an attempt to assess the importance of impermeabilty
of this wall in terms of antibiotic resistance. The addition of EDTA
significantly enhanced the activity of cefoperazone against 13-
lactamase negative as opposed to 13-lactamasepositive bacteroides.
From this they concluded that cell impermeability was a major
mechanism of resistance of cefoperazone in 13-lactamasenegative
isolates. Malouin and Lamothe (1987) found a significant increase of
susceptibility of bacteroides to cephalosporins with EDTA, indicating
a role for a permeability barrier. Also, Cuchural et al. (1986b)
reported 13-lactamase mediated imipenem resistance in B.tragilis
associated with a barrier to drug permeation determined by crypticity
measurements. Imipenem resistance in P.aeruginosa has been
shown to be associated with outer membrane protein composition
and decreased permeability (Buscher et al., 1987; Trias et al.,
1989).
Evidence of the association between cefoxitin resistance and
alteration of the porin proteins in Bacteroides species was put
forward by Piddock and Wise (1987). They described two cefoxitin
resistant strains, one of which was B.fragi/is and the other
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B.thetaiotaomicron, in whlch resistance was not ~-Iactamase
mediated but related to alteration in outer membrane protein profiles
together with PBP changes. An outer membrane protein, possibly a
porin protein, of molecular weight approximately 50 kOa was absent
from both strains.
A correlation between lipopolysaccharide structure and
resistance due to lack of permeability of ~-Iactam antibiotics in
Bacteroides spp. has not been demonstrated. However, this has
been shown with P. aeruginosa (Godfrey et al., 1984).
1: 14 Alteration of penicillin binding proteins
In many species of aerobic Gram negative bacteria, the
modification of PBP affinity has been shown to result in ~-Iactam
antibiotic resistance (Malouin and Bryan, 1986). However, there is
less evidence of changes in particular penicillin binding proteins as a
resistance mechanism in Bacteroides species. Bacteroides species
are naturally resistant to monobactam antibiotics because of the poor
affinity of these compounds for any of the PBPs. Aztreonam has been
shown to bind poorly or undetectably to all PBPs of B.tragi/is
(Georgopapadakou et al., 1982).
Georgopapadakou et al. (1983) were the first to report
reduced affinity for piperacillin, cefoperazone, cefotaxime, ceftazidime
and imipenem to PBP 2 in a resistant strain of B.tragilis. Changes in
the affinity of PBP 1 or PBP 2 in laboratory derived mutants have also
been correlated with a decrease in susceptibility to cefoxitin (Piddock
and Wise, 1987). Yotsuji et al. (1988) proposed that decreased
affinity for PBP 3, and not ~-Iactamase hydrolysis or membrane
permeation, was the important factor in the resistance to ceftezole,
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cefazolin and cephalothin in a B.fragi/is strain. More recently, Wexler
and Halebian (1990) reported changes in both the PBP-1 complex
and the affinity of one of the PBP-1 proteins for cefoxitin between
cefoxitin sensitive and resistant strains of B.thetaiotaomicron.
Resistant strains of B.uniformis also showed changes in the PBP-1
complex in comparison with sensitive strains. In addition, they
showed that a laboratory derived cefoxitin resistant mutant of
B.distasonis displayed reduced binding to the PBP-1 complex
compared with its wild type parent and cefoxitin sensitive revertant.
No obvious changes in outer membrane profiles were detected to
indicate changes in permeability.
1: 15 Aims of study
This study set out to investigate the mechanisms by which
Bacteroides species can resist the antibacterial activity of f3-lactam
antibiotics. It was proposed to determine initially the prevalence of f3-
lactam resistance by evaluation of current susceptibility patterns of
randomly selected clinical isolates of Bacteroides species to certain
f3-lactam antibiotics. The degree of f3-lactamase production of these
strains was also examined. The findings were compared with those of
previous studies to determine any changes in these values with time.
The role of f3-lactamases activity in the resistance of the
bacteroides isolates was assessed. f3-Lactamases from the
bacteroides isolates were examined in terms of a range of physical
and chemical properties. These findings were used to categorise the
f3-lactamases in order to clarify the problematic classification of f3-
lactamases from Bacteroides species.
Mechanisms of resistance of bacteroides to f3-lactam
antibiotics, other than that due to f3-lactamase activity, are poorly
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defined. The outer membrane structure has only been examined in a
few resistant strains. Scanty reports refer to changes in porin proteins
in association with antibiotic resistance, and the lipopolysaccharide
composition has not been implicated. The PBPs of Bacteroides
species have not been studied extensively and results have often
been conflicting. A few studies have described reduced affinity for J3-
lactam antibiotics to the PBPs of resistant bacteroides strains.
However, only a limited number of antibiotics and Bacteroides
strains have been investigated.
In an attempt to clarify this situation, mechanisms of resistance
were explored in detail in B.tragi/is strains with increased resistance
to carbapenems. Carbapenemase activity was determined and these
J3-lactamases investigated further. Isolates exhibiting non-s-
lactamase mediated resistance were identified and their resistance
mechanisms examined. Reduction in antibiotic penetration into the
bacterial cell was investigated. The PBPs of these isolates were
detected and compared to those of normal sensitive B.tragi/is strains.
The interaction of these means of resistance was also considered.
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Ct:tAPTER.2
MATERIALS AND METHODS
2: 1 Growth media and incubation conditions
The following media were used throughout the study:
(i) Horse blood agar (blood agar base No.2 (Unipath Ltd.,
Basingstoke, Hampshire) containing 7% horse blood (Tissue Culture
Services Ltd., Buckingham».
(ii) Brain Heart Infusion with supplements (BHIS) comprising
Brain Heart Infusion broth (Unipath), yeast extract 5 gil (Unipath),
haemin (Sigma Chemical Co. Ltd., Poole, Dorset) 5 mg/l and
menadione (Sigma) 1 mgll. BHIS agar was obtained by the addition
of 1% agar No.1 (Unipath).
Throughout the study, anaerobic incubation was carried out at
370e in a Mark 2 Don Whitley anaerobic cabinet (Don Whitley
Scientific Ltd, Shipley, Yorkshire) with a gas mixure of 10% hydrogen,
10% carbon dioxide and 80% nitrogen.
All media were pre-reduced overnight in the anaerobic cabinet
before use.
2:2 Bacterial strains
Clinically significant isolates of anaerobic Gram negative bacilli
were collected randomly from specimens submitted to Nottingham
Public Health Laboratory in 1989 and 1990. These strains were
originally isolated on horse blood agar containing neomycin at a
concentration of 60 mg/l. They were then subcultured to horse blood
agar with a metronidazole disc (5J,1g/disc)and checked for purity after
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anaerobic incubation for 48 hours.
Bacteroides strains wete distinguished from other anaerobic
Gram negative bacilli by their ability to hydrolyse aesculin and by their
tolerance to bile. They were identified to species level, if possible, by
the use of carbohydrate fermentation and indole production tests.
These results were compared with the identification scheme
described by Duerden (1990) which is summarised in Table 2.1.
Aesculin hydrolysis was tested by the method of Phillips (1976)
modified to include a test for bile tolerance. Horse blood agar plates
containing 20% bile were spread with a ferric citrate-aesculin solution
to give a final concentration of 0.1% aesculin and spot-inoculated.
After 48 hours of anaerobic incubation, bile tolerance was detected by
growth of the organisms and aesculin hydrolysis by blackening of the
medium.
The fermentation of glucose, rhamnose, trehalose, salicin and
mannitol was assessed by the methods described by Phillips (1976).
A sterile 20% solution of carbohydrate substrate was spread over the
surface of a horse blood agar plate and allowed to dry. Test cultures
were spot inoculated and the plates incubated anaerobically for 48
hours. A control horse blood plate was also included. Fermentation of
the carbohydrate-was indicated by a zone of haemolysis.
Equivocal carbohydrate fermentation reactions were repeated
with Difco (Bacto) Differentiation Disks (Difco Laboratories, West
Molesey, Surrey). The surface of a horse blood agar plate was spread
with the test strain suspension in SHIS broth to produce a confluent
growth. The filter paper Differentiation Disks, impregnated with a
carbohydrate, were placed on the agar (2 per plate) and the plates
incubated anaerobically for 48 hours. Carbohydrate fermentation was
detected by enhanced bacterial growth around the disc together with
57
Table 2.1 Identification scheme for Bacteroides species
Production of acid from: Indole
production
Species Glucose Rhamnose Trehalose Salicin Mannitol
B.fragills +
B.ovatus + + + + + +
B. thetaiotaomicron + + + + +
B.dlstasonis + + /- + +
B.vulgatus + +
B. unitormis + + +
B.caccae + + +
B. eggerthii + + + +
B.merdae + + +
B. stercorls + + +
From Duerden (1990)
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a decrease in pH indicated by a colour change to yellow after the
addition of one drop of 0.5% phenol red onto the disk.
The test for indole production was carried out as described by
Summanen et al. (1993). One ml of xylene was added to 2 ml of
cooked meat broth (Unipath) culture and mixed well. Ehrlich's reagent
was then added and the development of a pink colour indicated a
positive reaction.
When the results of the above tests proved difficult to interpret
or were persistently equivocal, identification of the bacteria was
obtained by the ATB 32 A system (API-bioMerieux, Basingstoke,
Hampshire) which consists of 29 cupules containing dehydrated test
substrates. The system was used according to the manufacturer's
instructions.
Those clinical isolates identified as species of Bacteroides
were then maintained in duplicate. Pure bacteroides cultures were
harvested from horse blood agar plates and a heavy inoculum was
emulsified into 1.5 ml of skimmed milk (Unipath) in plastic vials which
were then frozen at -70°C.
In addition to these recently isolated clinical strains of
bacteroides, five B.fragilis strains from previous studies were used in
certain sections of the present study (Eley and Greenwood, 1986a,b):
B.fragiJis 0423, originally supplied by V. L. Sutter (Wadsworth
Veterans Administration Medical Centre, Los Angeles, USA),
B.fragi/is 2013E, donated by I.N. Simpson (Glaxo Ltd, Greenford,
Middlesex) and B.fragi/is 57, 97 and 119, clinical isolates from the
Nottingham Public Health Laboratory. Also, B.fragiJis NCTC 9344
was used as a control strain throughout the study. These four strains
were maintained in skimmed milk at -70°C as previously described.
Test strains were reconstituted by touching the surface of the
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frozen skimmed milk bacterial suspension with a hot loop and
spreading the bacteria on a horse blood agar plate which was then
incubated anaerobically. The vial containing the frozen bacteria was
immediately replaced at -70oC after use without thawing.
2: 3 Semi-quantif,ication of ~-Iactamases in intact bacteria
Cephalosporinases were detected by a colour change
resulting from the hydrolysis of the chromogenic cephalosporin
nitrocefin as described by Aldridge et al. (1983). A solution
containing nitrocefin 250 mgll was prepared by dissolving lyophilised
nitrocefin (Unipath) in rehydration fluid (Unipath) containing 0.1M
phosphate buffer (pH 7.0) and dimethylsulphoxide. Three drops of
this solution were added to a microtitration tray well and seeded with
several colonies from an overnight culture grown on BHIS agar. The
presence of cephalosporinase was indicated by a colour change from
yellow to red at room temperature which was quantified visually over
a one hour period.
The method of Escamilla (1976), which relies on the pH
change resulting from the hydrolysis of benzylpenicillin to peniCilloic
acid, was used to detect the presence of penicillinase. A penicillin -
phenol red reagent was prepared by dissolving 560 mg
benzylpenicillin in 4.5 ml of distilled water and adding 0.5 ml of a
0.5% aqueous solution of phenol red. One drop of 1M sodium
hydroxide was then added to give a violet colour at pH 8.5. Three
drops of the penicillin - phenol red reagent were added to each well
of a microtitre tray and seeded as before. The extent of a colour
change from red to yellow was visually assessed during incubation at
room temperature for one hour.
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2: 4 Antibiotics and antibiotic titr-ations
Solutions of benzylpenicillin sodium salt (Glaxo), clavulanic
acid lithium salt (SmithKline Beecham Pharmaceuticals, Brentford,
Essex), cefoxitin sodium salt (Merck, Sharp and Dohme Ltd,
Hoddesdon, Hertfordshire), latamoxef disodium salt (Eli Lilly and Co.
Ltd, Basingstoke, Hampshire), sulbactam sodium salt (Pfizer Ltd,
Sandwich, Kent) and cloxacillin sodium salt (SmithKline Beecham)
were freshly prepared as required in sterile distilled water.
Appropriate concentrations of imipenem (Merck, Sharp and Dohme)
were dissolved in 0.01 M phosphate buffer, pH 7.0.
Mininum inhibitory concentrations (MICs) were determined for
the clinical isolates of bacteroides by the agar incorporation method.
Serial doubling dilutions of antibiotic were incorporated in BHIS agar.
Overnight cultures of test and control strains in BHIS broth were
diluted 1 in 10 with fresh BHIS broth. These were spot inoculated on
to the antibiotic-containing plates by use of a multipoint inoculator
(Denley Instruments, Billingshurst, Sussex) resulting in an inoculum
of approximately 105-106 bacteria per spot. An antibiotic-free control
plate was also included. The plates were incubated anaerobically for
48 hours and the MIC was taken as the lowest antibiotic concentration
that completely inhibited growth.
2:5 Preparation of crude f3-lactamase extracts
Bacterial growth of each test strain was harvested after 48
hours of anaerobic incubation from two horse blood agar plate
cultures with a sterile cotton wool swab. The bacteria were
suspended in a glass tube containing 4 ml phosphate buffer (0.02 M;
pH 7.0) which was kept cooled in a beaker of iced water. The
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bacterial suspensions were then subjected to six bursts of sonication,
each of 30 seconds, with cooling periods of 30 seconds between
bursts, in a Soniprep 150 ultrasonicator (MSE Scientific Instruments,
Crawley, Sussex). The disrupted cells were centrifuged at 4000 rpm
for 30 minutes at 40C in a 'Coolspin' centifuge (MSE). The supernate
(crude ~-Iactamase extract) was divided into 0.5 ml portions and
stored at -700C, or split into 2 ml portions and freeze dried (Freeze
Drier 3.5, Birchover Instruments Ltd., Letchworth, Hertfordshire), to be
reconstituted later in a concentrated form with phosphate buffer.
2: 6 Determination of specific activity
(1) with nitrocefin as substrate
The method used was based on that described by Q'Caliaghan
et al. (1972): 1.9 ml of a nitrocefin solution (52 mgll nitrocefin in 0.02
M phosphate buffer pH 7) and 0.1 ml crude enzyme extract were
mixed in a cuvette to give a final nitrocefin content of 0.2 11 moles. The
rate of hydrolysis of nitrocefin was measured over a three minute
period at 37°C and 482 nm in a spectrophotometer with heated
cuvette compartment (UV-160A, Shimadzu, Kyoto, Japan). The
enzyme concentration was adjusted to give complete hydrolysis of the
substrate in approximately seven minutes. This was achieved by
appropriate dilution of the extracts in phosphate buffer when the
hydrolysis was too rapid, or with reconstituted freeze dried
concentrates when the enzyme activity was too slow .
The total soluble protein content of the crude extract was
measured with a Sigma Protein Assay Kit (Sigma) in accordance with
the manufacturer's instructions. The procedure is based on a
modification of the Lowry protein determination method as described
by Peterson (1977).
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Specific activity (SA) was calculated from the formula:
SA = ~OOtmin x 11 moles nitrocefin present x enzyme dilution
total ~ 00 protein content (mgtml)
where ~OO is the change in optical density. The SA was expressed
as: the amount (IJ moles) of nitrocefin hydrolysed/mintmg of protein.
(2) with imipenem as substrate
The specific imipenemase activities, defined as IJ moles
imipenem hydrolysed/min/mg of protein, were assessed for those
strains shown to be capable of imipenem hydrolysis. A mixture of 100
IJI of concentrated crude cell extract, 200 IJI imipenem 250 mgtl (0.16
urnoles) and 700 IJI phosphate buffer was placed in a 1 ml cuvette
and maintained at 370e in a spectrophotometer (UV-160A,
Shimadzu). The rate of change in absorbance at 299 nm was
measured over a five minute period and the degree of concentration
of crude cell extract chosen gave complete hydrolysis of imipenem
within one hour. The change in absorbance representing complete
hydrolysis was obtained by subtracting the absorbance at the
beginning of the experiment from that after one hour's incubation. The
protein concentration of the crude cell extracts and the calculations of
specific activity were performed as previously stated in section 2:6 (1).
2:7 Isoelectric focusing
The method used was that originally described by Ambler and
Walker (1979) and subsequently employed by Eley et al. (1983) to
examine the isoelectric points of bacterial f3-lactamases.
Sepraphore III 57 x 127 mm cellulose acetate membranes
(Gelman Sciences Ltd., Northampton) were passed through
increasing concentrations of methanol in water until present in
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absolute methanol. The membranes were then methylated by being
submerged for one hour at '47oC in 14% boron trifluoride (BDH
Chemicals, Poole, Dorset) diluted 2 in 3 with absolute methanol. The
treated membranes were then washed and stored in absolute
methanol. Before use the treated membranes were equilibrated by
soaking for 30 min in a solution of 4% ampholine (Bio-Lyte, pH range
3-10, Bio-Rad Laboratories Ltd., Hemel Hempstead, Herts.) and 7.5%
glycerol.
The membranes were then transferred to the glass cooling
plate of an LKB 2117 Multiphor (LKB Instruments Ltd., South
Croydon, Surrey) and electrode wicks placed in position. The
electrode solutions were 3% citric acid at the anode and 1.75%
ethanolamine at the cathode, both solutions containing 7.5% glycerol.
A constant 400 volts with an initial current of 3.0 rnA was then applied
across the membrane for 10 minutes. Eight 0.25 J.11applications of
seven neat or freeze dried concentrated crude rJ-lactamaseextracts,
together with a mixture of visible pi marker standards (pH range 4.7-
10.6; BDH), were made approximately one third of the way down the
membrane from the anode using a double wire applicator (Gelman
sctences), The voltage was reapplied and focusing was complete
when the pi markers had reached their equilibrium in the pH gradient,
normally within two hours.
Visualization of the rJ-lactamase bands was achieved by
overlaying the membranes with 0.8% agarose containing 250 mgll
nitrocefin. The pi values of the rJ-lactamaseswere then determined by
comparison with the pi markers.
2:8 Inhibitor profiles
Enzyme inhibition analysis was performed in a centrifugal fast
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analyser (Centrifichem 400, Union Carbide, New York, USA) as
described initially by Jones et al. (1982) and subsequently by Eley
and Greenwood (1986b). The colour change induced in nitrocefin at
482 nm as a result of hydrolysis by crude ~-Iactamase extracts was
followed in the presence of serial 10-fold concentrations of ~-
lactamase inhibitors.
The inhibitors tested were p-chloromercuribenzoate (pcmb)
(Sigma), cloxacillin, clavulanic acid, sulbactam, cefoxitin, latamoxef
and imipenem at concentrations in the range 0.1-100 IlM. The pcmb
was initially dissolved in a minimum volume of 1M sodium hydroxide,
made up in distilled water and adjusted to pH 7 with 1M hydrochloric
acid. The activities of the crude ~-Iactamase extracts were
standardised before testing by appropriate dilution of the neat or
concentrated freeze dried extracts with 0.02 M phosphate buffer (pH
7).
The total reaction volume was 300 III which comprised the
following: 250 III nitrocefin (60 mgll), 25 III distilled water, and a
mixture of 15 III crude ~-Iactamase extract and 10 III diluted inhibitor.
All assays were performed at 370C after equilibration of the
temperature of the reactants for 15 minutes before mixing.
Appropriate enzyme and substrate controls were included with each
experiment. Reactions were followed for five minutes with readings at
one minute intervals. The lowest concentration of inhibitor required to
produce 50% or more inhibition of nitrocefin hydrolysis compared to
the control, which containined water instead of inhibitor, was defined
as the ICso.
2: 9 Antibiotic degradation by crude enzyme extracts
The kinetics of hydrolysis by crude ~-Iactamase extracts of
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benzylpenicillin (in the presence of clavulanic acid 4 mgll), latamoxef,
cefoxitin, imipenem, and in later studies meropenem, was
investigated by High Pressure Liquid Chromatography (HPLC).
Enzyme extract (0.2 ml) concentrated five times by freeze
drying, was mixed in a screw topped reaction vial with 0.8 ml of
antibiotic solution to give a final concentration of 50 mgll and
incubated at 370C in a water bath. Samples of 0.25 ml were removed
for HPLC analysis after 0, 2, 4 and 24 hours of incubation. Antibiotic
controls,in which phosphate buffer (0.02 M, pH 7) replaced the r3-
lactamase extract, were included and examined in parallel.
For all analyses, 50 III of sample was introduced by a Gilson
model 231 sample injector (Anachem, Luton, Beds.) onto a reverse-
phase separation column packed with Hypersil 5 ODS (HPLC
Technology, Macclesfield, Cheshire). The sample, together with the
mobile phase, was then pumped at a flow rate of 1 mllmin by means
of a Gilson model 302 pump (Anachem). A variable wavelength U.V.
absorbance detector (PU 4020; Pye Unicam, Cambridge) was used to
detect the presence of antibiotic in the eluate. The mobile phase and
detection wavelength for the analysis of each antibiotic is given in
Table 2.2.
A series of known antibiotic concentrations was processed to
obtain an accurate value for the retention time and peak heights for
comparison with sample peaks. From these, the antibiotic
concentration in each sample could be calculated.
2.10 Turbidimetry
Continuous opacity records of bacterial growth were obtained
by use of the 12-channel Electrotek anaerobic data logging opacity
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Table 2.2 HPLC condltlons us-ed for ~-Iactam antibiotic
analysis.
Detection
Antibiotic Mobile phase+ wavelength (nm)
Benzylpenicillin III (40:60)methanol :water 277
Cefoxitin III (40:60) 235methanol :water
Latamoxef
III
250methanol :water (25:75)
Meropenem IIImethanol :water (25:75) 299
Imipenem IIImethanol :water (20:80) 299
+ phosphoric acid (10/0) included as mobile phase modifier
III
HPLC grade (BOH)
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system (Electrotek, Keighley, Yorks.) shown in Fig. 2.1. This
comprised an air tight chamber in which a 12 well block was situated.
The block could be maintained at a constant temperature of 37°C by
an electric heater band. A centrally positioned festoon bulb light
source within the block was focused onto photocells by culture tubes
present in the wells. A BBC Master series computer examined
amplified signals from each channel in turn and these data were
simultaneously stored on floppy disc and displayed as percentage
opacity against time on a monitor.
The maximum and minimum opacity settings for each channel
were adjusted using an uninoculated broth and a fully grown culture.
Ten ml volumes of pre-reduced BHIS broth were placed in sterile
glass tubes each with a sterile magnetic spinbar (R.B.Radley Ltd.,
Safron Walden, Essex). They were then inoculated with 0.1 ml of a 1
in 10 diluted overnight culture to give inocula of approximately 105
ctu/m!.
For low inoculum experiments, 0.1 ml of an appropriate dilution
of antibiotic (or sterile distilled water control) was added to the
inoculated tubes to give the required final concentration. Culture
tubes were placed in the wells within the chamber. Catalyst
envelopes and. a GasPak disposable anaerobic indicator (BBL
Microbiology Systems, Cockeysville, USA) were then positioned and
the lid sealed. The chamber was evacuated and anaerobic gas
mixture (80% nitrogen, 10% carbon dioxide, 10% hydrogen) admitted.
Evacuation and gas replacement were repeated three times. The
stirring mechanism was then turned on and the growth monitored
continuously for 30 hours.
To test the response of high inocula, 0.1 ml of a suitable
dilution of antibiotic was added to cultures within the chamber when
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Fig. 2.1 12-channel Electrotek anaerobic data logging opacity
system.
B
c A o
A anaerobic chamber containing 12-well block
B septa to allow passage of fluid into and out of chamber
C adjusters for maximum and minimum opacity settinqs
o control panel
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growth had raised the opacity to 30% of that of a fully grown culture,
equivalent to approximately 108 cfu/ml. Addition of antibiotic was
achieved by the use of syringes which passed through septa in the
chamber lid, allowing addition of fluid into the culture tubes without
loss of anaerobiosis. Broth cultures could also be withdrawn through
these syringes for viable counts, antibiotic assay or morphological
examination.
At the end of each experiment, broth from each tube was
streaked onto two horse blood agar plates which were incubated
aerobically and anaerobically. After 48 hours, the plates were
examined to ensure that no contamination of the broth cultures had
occurred. Continuous opacity records of bacterial growth were plotted
with an 672-XD graph plotter (Hitachi, Tokyo, Japan).
2: 11 Degradation of sub-MIC concentrations of antibiotics
by growing cultures of resistant strains
Isolates found to exhibit increased resistance to one or more of
the test antibiotics were used in this part of the study. One hundred IJI
of overnight broth cultures of these resistant strains, diluted 1/10 in
BHIS broth, were inoculated into 10 ml BHIS broths containing
imipenem 0.5· mgll; latamoxef 16 mgll; cefoxitin 16 mgll or
benzylpenicillin 0.5 mgll (with 4 mg/l clavulanic acid). These
concentrations were below the Mle for most of the resistant isolates
and were detectable in broth residues. After 22 hours of anaerobic
incubation at 37oe, the broths were centrifuged and the supernates
stored at -70oe. Antibiotic control broths, without bacteria, were also
included.
The residual antibiotic was measured by microbiological
assay. Indicator organisms were grown for four hours at 370e in an
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appropriate broth and diluted 1/100 in saline. These were a clinical
isolate of Streptococcus P'logenes for imipenem, E.co/; NCTC
10418 for latamoxef and the 'Oxford' staphylococcus NCTC 6571 for
cefoxitin and benzylpenicillin. The bacterial suspensions were
flooded onto Iso-sensitest agar (Unipath) in 20 x 20 cm glass plates
and allowed to dry. Wells (7 mm diameter and at least 5 cm apart)
were made in the agar and filled with standard dilutions of antibiotic in
BHIS or spent broth supernate. After overnight aerobic incubation at
37oC, the zones of inhibition around the wells were measured. A
calibration graph was plotted of the square of the zone size against
the standard concentrations in 1092steps, and the concentrations in
the test samples were derived by reference to this graph.
2: 12 Time course of hydrolysis of sub·MIC concentrations
of imipenem by growing cultures of B.fragilis strains
exhibiting reduced susceptibility to the drug
Ten ml volumes of BHIS broth containing imipenem 0.5 mg/l
were seeded with 100 /JI of an overnight B.fragilis culture in BHIS
diluted diluted 1 in 10 with fresh broth. A control without bacteria was
also included. These tubes were placed in the Electrotek opacity
system and the 'cultures incubated as described in section 2:10. One
ml samples were withdrawn after 0, 6 and 24 hours of incubation and
the growth phase at which sampling took place monitored. The
culture samples were centrifuged and the amount of imipenem
remaining in the supernate was determined by microbiological assay
as described in section 2:11.
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2: 13 Degradation of imipenem (50 mg/l) by whole cells of
a.fragi/is strains exhibiting reduced susceptibility to the
drug
Ten ml of BHIS broth cultures of a.tragi/is strains with reduced
susceptibility to imipenem, and a.tragi/is NCTC 9344, were grown in
the Electrotek opacity system in the absence of antibiotic as described
for high inoculum experiments in section 2:10. When growth reached
70% of maximum opacity, 0.1 ml of a solution of imipenem was added
to achieve a final concentration of 50 mg/l and the experiment
allowed to run for a total time of 24 hours. This enabled the imipenem
to be in contact with the growing bacteria for approximately 18 hours.
After this period the amount of residual imipenem was determined by
microbiological assay as described in section 2:11, except that the
'Oxford' staphylococcus was used as the indicator organism for these
higher imipenem concentrations and the residue was diluted 1 in 10.
Residual imipenem was also measured by HPLC as described in
section 2:9. Before chromatography, the broth supernates were
treated with acetonitrile (Fisons, Loughborough, Leics.), at a ratio of
1:1, to remove proteins. Antibiotic control broths were also included.
2:14 Determination of inoculum effect
Low and high inoculum experiments were carried out in the
Electrotek opacity system as described in section 2:10. a.tragi/is
strains with reduced susceptibility to imipenem were exposed to serial
doubling dilutions of the drug. From the growth response curves,
MICs and minimum antibacterial concentrations (MACs) were
determined and compared. The MIC was defined as the lowest
antibiotic concentration required to suppress growth for the whole
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period of observation, and the MAC as the lowest antibiotic
concentration causing deviation from normal growth.
2: 15 Detection of metallo-J3-lactamases
(1) With imipenem as substrate
The ability of fJ-lactamases to hydrolyse imipenem, in the
presence and absence of the chelating agent EDTA or EDTA with
zinc sulphate or zinc sulphate with phosphate buffer, was determined
spectrophotometrically by the methods described by Cuchural et al.
(1986b), Bandoh et al. (1991) and Hedberg et al. (1992), One
hundred J.1Iof concentrated (xS) crude enzyme extract were mixed
with 200 J.1IEDTA (S mM) or phosphate buffer (0.02 M; pH 7.0) in a
one ml cuvette and incubated at 370C for 30 minutes. Two hundred J.1I
of either zinc sulphate (S mM) or phosphate buffer were then added,
together with 200 J.1Iimipenem 2S0 mg/l and a futher 300 J.1Iof
phosphate buffer. The absorbance of the imipenem solutions was
measured by a spectrophotometer (UV-160A, Shimadzu) at 299 nm
after 0, O.S,1 and 2 hours incubation at 37oC.
(2) With nitrocefin as substrate
The effect of EDTA, in the presence and absence of zinc
sulphate, on the hydrolysis of nitrocefin by crude J3-lactamaseextracts
was examined by the method described above (section 2.1S (1»,
except that 200 J.1I250 mgtl nitrocefin was added to the cuvette as
substrate and the change in absorbance per min was measured over
a five minute period at 482 nm and 37oC.
2: 16 Effects of clavulanic acid and zinc acetate on broth
dilution MICs of imipenem
MICs of imipenem, with and without the J3-lactamaseinhibitor
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clavulanic acid, were determined by the broth dilution method for
bacteroides strains with reduced susceptibility to imipenem. Each
strain was tested against twofold dilutions of imipenem in 5 ml of
BHIS broth, in the presence and absence of clavulanic acid 4 mgll.
Fifty III of a 1110 dilution of overnight culture in BHIS broth were
added to the antibiotic containing broths which were then incubated
anaerobically at 370C for 48 hours. The MICs were read as the lowest
antibiotic concentration required to suppress visible growth.
The impact of increased zinc concentration on the susceptibility
of isolates of B.fragi/is to imipenem in BHIS medium was also
assessed. The zinc ion content of BHIS broth was measured using an
AA-460 flame atomic absorption spectrophotometer (Perkin Elmer,
Beaconsfield, Bucks) in accordance with the manufacturer's
instructions and MICs of imipenem were determined in this medium.
Sufficient zinc acetate was added to further BHIS broth to double the
zinc ion content (from 75 to 150 umols/l) and the MICs of imipenem
were measured again.
2: 17 f3-Lactamase crypticity measurements
f3-Lactamase crypticity was defined as the ratio of the activity
observed in preparations of disrupted cells to that of intact cells. The
method used was that described by Cuchural et al. (1986b) with the
degradation of nitrocefin followed spectrophotometrically.
Bacteria from an overnight culture in 10 ml BHIS broth were
sedimented by centrifugation and resuspended in 10 ml phosphate
buffer (pH 7). This 10 ml suspension was divided into two 5 ml
portions, one of which was sonicated to cause cell disruption as
described in section 2:5. The rate of hydrolysis of nitrocefin by f3-
lactamases present in the whole cell suspension and the sonicate
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was measured by a spectrophotometer (UV-160, Shimadzu) at 482
nm and 37°C. The reaction mixture present in the cuvette comprised
0.2 ml nitrocefin (250 mg/l), 0.3 ml cell suspension or sonicate and 0.5
ml phosphate buffer (pH 7).
2: 18 Outer membrane protein analysis
Outer membrane proteins were examined by a method based
on that described by Carlone et al. (1986). Overnight cultures of test
strains were grown in 20 ml SHIS broth and their optical densities
made uniform by the addition of sterile SHIS broth. The cultures were
then centrifuged at 4000 rpm for 15 min, the cell pellets washed twice
in 50 mM Tris-HCL pH 8 (Sigma) and resuspended in 1 ml Tris-HCl.
These were then sonicated on ice with 6 x 30 sec bursts in a
Soniprep 150 ultrasonicator (MSE). The sonicates were centrifuged
in Eppendorf tubes at 4000 rpm for 15 min to remove any unbroken
cells. Each supernate was mixed with 66 III 30% sodium N-Iauroyl
sarcosinate (sarkosyl) (SOH), to give a final concentration of 2% (w/v),
and incubated at room temperature for 30 min. The mixture was then
centrifuged at 13,000 rpm for 20 min in a MicroCentaur
microcentrftuqe (MSE) and the pellet washed twice in Tris-HCl. The
outer membrane proteins present in the pellet were then solubilised
by boiling for five minutes with 50 III Laemmli sample buffer (made up
of 4 ml distilled water, 1 ml 0.5 M Tris-HCL pH 6.8, 0.8 ml glycerol, 1.6
ml 10% (w/v) sodium dodecylsulphate (SOS) (Sigma), 0.4 ml 2-b-
mercaptoethanol (Sigma) and 0.2 ml 0.05% (w/v) bromophenol blue
(SOH». The samples were centrifuged at 6500 rpm for five minutes to
remove any insoluble components and stored at -700C until protein
separation was carried out by SOS-polyacrylamide gel
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electrophoresis (PAGE).
SOS-PAGE:
SOS-PAGE analysis was performed with the Mini-PROTEAN II
system (Bio-Rad) and a modification of the method described by
Laemmli and Favre (1973). The equipment was cleaned thoroughly
and assembled according to the instructions provided by Bio-Rad. A
gel thickness of 0.75 mm was used. A separating gel of 12%
acrylamide was made up from the constituents listed in Table 2.3 and
pipetted between two pairs of glass sheets up to 1 cm below the
position for the base of the comb. The gels was overlayed with water
and allowed to polymerise for one hour. The water was then poured
off, and the stacking gel (4% acrylamide, detailed in Table 2.3)
pipetted on top of the separating gels with the combs in position. After
30 min, the combs were removed and the gels placed in position on
the inner cooling core. Running buffer (Table 2.3) was poured
between the gels until the top of the glass plates was covered. Fifteen
III of each sample and 10 III of a mixture of low range (97 kOa to 14
kOa) molecular weight standards (Bio-Rad) were applied to the gel
wells with a P 20 Gilson Pipetman (Anachem). The inner cooling core
was placed in an electrophoresis tank and running buffer poured in to
cover the bottom of the cooling core. The terminals on the inner
cooling core were then connected to a power pack and a constant
voltage of 150 v passed. Electrophoresis was allowed to continue
until the dye front was 0.5 cm from the bottom of the gel. The gels
were then removed from the glass plates and submerged overnight in
0.1% Page Blue 90 stain made up in 40% methanol, 10% acetic acid
and 50% distilled water. Oestaining was carried out by immersing the
gels in 5% methanol, 10% acetic acid and 850/0distilled water until
the blue background was removed, which normally occurred within
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Table 2.3 Constituents of (A) separating gel (B) stacking
gel and (C) running buffer: used for outer membrane protein
analysis
A). Separating gel
Distilled water
1.5M Tris-HCL 1 (pH 8.8)
10% SDS1
Acrylamide2 (30%) with (0.03%)
N-N bis-methylene-acrylamide2
10% Ammonium persulphate 1
(freshly prepared)
TEME[)3
12% acrylamide 10.5% acrylamide
3.35 ml 3.85 ml
2.5 ml
100 /JI
2.5 ml
100 /JI
4 ml
50 /JI
3.5 ml
50 /JI
B). Stacking gel (4% acrylamide)
Distilled water
0.5M Tris-HCL (pH 6.8)
100/0 SOS
Acrylamide (30%) with (0.03%)
N-N bis-methylene-acrylamide
100/0 Ammonium persulphate
(freshly prepared)
TEMED
6.1 ml
2.5 ml
100 /JI
1.3 ml
50 /J1
C). Running buffer (x5 conc.) pH 8.3
Tris base3
Glycine2
SOS
Distilled water
7.5g
36g
2.59
500 ml
Suppliers: 1 Sigma Chemical Co. 2 BDH Chemicals
3 Bio Rad Laboratories Ltd
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one hour. The gels were photographed and the molecular sizes of
protein bands calculated by compartson with the standards.
2: 19 Lipopolysaccharide analysis
Lipopolysaccharides (LPS) present in the outer membrane
were investigated by a method developed by Hitchcock and Brown
(1983). Bacteria were harvested from 10 ml overnight BHIS broth
culture by centrifugation at 4,000 rpm for 15 min, and washed once in
phosphate buffered saline (PBS). They were then suspended in PBS
to give spectrophometric readings of between 0.5 and 0.6 at 525 nm.
Bacteria from 1.5 ml of this suspension were sedimented in a
MicroCentaur microcentrifuge (MSE) at 6500 rpm for five minutes.
The cell pellet was mixed with 0.05 ml Laemmli sample buffer
(detailed in section 2:18) and heated at 1000C for 10 min. Ten III of a
solution of 5 mg proteinase K (Sigma) in 2 ml Laemmli sample buffer
were added, and the mixture incubated at 600C for one hour. The
lipopolysaccharides were separated by electrophoresis as described
in section 2:18, except that the separating gels were composed of
14% polyacrylamide without SOS as follows: 2.68 ml distilled water,
2.5 ml Tris-HCL pH 8.8, 4.66 ml 30% acrylamide with 0.03% N-N bis-
methylene-acrylamide, 50 III 10% ammonium persulphate and 10 III
TEMEO. SOSwas also omitted from the stacking gels.
The separating gels were stained by silver stain following the
method of Hancock and Paxton (1988). The gels were fixed overnight
in 200 ml 25% propan-z-ot (Fisons) and 7% acetic acid. They were
oxidised for five minutes in a freshly prepared solution of 1.05 g
periodic acid (Sigma) in 150 ml distilled water containing 4 ml of the
propan-z-ot fixative, and washed in four changes of 200 ml distilled
water over a four hour period. A solution of ammoniacal silver nitrate
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was then freshly prepared as follows: 1.4 ml ammonia solution
(specific gravity 0.88) was added to 21 ml 0.36% sodium hydroxide
and 4 ml of 19.4% silver nitrate (Sigma) solution was slowly added
with vigorous agitation. The final volume was made up to 100 ml with
distilled water. The gels were stained in ammoniacal silver nitrate for
15 min, removed from the silver solution and washed four times in
200 ml distilled water over a period of 40 min. They were then soaked
in fresh 0.005% citric acid in 200 ml of 0.019% formaldehyde at 250C
for 15 min, and washed repeatedly with distilled water. The gels were
photographed and the LPSs of each strain compared.
2: 20 Analysis of penicillin binding proteins (PBPs)
The method used was based on the procedure described by
Spratt (1977a). BHIS broth (200 ml) was inoculated with 7.5 ml of an
overnight culture of the test strain in BHIS broth. After four hours of
anaerobic incubation at 37oC, the bacteria were harvested by
centrifugation at 4,000 rpm for 15 min. They were washed once and
resuspended in 10 ml phosphate buffer (0.02 M, pH 7.0). The
bacterial suspension was sonicated on ice for 6 x 30 sec in a
Soniprep 150 ultrasonicator (MSE), then centrifuged at 4,000 rpm for
15 min to remove the unbroken cells. The supernate was centrifuged
at 40,000 rpm and 40C for 30 min in a Model L5-65 ultracentrifuge
(Beckman, High Wycombe, Bucks.) to sediment the cell membranes
which were then washed in phosphate buffer five times. The pellet
was resuspended in 2 ml of phosphate buffer and the protein content
measured with a Sigma Protein Assay Kit (Sigma) in accordance with
the manufacturer's instructions. The suspension was centrifuged to
pellet the cell membranes which were then reconstituted in
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phosphate buffer to achieve a protein concentration of 10 mgtml. The
sample was tested for the presence of penicillinase by the method of
Escamilla (1976) (See section 2:3), divided into 50 III portions and
stored at -70oC until use.
Twenty III of cell membrane suspension and 5111distilled water
were pre-warmed to 30oC. Five III of 3H-benzylpenicillin (Amersham
International pic, Aylesbury, Bucks.), with a radioactive concentration
of 1.0 mCitml and a benzylpenicillin concentration of 18.8 mgtl (final
penicillin concentration 3.1 mgtl and a radioactive content of 5 IlCi),
were added and the mixture left for 10 min at 30oC. Excess non-
radioactive penicillin was introduced by adding 5 III benzylpenicillin
at a concentration of 120 mgtl. Thirty-five III of double strength
Laemmli sample buffer (see section 2:18) was added and the mixture
boiled for five minutes to solubilise the proteins present. The sample
was then divided into 17.5 III portions and stored at -70oC. In later
experiments, 15 III and 30 III of 3H-benzylpenicillin were used with a
corresponding increase in volume of double strength sample buffer.
Also, the 5 III volumes of distilled water added to the cell membrane
suspension were replaced by clavulanic acid or sulbactam to give
final concentrations of 5 mgll and 10 mgll respectively and exposed to
10 III 3H-benzypenicillin. For competition assays, 5 III volumes of
doubling dilutions of imipenem were used instead of distilled water,
together with 5 III 3H-benzylpenicillin.
The cell membrane proteins were then separated on SDS-
PAGE gels as described in section 2:18. Separating gels containing
10.5% acrylamide were used with 4% acrylamide present in the
stacking gels (See table 2.3). The gels were either divided into
segments which were examined by scintillation counter or analysed
by fluorography.
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(1) Scintillation counts of gel segments
Each protein track was cut into two or more segments
representing known molecular weight ranges by reference to the
molecular weight markers. Each gel segment was then placed in a
glass vial with 3 ml scintillation fluid made by mixing 0.1g 1,4-0i-[2-(5-
phenyloxazoyl)]-benzene (Koch-Light Ltd, Hatfield, Herts.) and 3g 2,
5-0i phenyloxazole (Koch-Light) in one litre of low sulphur grade
toluene (Fisons). After ten days, the level of radioactivity was counted
in a SL 3000 liquid scintillation counter (Kontron, Watford, Herts.).
Segments from an area of gel away from the sample tracks were
processed in a similar fashion to provide a count of the background
radioactivity.
(2) Fluorography
The water used for storing the stained gel was poured off and,
in the fume cupboard, enough En(3H)ance (NEN Research Products,
Boston, USA) was added to cover the gel. After one hour the
En(3H)ance was poured off and the gel covered with deionized water
and left for a further hour. The water was then replaced with fresh
deionized water. The gel was then removed, placed on a sheet of
filter paper, covered with cling film and dried at 80aC under vacuum
on a model443 slab drier (Bio-Rad). The dried gel was taken into the
dark room where all procedures were carried out under safe light. A
Kodak X-OMAT XAR 5 film (Sigma) was pre-fogged by use of a flash
gun. The intensity of the flash was reduced by placing the flash gun
inside a black bag with a small hole and aiming it at the ceiling of the
dark room. The gel was placed on the pre-fogged side of the film, and
the gel and film sandwiched between two aluminium plates which
were then placed in an exposure cassette (Sigma). The cassette was
then sealed inside two black plastic bags and stored at -70aC. After
81
three weeks (seven weeks in later experiments) the cassette was
returned to the dark room and, under safe light, the film removed after
the position of the gel had been recorded by small cuts on the side of
the film. The film was then developed by immersion in a 1 in 10
dilution of PO Universal Developer (liford, Mobberley, Cheshire) for 6
min, followed by a 1 in 40 dilution of acetic acid for 10 sec and then
Ilfospeed fixer (llford) diluted 1 in 4 for 2 min. After washing the film,
the position of the dark bands, indicating emitted radioactivity of
PBPs, could be measured and, by reference to the position of the
protein markers on the gel, the molecular weight of the radioactive
proteins determined.
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CHAPTER3
IDENTIFICATION, ANTIBIOTIC SUSCEPTIBILITY AND~-
LACTAMASE PRODUCTION OF CLINICAL ISOLATES OF
BACTEROIDES
3: 1 Introduction
Clinically significant bacteroides strains, isolated at the
Nottingham Public Health Laboratory during 1989 and 1990, were
investigated to determine their species, susceptibility to various ~-
lactam antibiotics and degree of ~-Iactamase production. These
findings were compared with those of previous studies. The degree of
resistance to ~-Iactam antibiotics was assessed to detect any
increase in resistance since the report of a similar study in
Nottingham was published in 1986 (Eley and Greenwood, 1986a).
The extent of the correlation between antibiotic resistance and ~-
lactamase production was also examined. Isolates exhibiting
increased resistance to ~·Iactam antibiotics were identified and used
for subsequent studies into their mechanisms of resistance.
3:2 Identification of isolates
Of the 121 anaerobic Gram negative bacilli collected, 108 were
found to belong to the Bacteroides genus, and were used in the
study. They were identified as follows: B.fragi/is (69), B.distasonis
(16), B.ovatus (13), B.thetaiotaomicron (6) and B.vu/gatus (4).
3:3 Antibiotic titrations
MICs of the antibiotics for all 108 test strains are summarised in
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Table 3.1. MICgO values for imipenem and for benzylpenicillin in the
presence of clavulanic acid(4 mg/l) were 1 and 2 mg/l respectively,
substantially lower than those of latamoxef, cefoxitin or
benzylpenicillin alone (MICgo: 16->64 mg/l).
3: 4 Semi-quantification of (3-lactamase activity in intact
bacteria
Of the 108 isolates tested, 82 (76%) produced (3-lactamase
(cephalosporinase) as indicated by the induction of a colour change
in the chromogenic cephalosporin nitrocefin. Sixty-one strains (57%)
produced a slight colour change and 21 (19%) produced elevated (3-
lactamase levels causing a complete colour change within one hour.
The remaining 26 strains failed to induce a colour change. The 21
strains which produced elevated levels of cephalosporinase
comprised 14 B.fragilis, 5 B.ovatus, 1 B.thetaiotaomicron and 1
B.distasonis (Table 3.2).
Fifteen (14% of all strains examined) of these 21 strains also
gave a positive reaction in the phenol red test for penicillinase.
although two of these strains produced only a weak reaction. Nine of
the 12 strains ~hich produced a rapid and complete colour change in
the nitrocefin cephalosporinase test elicited a rapid reaction in the
phenol red test for penicillinase production.
Further studies were restricted to these 21 isolates of
bacteroides which produced raised amounts of f3-lactamase.
3:5 Antibiotic titrations for strains with raised (3-
lactamase levels
Results of antibiotic titrations for the 21 strains with raised (3-
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Table 3.1 Susceptibilities of 108 isolates of bacteroides
to selected (3-lactam antibiotics
Minimum inhibitory concentration (mgll)
Antibiotic Range MICso MICgO
----------------------------
Benzylpenicillin 0.5->64 16 >64
Benzylpenicillin +
clavulanic acid" 0.06-16 0.25 2
Cefoxitin 0.25->128 16 32
Latamoxef 0.25->128 1 16
Imipenem 0.03-4 0.5 1
MICSO and MICg01 concentrations inhibiting 50% and 90% of
strains respectively
*Clavulanic acid at fixed concentration of 4 mgll
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Table 3.2 Semi-quantification of cephalosporinases and
penicillinases in intact bacteroides with raised t}-Iactamase
activity.
Bacterial strain cephalosporinase
(nitrocefin test)
penicillinase
(phenol red test)
B.fragilis R106 +++
B.fragilis R130 ++
B.fragilis R249 ++
B.fragi/is R251 +
B.fragilis R186 +++
B.fragilis R240 ++
B.ovatus R137 ++
B.ovatus R111 +++
B.distasonis R118 ++
B.fragilis R208 ++
B.fragilis R141 ++
B.fragilis R126 +++
B.ovatus R215 ++
B.fragilis R152 +++
B.ovatus R112 +++
B.fragilis R22'6 +++
B.fragilis R216 +++
B.ovatus R102 +++
B.fragilis R212 +++
B.fragilis R134 +++
B. thetaiotaomicron R233 +++
B.fragi/is NCTG 9344* + /-
++
++
++
+
+
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
------------------------------------------
-,+/-,+,++,+++ indicates levels of enzyme activity assessed visually
according to the speed and completeness of the colour change.
'" control strain
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lactamase levels are displayed in Table 3.3. Fourteen of these strains
exhibited increased resistanee to benzylpenicillin (MIC ~32 mgtl).
Clavulanic acid (4 mgtl) reduced the MIC of benzylpenicillin more
than two-fold for all but three of the 21 strains (B.fragiJis R186, R240
and R249) and resulted in MICs of benzylpenicillin of <2 mgtl for all
but six of the strains (B.fragilis R186, R212, R233, R240, R249 and
R251). A wide range of susceptibilities to the other test antibiotics was
displayed. Nine strains showed an increase in resistance to cefoxitin
(MIC ~32 mgtl), latamoxef (MIC ~32 mgtl) or imipenem (MIC ~2 mgtl)
with MICs of at least two of these antibiotics greater than or equal to
their corresponding MICgo. Three of these strains, B.fragilis R208,
B.fragi/is R212 and B.thetaiotaomicron R233, showed reduced
susceptibility to cefoxitin, latamoxef and imipenem. Four strains,
B.fragilis R251, B.fragiJis R186, B.fragi/is R240 and B.distasonis
R118, showed increased resistance to imipenem and cefoxitin. Also,
B.ovatus R215 showed marked resistance to cefoxitin and latamoxef
and the MICs of these antibiotics for B.ovatus R102 were raised.
This group of 21 high level t3-lactamase producers contained
all the strains which were resistant to the test antibiotics with the
exception of three other bacteroides isolates (2 B.distasonis and 1
B.thetaiotaomicron) for which the MIC of cefoxitin was 32 mg/l; these
isolates were susceptible to latamoxef and imipenem. The remaining
84 isolates were sensitive to the test antibiotics. (MICs of cefoxitin and
latamoxef <32 mgtl; MIC imipenem <2 mg/l).
Therefore, 12 of the 108 isolates tested (11% of strains)
showed increased resistance to cefoxitin. Of these, nine (8%)
produced elevated amounts of t3-lactamases; two of these strains
(2%) showed high resistance levels (MIC cefoxitin >64 mg/l). Five
isolates (5%) were resistant to latamoxef and seven (6%) showed
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Table 3.3 Antibiotic susceptibility (MIC mgll) of 21 strains of
Bacteroides that exhibited increased t3-lactamase activity
Minimum inhibitory concentration (mg/l)
Bacterial strain benzyl benzylpenicillin cefoxitin latamoxef imipenem
penicillin +clavulanic acid#
B.fragilis R106 32 0.5 16 0.5
B.fragilis R130 32 0.5 8 1 0.25
B.fragilis R249 4 2 16 0.5
B.fragilis R251 16 2 32 4 2
B.fragilis R186 8 4 32 2
B.fragilis R240 8 4 32 4
B.ovatus R137 16 0.5 8 0.5
B.ovatus R111 16 0.25 4 0.5
B.distasonis R118 32 32 16 2
B.fragi/is R208 >64 1 32 >128 4
B.fragilis R141 16 0.25 16 0.5 0.06
B.fragilis R126 >64 16 16 0.5
B.ovatus R215 >64 0.5 64 >128
B.fragilis R152 >64 <0.12 8 8 0.12
B.ovatus R112 >64 0.25 16 16 0.5
B.fragilis R226 >64 0.5 8 16
B.fragilis R216 >64 8 8
B.ovatus R102 >64 1 32 32 0.5
B.fragilis R212 >64 4 128 >128 2
B.fragilis R134 >64 0.25 16 16 0.25
B.thetaiotaomicron R233 >64 16 >128 >128 4
B.fragilis NCTC 9344" 16 0.25 8 0.25 0.12
.. control strain
# clavulanic acid at a fixed concentration of 4 mg/l
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reduced susceptibility to im.ipenem. These strains all produced
elevated amounts of ~-Iactamase and were cefoxitin resistant. Four of
the latamoxef resistant strains were highly resistant (MICs >64 mgll),
whereas none of the strains showing raised MICs to imipenem were
highly resistant (MIC >64 mgll).
3:6 Discussion
Modest inconsistancies are apparent between this study and
previous reports in terms of the types of species of Bacteroides
isolated from clinical samples and the degree of ~-Iactamase
production by these strains. These discrepancies may have been due
to differences in the clinical material examined, technical procedures,
evaluation of test results or simply natural variation.
Most (89%) anaerobic Gram negative bacilli isolated from
clinical material in this study were identified as Bacteroides species,
which is consistant with previous studies (Holland et al., 1977).
B.fragilis, the predominant species, comprised 57% of the of the
clinically significant anaerobic Gram negative bacilli and 64% of the
bacteroides, reflecting this organism's pathogenic potential and
virulence properties. These findings are similar to those of Duerden
(1980a), who reported that 51% of all isolates of anaerobic Gram
negative bacilli and 78% of the 'fragilis group' were B.fragi/is. Eley
and Greenwood's Nottingham study in 1986, however, described 60
of their 78 clinical isolates (77%) as B.fragi/is, the remainder
belonging to the 'fragilis group' (Eley and Greenwood, 1986a).
Duerden (1980a) and Eley and Greenwood (1986a) found
B.thetaiotaomicron to be the second most common Bacteroides
species representing 13% and 20% of the bacteroides isolated
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respectively. However, in this study, B.thetaiotaomicron only
comprised 6% of the bacteroides strains. The most common
Bacteroides species after B.tragi/is were B.distasonis and
B.ovatus, comprising 15% and 12% of the isolates respectively.
Imipenem and the combination of benzylpenicillin with
clavulanic acid were shown to be considerably more active than the
other ~-Iactam antibiotics tested, as judged by conventional MIC
titrations. These findings are comparable with the results of the study
by Eley and Greenwood (1986a) and with recent reports from Europe
and USA (Betriu et al., 1992; Dubreuil et al., 1992; Phillips et al.,
1992; Goldstein et al., 1993).
Most clinical strains of bacteroides (76%) have been shown to
produce ~-Iactamases which are predominately cephalosporinases.
Olsson et al. (1977) described the production of small amounts of ~-
lactamase by most bacteroides isolates (87%), with 6% of strains
forming elevated amounts of the enzyme. More recently, Aldridge et
al. (1988) found that 97% of 246 B.tragi/is isolates from the United
States produced ~-Iactamases. Eley and Greenwood (1986a)
reported that 74 of the 78 (95%) clinical isolates from Nottingham
showed ~-Iac~amaseactivity when nitrocefin was used as substrate,
13 (17%) of these were shown to produce elevated levels of the
enzyme. Other reports on ~-Iactamase-producing B.tragi/is give
frequencies of 50% and 90%, depending on the sensitivity and type of
assay used and the definition used to designate positive test results
(Darland and Birnbaum, 1977; Montgomery et al., 1979). Eley and
Greenwood (1986a) reported that ten (13%) out of the 78 clinical
isolates from Nottingham gave positive reactions in the phenol red
test for penicillinase, similar to the findings of this study where 14% of
strains gave positive reactions with benzylpeniciUin as substrate.
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Eley and Greenwood (1986a) classified all but one of the 13
'high 13-lactamase'producers ~asB.fragilis. This is in contrast to the
findings of this study, where only 14 of the 21 strains which produced
elevated levels of cephalosporinase were identified as B.fragilis.
The correlation between elevated 13-lactamaseproduction and
13-lactam antibiotic resistance, described many years ago by
Anderson and Sykes (1973) and Olsson et al. (1977), was also
observed in this present study. The 14 isolates showing high level
resistance to benzylpenicillin, and nine of the twelve strains with
increased resistance to cefoxitin which included those with increased
resistance to latamoxef or imipenem or both, belonged to the group of
21 strains with elevated 13-lactamaselevels. These findings reinforce
the notion that 13-lactamasesare a major factor in the resistance of
Bacteroides species to 13-lactam antibiotics (Rasmussen et al.,
1993). Also, benzylpenicillin in combination with clavulanic acid has
been shown to be highly active against clinical isolates of
bacteroides. The 13-lactamase inhibitor restored high activity to
benzylpenicillin in all but six B.fragi/is strains indicating the
importance of clavulanic acid sensitive 13-lactamasesin bacteroides
resistance. However, three isolates, that did not produce elevated
levels of 13-lactamase,showed low resistance to cefoxitin, suggesting
the role of resistance factors other than j3-lactamases.
The high level resistance to latamoxef and cefoxitin detected in
the present study appeared marginally more prevalant than that
described by Eley and Greenwood (1986a) who found no highly
cefoxitin resistant bacteroides, although the MIC of cefoxitin for 4% of
the total number of strains tested was 32 mg/l. Each of these strains
exhibited increased 13-lactamaseactivity. These authors reported 6%
and 4% of the total number of test strains as resistant to latamoxef and
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imipenem respectively. Only one out of the five isolates for which the
MIC of latamoxef was raised was highly resistant to the antibiotic, and,
as in the present study, no highly imipenem resistant strains were
reported. Highly imipenem resistant strains have been occasionally
isolated in other centres. Cuchural et al. (1986b) found two out of
over 350 isolates tested in Boston, USA, to be highly resistant to
imipenem, and other sporadic isolates have been reported from
Japan, France and Sweden (Bandoh et al., 1991; Podglajen et al.,
1992a; Hedberg et al., 1992).
The extent of resistance to the 'f3-lactamase stable' f3-lactams
cefoxitin, latamoxef and imipenem in Nottingham appears low and
has not increased in the intervening five years since isolates were
collected for the Eley and Greenwood (1986a) study, with the
exception of a modest increase in cefoxitin resistance. Interestingly, a
lower cefoxitin resistance rate (3%) compared to the present study,
which was similar to that reported by Eley and Greenwood (1986a),
was found Phillips et al. (1992) in a European study. These findings
are reassuring in that they do not expose a rapidly increasing
resistance problem associated with this group of organisms and
antibiotics.
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CHAPTER 4
CHARACTERISATION AND CLASSIFICATION OF
BACTEROIDES 13-LACTAMASES
4: 1 Introduction
Characterisation of 13-lactamases produced by Bacteroides
species has traditionally resulted from the investigation of physical
and chemical properties including specific activity, isoelectric point,
inhibitor profiles, molecular weight and hydrolysis capability (Leung
and Williams, 1978; Nord and Olsson-Liljequist; 1981; Timewell et
al., 1981). By use of these features, typical B.fragi/is 13-lactamases
have been characterised and categorised (Britz and Wilkinson, 1978;
Bush, 1989c). Other diverse 13-lactamase types from Bacteroides
species have been described and attempts to classify them have
been made. (Sato et al., 1980, 1982; Cuchural et al., 1983, 1986b;
Yotsuji et al., 1983; Eley and Greenwood, 1986a,b; Bandoh et al.,
1991; Hedberg et al., 1992). In this part of the study, 13-lactamases
from the 21 strains which produced elevated amounts of the enzyme
were examlnsd. Their characteristics were classified and compared to
those of other studies.
4:2 Specific cephaJosporinase activity
Specific cephalosporinase activity (urnoles of nitrocefin
degraded/min/mg of protein) of the crude enzyme extracts ranged
from 0.01 to 1.33 (Table 4.1). These values were generally lower than
those obtained for the 13 clinical isolates of bacteroides described by
Eley and Greenwood (1986a), who used similar methods with
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Table 4.1 Specific activities of isolates of bacteroides that
exhibited increased rJ-lactamase' activity.
Bacterial strain Specific activity#
------------------------------------------
B.fragilis R106 0.01
B.fragilis R130 0.01
B.fragilis R249 0.01
B.fragilis R251 0.01
B.fragilis R186 0.02
B.fragilis R240 0.02
B.ovatus R137 0.03
B.ovatus R111 0.05
B.distasonis R118 0.07
B.fragilis R208 0.08
B.fragilis R141 0.09
B.fragilis R126 0.15
B.ovatus R215 0.16
B.fragilis R152 0.21
B.ovatus R112 0.44
B.fragilis R226 0.68
B.fragilis R216 0.71
B.ovatus R102 0.87
B.fragilis R212 0.88
B.fragilis R134 0.93
B. thetaiotaomicron R233 1.33
B.fragi/is NCTC 9344* 0.003
-
"control strain
#Ilmoles nitrocefin degraded/min/mg of protein
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nitrocefin as substrate. These differences may be due to the different
population of organisms under investigation. Also, it has been shown
that variations in the conditions of growth and time of harvesting of the
organisms, and concentration and storage of the enzyme extracts,
may profoundly affect the results (Olsson et a/., 1976; Edwards and
Greenwood, 1990). Comparison of specific activity with data present
in other reports is difficult due to differences in methods and substrate
used.
As expected, good correlation was shown between the specific
activity and whole cell cephalosporinase and penicillinase tests (See
section 3.4). All the strains with specific activity of more than 0.2
exhibited rapid and complete penicillinase and cephalosporinase
activity as determined by the whole cell semi-quantitative tests. None
of the isolates with specific activity of less than 0.1 showed high
penicillinase activity and these included six bacteroides isolates in
which no penicillinase was detected. Four of the 13 strains with
specific activity of less than 0.2 displayed high whole cell
cephalospo rinase activity.
4:3 Isoelectrlc focusing
The isoelectric points of ~-Iactamases present in crude extracts
of bacteroides isolates with elevated ~-Iactamase levels are listed in
Table 4.2. Most B.tragi/is strains yielded a single isoelectric point
between 4.9 and 5.3. No band was detected in extracts of three other
B.tragi/is strains (R240, R249 and R251) despite repeated testing.
Two strains, B.distasonis R118 and B.ovatus R215, possessed
enzymes which focused at two isoelectric points. Enzymes from the
five B.ovatus strains displayed a wide range of pi values (4.5-6.7).
These findings are in broad agreement with previous reports.
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Table 4.2 Isoelectric points (pi values) of f3-lactamases from
isolates of bacteroides with elevated f3-lactamase levels.
Bacterial strain Isoelectric point
B.fragilis R106 5.3
B.tragi/is R130 5.0
B.fragiJis R249 I'D
B.tragi/is R251 NJ
B.tragilis R186 4.9
B.fragilis R240 NJ
B.ovatus R137 4.5
B.ovatus R111 4.8
B.distasonis R 118 4.6,5.0
B.tragilis R208 5.0
B.tragilis R141 5.0
B.fragilis R126 5.0
B.ovatus R215 5.0,6.7
B.tragi/is R152 5.2
B.ovatus R112 5.1
B.fragilis R226 4.9
B.fragiJis R216 4.9
B.ovatus R102 5.0
B.fragilis R212 5.1
B.fragilis R134 4.9
B.thetaiota omicron R233 4.6
B.fragilis NCTC 9344- 5.1
--------------------------------
NO not detected
* control strain
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Dornbusch et al. (1980) described an isoelectric point of 4.9 for 20
isolates of B.tragi/is. Diverse' pi values for B.ovatus B-Iactamases,
4.0-7.1, have also been reported (Leung and Williams, 1978;
Dorndusch et al., 1980; Timewell et al., 1981). Leung and Williams
(1978) and Tally et al. (1979) gave isoelectric points for B.distasonis
of 5.1 and 4.8, and for B.thetaiotaomicron 4.5 and 4.6 respectively,
similar to the results of this study.
4:4 Inhibitor profiles
Results of experiments designed to test the ability of p-
chloromercuribenzoate (pcmb) and various antimicrobial compounds
to inhibit enzyme activities are shown in Table 4.3.
The concentrations of inhibitors required to achieve inhibition
of the individual enzymes varied considerably. There were only two
profiles common to more than one strain. These were those shown by
B.tragi/is R130 and B.tragi/is R152, and B.ovatus R137 and
B.tragilis R141. Five of the 21 strains, (B.tragi/is R106, B.tragi/is
R216, B.tragi/is R226, B.ovatus R111 and B.ovatus R112)
produced B-Iactamases which were at least partially susceptible to all
the inhibitors'tested, and a further seven isolates were susceptible to
some degree to all but pcmb.
The B-Iactamase from B.tragi/is R186 was not inhibited by any
of the agents tested, and those from B.tragilis R240, B.fragi/is R249
and B.tragilis R251 displayed very low levels of susceptibilty with no
inhibition by imipenem, latamoxef, cefoxitin, clavulanic acid or
sulbactam. All of the remaining 17 strains possessed B-Iactamases
which were fully susceptible to inhibition by imipenem. Four of these
enzymes showed some degree of inhibition by all of the four
compounds latamoxef, cefoxitin, clavulanic acid and sulbactam
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Table 4.3 Inhibitor profiles of·· B-Iactamases of 21 strains of
Bacteroides that exhibited increased ~-Iactamase activity
ICso (11M)
Bacterial strain pcmb imipenem latamoxef cefoxitin clavulanic sulbactam cloxacillin
acid
B.fragilis R106 10 <0.1 <0.1 <0.1 <0.1 <0.1 10
B.fragilis R130 >100 <0.1 <0.1 <0.1 <0.1 1 100
B.fragi/is R249 10 >100 >100 >100 >100 >100 100
B.fragilis R251 100 >100 >100 >100 >100 >100 100
B.fragilis R1B6 >100 >100 >100 >100 >100 >100 >100
B.fragilis R240 100 >100 >100 >100 >100 >100 >100
B.ovatus R137 >100 <0.1 <0.1 <0.1 <0.1 <0.1 100
B.ovatus R111 10 <0.1 <0.1 <0.1 <0.1 <0.1 100
B.distasonis R11B >100 <0.1 <0.1 <0.1 10 >100
B.fragilis R208 >100 <0.1 100 10 10 >100
B.fragilis R141 >100 <0.1 <0.1 <0.1 <0.1 <0.1 100
B.fragilis R126 >100 <0.1 <0.1 <0.1 <0.1 100
B.ovatus R215 >100 <0.1 10 100
B.fragilis R1S2 >100 <0.1 <0.1 <0.1 <0.1 100
B.ovatus R112 100 <0.1 <0.1 <0.1 <0.1 <0.1 100
B.fragilis R226 <0.1 <0.1 <0.1 <0.1 <0.1 10
B.fragilis R216 1 <0.1 <0.1 <0.1 <0.1 <0.1
B.ovatus R102 100 <0.1 <0.1 <0.1 <0.1 >100 >100
B.fragilis R212 >100 <0.1 100 1 >100
B.fragilis R134 >100 <0.1 <0.1 <0.1 <0.1 100
B.thetaiotaomicron R233 >100 <0.1 100 10 >100
B.tragi/is NCTC 9344" 10 <0.1 <0.1 <0.1 <0.1 <0.1 10
ICSO• lowest concentration of inhibitor producing >50% inhibition
pcrnb, p-chloromercuribenzoate
" control strain
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(B.fragi/is R208, B.ova.tLfs R215, B.fragi/is R212 and
B.thetaiotaomicron R233) and the ~-Iactamase from B.distasonis
R118 was not fully susceptible to clavulanic acid and sulbactam.
Typical B.fragi/is ~-Iactamases have been shown to be
inhibited by clavulanic acid and pcmb (Timewell et. al., 1981; Yotsuji
et al., 1983). Eley and Greenwood (1986a) described inhibitor
profiles of clinical bacteroides isolates by similar methods and
inhibitors to those used in this study. Of 13 strains studied, seven
were at least partially susceptible to all inhibitors tested, and a further
three were susceptible to some degree to all inhibitors except pcmb.
Two other strains showed overall low levels of susceptibility identical
to that displayed by B.fragilis R240 in this study.
4: 5 Antibiotic hydrolysis by crude ~-Iactamase extracts
Hydrolysis of the ~-Iactam antibiotics was assessed by HPLC.
Concentrated crude enzyme extracts from nine of the 21 isolates of
bacteroides producing elevated amounts of ~-Iactamase were able to
hydrolyse benzylpenicillin (in the presence of clavulanic acid),
cefoxitin, latamoxef or imipenem over the 20-hour incubation period
(Figs. 4.1-4.4). These nine strains included the eight isolates showing
increased resistance to cefoxitin, latamoxef or imipenem in MIC
titrations (See section 3:5) and B.fragi/is R249 which was of
intermediate susceptibility to cefoxitin and imipenem (MICs of 16 mgtl
and 1 mgll respectively), and susceptible to latamoxef (MIC 0.5 mgll)
(See table 3.3). Extracts of the other resistant strain, B.ovatus R102,
which showed low level resistance to cefoxitin and latamoxef (MICs of
32 mgll for both antibiotics), failed to hydrolyse any of the ~-Iactam
antibiotics tested.
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Fig. 4.1 Hydrolysis of benzylpenicillin in the
presence of clavulanic acid 4 mg/l by
enzyme extracts from bacteroides strains
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Fig. 4.2 Hydrolysis of cefoxitin by enzyme
extracts from bacteroides strains
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Fig. 4.3 Hydrolysis of latamoxef by enzyme
extracts from bacteroides strai ns
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In the presence of clavulanic acid, benzylpenicillin was
degraded by enzymes from all nine strains, although the enzymes
from B.fragilis R208, B.distasonis R118 and B.ovatus R215
hydrolysed benzylpenicillin more slowly than those from the other
strains. After 20 hours of incubation with extracts of B.tragi/is R208
and B.distasonis R118, hydrolysis of benzylpenicillin was
incomplete. Enzymes from B.distasonis R118 had little or no effect on
cefoxitin or fatamoxef in the test system. The other eight strains
possessed enzymes capable of degrading cefoxitin and latamoxef,
although only a minor degree of hydrolysis of these compounds by
B.tragi/is R208 was achieved. Latamoxef was hydrolysed more
rapidly than cefoxitin in all cases. Only four of the isolates, B.tragilis
R186, B.tragi/is R240, B.tragi/is R249 and B.tragi/is R251, were
active against imipenem. These isolates were able to hydrolyse the
antibiotic within two hours, although a small amount of the compound
was still detected after 20 hours of incubation. Interestingly, enzymes
from all four of these strains were capable of complete hydrolysis of
benzylpenicillin in the presence of clavulanic acid within 20 hours
indicating a lack of protection by this inhibitor.
Concentrated crude cell extract from the control strain,
B.tragi/is NCTC 9344, had minimal effect on the antibiotics tested.
The atypical 13-lactamasesfrom bacteroides isolates which are
able to hydrolyse 13-lactamasestable compounds such as cefoxitin,
latamoxef or imipenem are uncommon, comprising 6% of the strains
in this study and 4% of strains examined in a similar study in 1986
(Eley and Greenwood, 1986a).
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4:6 Hydrolysis of anttblotlcs by growing cultures of
bacteroides which show reduced susceptibility
To investigate the possibility that the hydrolysis of (3-lactam
antibiotics by crude cell extracts did not reflect the behaviour of cell-
bound enzyme, experiments were carried out with whole cells. The
hydrolysis of sub-MIC concentrations of antibiotic in broth cultures by
(3-lactamasesfrom growing cells was, therefore, assessed. The nine
bacteroides isolates which produced elevated amounts of (3-
lactamase and showed reduced antibiotic susceptibility (See section
3.5) were examined. The following concentrations of antibiotic were
added to the broth with the inoculum: benzylpenicillin 0.5 mg/l (in the
presence of clavulanic acid 4 mgJl), cefoxitin 16 mgJl, latamoxef 16
mgJl and imipenem 0.5 mgJl.These antibiotic concentrations allowed
growth of all the test strains except B.tragi/is R186, R240 and R251,
and B.distasonis R118 (with latamoxef). B.ovatus R215 (with
benzylpenicillin), and B.ovatus R102 (with imipenem). The antibiotic
residues, measured by microbiological assay, present after 22 hours
incubation are shown as percentages of the antibiotic control
(organism free) in Table 4.4.
Benzylpenicillin, in the presence of clavulanic acid, was
markedly degraded only by B.fragi/is R186. R212. R233, R240 and
R251. A residue of cefoxitin of >50% of the control value was found in
all cultures except B.fragi/is R212, B.ovatus R215 and
B.thetaiotaomicron R233. No latamoxef «10% of control) was
detected after 22 hours incubation with B.fragilis R212 and B.ovatus
R215, and >60% of the control value remained with B.ovatus R102,
B.tragilis R208 and B.thetaiotaomicron R233. More than 50% of the
control concentration of imipenem was detected after the incubation
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Table 4.4 Antibiotic remaining after 22 hours of
incubation with resistant isolates of bacteroides as a
percentage of the organism free control, measured by
microbiological assay.
Percentage of antibiotic remaining
benzyl-
11
imipenem latamoxef cefoxitin penicillin
Bacterial strain (0.5 mg/l) (16 mg/l) (16 mg/l) (0.5 mg/l)
-------------------------------
B.tragilis R186 <30+ f\G 64 <15+
B.fragi/is R208 66 70 73 51
B.fragiJis R212 75 <10+ <20+ <15
B.tragi/is R240 <30 f\G 55 <15
B.fragilis R251 <30 f\G 60 <15
B.distasonis R118 55 f\G 70 55
B.ovatus R102 f\G 81 88 88
B.ovatus R215 52 <10 48 f\G
B. thetaiotaomicron 57 62 <20 <15
R233
----------------------------------
NG = no growth
11 In the presence of clavulanic acid 4 mg/l
+ Limit of detection
Figures in brackets indicate the initial concentration of
antibiotic
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period in cultures of B.tragilis R208 and R212, B.distasonis R118,
B.ovatus R215 and B.thetaio·taomicron R233. No imipenem «30%
of the antibiotic control) was detected in the cultures of B.tragi/is
R186, R240 and R251.
Inactivation of ~-Iactamase stable ~-Iactam antibiotics by potent
~-Iactamases produced by whole cells of Bacteroides species have
been previously reported (Cuchural et al., 1983; Yotsuji et al., 1983;
Eley and Greenwood, 1986b). This study showed generally good
correlation between the degree of hydrolysis of ~-Iactams due to
concentrated crude ~-Iactamase extracts and whole growing cells.
Two exceptions, however, were apparent. B.thetaiotaomicron R233
displayed complete breakdown of latamoxef with the crude enzyme
extract but less than 50% inactivation of the antibiotic with whole cells.
This may have been due to the concentrated state of the ~-
lactamases in the crude extract. Also, B.distasonis A118 caused
some breakdown of cefoxitin and imipenem with whole cells only. It is
possible that inactivation of the ~-Iactamases of this strain occurred
during the sonication process of the crude cell extract preparation,
although this extract was able to partially breakdown benzylpenicillin.
4:7 Classification
The 21 ~-Iactamases were grouped into four distinct types, as
summarised in Table 4.5.
The first group consisted of the enzymes produced by
B.fragi/is A186, A240, R249 and R251. These had broadly similar
characteristics: low specific cephalosporinase activity; insusceptibiHy
to inhibition by ~-Iactamase inhibitors, including clavulanic acid;
relative resistance to imipenem. A distinctive feature of these strains
was the ability of crude enzyme extracts and whole cells to degrade
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Table 4.5 Characteristics of four types of fJ-lactamases from
24 bacteroides strains
MIC (mgtl) of
Type benzyl cefoxitin latamoxef imipenem
penicillin
Inhibitors of
s-iactamase
------------------------------------------------------
1 4-16 16 -32 0.5-4 1-4 Resistant
2 >16 >32 >128 1-4 Intermediate
3 >16 32 >8 2-4 Variable
4 4->64 4-32 0.5-32 ~ 1 Susceptible
Hydrolysis of
Type benzyl cefoxitin latamoxef imipenem
penicillin·
Activity of benzylpenicillin
restored by
clavulanic acid
--------------------------------------------------------
1 Yes Slow Yes Yes t\O
2 Yes Yes Yes t\O Partial
3 Slow t\O No t\O Yes
4 t\O t\O No t\O Yes
• In the presence of clavulanic acid
110
imipenem efficiently. These enzymes also hydrolysed latamoxef and,
more slowly, cefoxitin.
The second group was represented by B.fragi/is R212,
B.ovatus R215 and B.thetaiotaomicron R233. These strains
exhibited resistance to benzylpenicillin, cefoxitin and latamoxef, and
reduced susceptibility to imipenem. The fl-Iactamases displayed
intermediate or high specific activity and showed similar but not
identical inhibition profiles. These enzymes hydrolysed fl-Iactamase-
stable compounds other than imipenem, although the breakdown of
cefoxitin by B.ovatus R215 was modest, as was the degradation of
latamoxef by whole cells of B.thetaiotaomicron R233. These fl-
lactamases were not fully susceptible to clavulanic acid, and the
inhibitor failed to offer a high degree of protection to benzylpenicillin
in hydrolysis studies and, in the case of B.fragi/is R212 and
B.thetaiotaomicron R233, MIC titrations. Their isoelectric points were
diverse, as would be expected from these different species, indicating
that the enzymes are not identical.
The third group was composed of two strains, B.distasonis
R118 and BJragilis R208, which exhibited reduced susceptibility to
cefoxitin and imipenem, and, in the case of B.fragilis R208,
latamoxef. However, these antibiotics were hydrolysed poorly, or not
at all, by the crude enzyme extracts and whole growing cells. The
enzymes displayed variable inhibition profiles and intermediate levels
of specific activity. The activity of benzylpenicillin with both strains was
restored in the presence of clavulanic acid, although these enzymes
were not fully susceptible to the inhibitor in inhibition studies and slow
hydrolysis of benzylpenicillin was observed in the presence of
clavulanic acid.
Most of the strains encountered in this study retained a high
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degree of susceptibility to cefoxitin, latamoxef and imipenem, and
" .
belong to group four. Generally, these enzymes were fully susceptible
to ~-Iactamase inhibitors, and clavulanic acid fully restored the activity
of benzylpenicillin. These strains produced enzymes with a wide
range of specific activities that had no hydrolytic activity against ~-
lactamase-stable compounds. Their isoelectric points were all
between 4.5 and 5.3.
4:8 Discussion
The typical ~-Iactamase produced by B.fragilis has been well
characterised, and categorised as a member of group 2e of the Bush
classification scheme (Bush, 1989c). There is also a wide variety of ~-
lactamases, from B.tragi/is and other Bacteroides species, which
are more difficult to classify. Some have been allocated a position in
the Bush classification scheme in groups 1, 2d, 3 and 4 (Bush
1989b,c).
A general classification scheme for the diverse bacteroides ~-
lactamases would be beneficial. Two schemes have been put forward
by Eley and Greenwood (1986a,b). Using the characteristics of type
culture" strains and bacteroides known to hydrolyse cefoxitin,
latamoxef or imipenem, they defined three broad groups on the basis
of antibiotic hydrolysis and inhibitor profiles. The other study
examined clinical isolates of bacteroides and reported three groups
based on specific activity together with these other characteristics.
In this study, four enzyme types are apparent from the
characteristics of the sensitivity and hydrolysis of benzylpenicillin and
~-Iactamase stable ~-Iactam antibiotics, inhibitor profiles and effect of
clavulanic acid on the activity of benzylpenicillin, together with
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specific activity and isoelectric point.
These types appear' to have features similar to those of
bacteroides rJ-lactamasesdescribed by other workers. The properties
of strains of group one are similar to those previously described for
B.fragi/is 57, 97 and 119 by Eley and Greenwood (1989a,b) in that
they inactivated cefoxitin, latamoxef and imipenem and were
insusceptible to rJ-lactamaseinhibitors. Type one strains appear to be
similar to those belonging to Bush's class three which produce
carbapenem hydrolysing metallo-p-lactarnases (Cuchural et al.,
1986b; Bush, 1989c; Bandoh et al., 1991; Ajiki et al., 1991; Hedberg
et al., 1992). The failure to detect isoelectric focusing bands in three
of the four B.tragi/is strains of this group (R240, R249 and R251) is
anomalous and may reflect the low cephalosporinase activity of these
strains resulting in poor breakdown of nitrocefin, and hence poor
visibility, of the bands which represent the position of rJ-lactamaseon
the isoelectric focusing membrane. Interestingly, the two B.tragi/is
strains (TAL 2480 and 3636) reported by Cuchural et al. (1986b),
which produced zinc dependent carbapenemases, failed to focus well
enough to establish reliable pi values.
The f)-Iactamase types of group two are similar to those
enzymes produced by B.tragilis 0423, B.thetaiotaomicron 0456 and
B.distasonis R939 as previously described by Eley and Greenwood
(1986b). These strains are resistant to, and inactivate, latamoxef and
cefoxitin. They are more resistant than the type-culture strain to
imipenem, but do not inactivate it. Strain B.tragi/is 107, described by
Eley and Greenwood (1986a), has features similar to those of group
two except that it is generally more sensitive. This group of rJ-
lactamases also appears similar to other enzymes reported in the
literature, such as those from B.distasonis TAL 7860 and
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B.unitormis 2986, which hydrolysed cefoxitin and showed at least
partial inhibition with clavulanic acid (Olsson-Liljequist et al., 1980;
Hurlbut et al., 1990). The isoelectric points of these enzymes do,
however, cover a wide range.
Type three is difficult to relate to other unusual ~-Iactamases
produced by bacteroides which have been described by other
workers and categorised in the Bush classification scheme as
belonging to groups 1, 2d and 4. (Sato et al., 1982; Yotsuji et al.,
1983; Bush, 1989b,c). In many ways they resemble the type four
enzymes of this present study, and may be related to this group,
except for increased resistance to ~-Iactamase stable ~-Iactam
antibiotics and generally reduced susceptibility to ~-Iactamase
inhibitors.
Enzymes of type four appear to represent the typical
cephalosporinase that most bacterodes are known to produce and
belong to group 2e of the Bush classification scheme (Bush, 1989c).
The strains tested were chosen because of their ability to produce
enhanced levels of ~-Iactamase by the nitrocefin screening test. Type
four strains, therefore, probably produce greater than normal amounts
of this. common enzyme: B.tragi/is 2013E described by Eley and
Greenwood (1986b) as a high producer of typical B.tragilis ~-
lactamase is likely to belong to this group.
Groups one, two and four in this study, therefore, appear
consistent with the three categories described by Eley and
Greenwood (1986b).
Strains within groups two and three (B.tragi/is R208 and R212,
B.distasonis R118, B.ovatus R215 and B.thetaiotaomicron R233)
and B.ovatus R102 have been described which have reduced
susceptibility to cefoxitin, latamoxef or imipenem and possess ~-
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lactamases incapable of marked hydrolysis of these compounds. This
suggests that increased' resistance in these strains is due
mechanisms other than t}-Iactamase hydrolysis.
The remainder of this study was devoted to examining
resistance of B.fragilis to the carbapenems. Strains of groups one,
two and three contain bacteroides isolates with reduced susceptibility
to imipenem, having MICs of >1 mgll compared to 'normal' sensitive
strains with MICs of 0.06 mgll - 0.12 mgJl. Those of group one,
B.fragi/is R186, R240 and R251, produced t}-Iactamases that
hydrolyse imipenem rapidly. Increased resistance of these strains,
therefore, appears to be associated with carbapenemases and this
was examined further. Strains of types two and three, including
B.fragi/is R208 and R212, are incapable of rapid hydrolysis of
imipenem, suggesting other mechanisms of resistance, which were
also the subject of further examination.
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CHAPTER 5
CARBAPENEMASE ACTIVITY ASSOCIATED WITH
B.FRAG/LiS SHOWING INCREASED RESISTANCE TO
CARBAPENEMS
5: 1 Introduction
Of 108 clinical isolates of bacteroides, seven showed
increased resistance to imipenem (MIC >1 mg/l). All seven isolates
belonged to the group of 21 strains possessing elevated levels of rJ-
lactamase as judged by the semi-quantitative whole cell test with
nitrocefin. Five of these seven strains were B.tragi/is (R186, R208,
R212, R240, R251) which were studied in detail to elucidate the
mechanisms of resistance to imipenem. In addition, B.tragi/is 2013E,
0423 and 119, from the departmental culture collection, were
examined. These three strains have previously been reported as
having increased resistance to imipenem by Eley and Greenwood
(1986b) and represent the different B.fragilis types described in
section 4:8. Previous work in this study (Chapter 4) and by Eley and
Greenwood (1986b) indicated that B.fragilis R186, R240 R251 and
119 produced rJ-lactamasescapable of hydrolysis of imipenem.
The production, activity and characteristics of carbapenemases
from the resistant B.tragi/is strains were examined together with the
role of these enzymes in carbapenem resistance. Hydrolysis of
imipenem by whole cells of these eight isolates was again examined
to determine the rate of antibiotic degradation, and the residual
imipenem concentrations were measured by two assay methods and
compared. The impact of dense inocula on the activity of imipenem
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against these strains was investigated, as was the presence of the f3-
lactamase inhibitor, clavulanle' acid. The comparative susceptibility of
imipenem and meropenem to these carbapenemases was
determined. The specific imipenemase activites of the enzymes were
calculated and correlated with imipenem resistance. Also, the
carbapenemases were characterised in terms of cation dependency.
5:2 Susceptibility and imipenem stability of additional
B.fragilis strains
The MICs of imipenem obtained by the agar incorporation
method (BHIS agar) after 48 hours of incubation were found to be 2
mgll for B.tragi/is 2013E and 0423, and 16 mgll for B.tragilis 119.
These results were identical to, or within one dilution of, those values
obtained by Eley and Greenwood (1986b).
Rapid hydrolysis of imipenem by concentrated crude cell
extracts was shown only with B.tragi/is 119, which totally degraded
imipenem 50 mgll within two hours of incubation (Fig. 5.1). The
enzymes from B.tragi/is 0423 and 2013E caused slow hydrolysis of
imipenem so that after 20 hours of incubation 55% and 83% of the
control remained respectively. The amount of imipenem present was
only minimally reduced by enzymes from control strain NCTC 9344.
Eley and Greenwood (1986b) also reported complete hydrolysis of
imipenem by B.tragi/is 119, but they observed no detectable
breakdown of imipenem with B.tragilis 0423 and 2013E.
5:3 Hydrolysis of imipenem by B.fragilis strains
exhibiting reduced susceptibility to the drug
The hydrolysis of imipenem was assessed at two
concentrations, 0.5 mg/l and 50 mgll, with whole cells of B.tragilis
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Fig. 5.1 Hydrolysis of imipenem by enzyme extracts of B.fragilis
culture collection strains with increased resistance to the drug
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strains showing increased resistance to imipenem. Tests were carried
out in BHIS broth.
The lower imipenem concentration, 0.5 mg/I, which was below
the MIC for the moderately resistant test strains, was added with the
inoculum at the begining of the experiment. The speed of hydrolysis
by rJ-lactamases from these growing cells was determined by
measuring the concentration of imipenem by microbiological assay
after 6 and 22 hours incubation.
The higher imipenem concentration, 50 mg/I, was also used to
assess hydrolysis by enzymes produced by whole cells and to
compare the measurements of residual imipenem as determined by
microbiological assay and HPLC. In these experiments, antibiotic was
added to bacterial cultures in the late logarithmic phase of growth.
Growth was monitored turbidimetrically and drug added when growth
had raised the opacity to a level of 70% of maximum, equivalent to a
viable count of ca 108 cfu/ml.
(1) Hydrolysis of imipenem 0.5 mgtl by growing B.fragilis
cultures
With B.fragilis R186, R240, R251 and 119 between 29% and
44% of'the control concentration of imipenem was lost after 6 hours of
incubation and <30% of the organism-free control value remained
after 22 hours (Table 5.1). Cultures of B.fragi/is R208, R212, 2013E
and 0423 had little or no effect on the imipenem concentration after 6
hours of incubation and between 54% and 75% of the control value
remained after 22 hours.
The rate of hydrolysis of imipenem by whole cells appeared to
be less than that with concentrated crude cell extracts. After two hours
exposure with crude extract of type one enzymes, hydrolysis of
imipenem 50 mg/I was virtually complete. Using growing cells and
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Table 5.1 Hydrolysis of imipenem (0.5 mgll) by cultures of
B.fragi/is that exhibited reduced susceptibility to the drug.
Bacterial strain
Percentage of imipenem control
*remai ning after
6h 22h
--------------------
B.fragilis R186 68 <30+
B.fragilis R240 56 <30
B.fragilis R251 71 <30
B.fragilis 119 60 <30
B.fragilis R208 100 54
B.fragilis R212 100 60
B.fragilis 2013E 100 75
B.fragilis 0423 93 62
+ limit of detection = 0.06 mgll
* Measured by microbiological assay with a clinical isolate
of Strep. pyogenes as indicator organism.
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one hundreth of that lrnlpenem concentration, more than 50% of the
imipenem remained after six hours. After 20 hours incubation, with
both the whole cells (Table 5.1) and concentrated cell extract (Figs.
4.4 and 5.1), type one enzymes (B. tragi/is R186, 240, 251 and 119)
hydrolysed imipenem to <30% of the antibiotic control, and with types
two and three (B.tragi/is R208, R212, 2013E 0423) >50% of the
antibiotic remained.
(2) Hydrolysis of imipenem 50 mg/I by whole cells of
B.fragi/is
Both microbiological assay and HPLC revealed that ~60% of
the imipenem control concentration remained after 18 hours of
incubation in the presence of whole cells of B.tragilis R208, R212
2013E and 0423 (Table 5.2). B.tragi/is R186, R240 and 119,
however, caused a marked hydrolysis of imipenem with no drug
detected after 18 hours of incubation. B.tragi/is R251 also caused a
substantial reduction in the residual imipenem concentration with
<20% of the control remaining.
The results obtained with the two assay methods were
genera~ly similar, although those obtained by HPLC tended to be
higher compared to imipenem concentrations measured by
microbiological assay. Hydrolysis of imipenem (50 mgJl)by crude cell
extracts measured by HPLC after 20 hours of incubation (Fig. 4:4)
resulted in imipenem residues similar to those seen with whole cells
(Table 5.2).
5:4 Turbidimetry and inoculum effect
The effect of imipenem on inocula of ca. 105 and 108 cfu/ml
was examined turbidimetrically to investigate the influence of (3-
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Table 5.2 Hydrolysis of imipenem (50 mg/l) by late-
logarithmic phase cultures of B.fragilis. Results expressed
as percentage of antibiotic control remaining after
incubation for 18 hours, as judged by biological assay and
HPLC.
Bacterial strain
Percentage imipenem remammg
Biological assay 1< HPLC#
B.fragi/is R186 <5+ <15++ (17)
B.fragi/is R240 <5 <15 (10)
B.fragi/is R251 11 19 (14 )
B.fragi/is 119 <5 <15 «5)
B.fragi/is R208 84 90 (72)
B.fragilis R212 100 100 (90)
B.fragi/is 2013E 60 88 (83)
B.fragilis 0423 65 70 (55)
B.fragilis NCTC 9344 100 100 (93)
---------------------------
1<
with 'Oxford' Staphylococcus as indicator organism and
residue diluted 1 in 10 before assay
+ Limit of detection (=0.12 mg/l)
++ Limit of detection (=5 mg/l)
In parentheses: results after exposure of imipenem (50 mg/l)
to crude cell extracts for 20 hours of incubation measured by
HPLC (from Figs 4.4 and 5.1)
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lactamase on the response of whole cells to the antibiotic. In this
system, susceptibility of th'e' antibiotic to a particular ~-Iactamase
should be reflected in an altered response of the larger inoculum.
Greater numbers of bacteria should result in an increase in the total
amount of intracellular ~-Iactamase present in the culture which is
available to inactivate the susceptible tHactam antibiotic, leading to
an increase in resistance.
Continuous opacity records obtained in low and high inoculum
experiments with each of the B.tragi/is strains are given in Figs. 5.2-
5.19. A summary of the results of these turbidimetric data in terms of
MACs (lowest antibiotic concentration causing deviation from normal
growth) and MICs (lowest antibiotic concentration required to
suppress growth for the whole period of observation) for each
inoculum is given in Table 5.3.
An inoculum effect that was reflected most markedly in a
change in the MAC of imipenem, but also to a lesser extent in the
turbidimetric MIC, was observed with those strains that produced
enzymes able to degrade imipen&m, i.e. B.tragi/is R186, R240, R251
and was particularly marked with B.fragi/is 119. For these strains,
MACs of imipenem in the high inoculum experiments were at least
eight fold higher than those obtained with the low inoculum, and the
MICs for the high inoculum were at least twice the low inoculum MICs.
No inoculum effect was observed with B.tragi/is R212 and 0423.
B.tragi/is R208 and 2013E showed a slight inoculum effect, the
MACs of imipenem increasing by a factor of two as the inoculum was
raised. This was also the case for the B.tragilis NCTC 9344 control.
These results indicate that imipenem is susceptible to ~-Iactamases of
B.tragi/is R186, R240, R251 and 119, and these ~-Iactamases are a
factor in the resistance of these strains to the drug.
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Fig. 5.2 Continuous opacity records of B.fragi/is R186
exposed at time zero to imipenem at the concentrations shown
(mg/l). The inoculum was ca. 105 etu/ml in each case
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Fig. 5.3 Continuous opacity records of B.fragilis R186 with
imipenem added at 30% opacity (indicated by arrow) to achieve
the concentrations (mgll) shown
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Fig. 5.4 Continuous opacity records of B.fragilis R240
exposed at time zero to imipenem at the concentrations shown
(mgJl). The inoculum was ca. 105 ctu/ml in each case
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Fig. 5.5 Continuous opacity records of B.fragilis R240 with
imipenem added at 300/0 opacity. (indicated by arrow) to achieve
the concentrations (mgl1) shown
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Fig. 5.6 Continuous opacity records of B.fragiJis R251
exposed at time zero to imlpenem at the concentrations shown
(mgll). The inoculum was ca. 105 cfu/ml in each case
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Fig. 5.7 Continuous opacity records of B.fragi/is R251 with
imipenem added at 300/0 opacity (indicated by arrow) to achieve
the concentrations (mg/l) shown
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Fig. 5.8 Continuous opacity records of B.fragilis 119 exposed
at time zero to imipenem at. the concentrations shown (mgll).
The inoculum was ca. 105 cfu/ml in each case
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Fig. 5.9 Continuous opacity records of B.fragilis 119 with
imipenem added at 30% opacity (indicated by arrow) to achieve
the concentrations (mg/l) shown
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Fig. 5.10 Continuous opacity records of B.fragi/is R208
exposed at time zero to imipenem at the concentration shown
(mgll). The inoculum was ca. 105 efu/ml in each case.
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Fig. 5.11 Continuous opacity records of B.fragilis R208 with
imipenem added at 30% opacity (indicated by arrow) to achieve
the concentration (mgtl) shown
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Fig. 5.12 Continuous opacity records of B.fragi/is R212
exposed at time zero to imipenem at the concentration shown
(mgll). The inoculum was ca.' 105 cfu/ml in each case.
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Fig. 5.13 Continuous opacity records of B.fragilis R212 with
imipenem added at 30% opacity (indicated by arrow) to achieve
the concentration (mgtl) shown
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Fig. 5.14 Continuous opacity records of B.fragiJis 2013E
exposed at time zero to imipenem at the concentration shown
(mg/l). The inoculum was ca. '1'05 cfu/ml in each case.
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Fig. 5.15 Continuous opacity records of B.fragilis 2013E
with imipenem added at 300/0 opacity (indicated by arrow) to
achieve the concentration (mg/l) shown
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Fig. 5.16 Continuous opacity records of B.fragi/is 0423
exposed at time zero to imipenem at the concentration shown
(mg/l). The inoculum was ca. 105 cfu/ml in each case.
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Fig. 5.17 Continuous opacity records of B.fragilis 0423 with
imipenem added at 300/0 opacity (indicated by arrow) to achieve
the concentration (mgll) shown
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Fig. 5.18 Continuous opacity r:ecords of B.fragi/is NCTC 9344
exposed at time zero to imipenem at the concentration shown
(mg/l). The inoculum was ca. 105 cfu/ml in each case.
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Fig. 5.19 Continuous opacity records of B.fragilis NCTC 9344
with imipenem added at 30% opacity (indicated by arrow) to
achieve the concentration (mgll) shown
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Table 5.3 Summary of turbidimetric data showing the MACs
and MICs of imipenem for the high and low inocula of each
isolate.
Bacterial strain inoculum MAC (mg/l) MIC (mg/l)
B.fragiJis R1B6 low S;0.25 2
high 2 4
B.fragiJis R240 low 0.12 2
high 1 4
B.fragiJis R251 low S;0.25 2
high 2 4
B.fragilis 119 low S;1 16
high 16 64
B.fragiJis R20B low 0.12 1
high 0.25 1
B.fragiJis R212 low 1 2
high 1 2
B.fragilis 2013E low 0.06 0.25
high 0.12 0.25
B.fragilis 0423 low 0.12 0.5
high 0.12 0.5
B.fragi/is NCTC 9344 low 0.06 0.25
high 0.12 0.25
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A striking effect noted in experiments in which low inocula of
B.tragi/is R186, R240, R251, 119, 2013E and NCTC 9344 were
exposed to imipenem was a marked increase in turbidity that
occurred up to 10 hours after the addition of the antibiotic before the
onset of cell lysis and subsequent regrowth (Figs. 5.2, 5.4, 5.6, 5.8,
5.14 and 5.18). This initial increase in turbidity before cell lysis was
less marked with B.tragi/is 0423 and R208, and absent with
B.tragi/is R212 (Figs. 5.10, 5.12 and 5.16). These findings could not
be associated with any morphological changes and remain
unexplained.
5:5 Effect of clavulanic acid on broth dilution MICs
of imipenem
The effect of the B.fragilis J3-lactamases on the activity of
imipenem was also investigated by the use of the J3-lactamase
inhibitor, clavulanic acid. Inhibitor profiles (section 4.4) indicate that
the response of J3-lactamasesof B.tragi/is test strains to clavulanic
acid were diverse: B.tragi/is R186, R240, R251 and 119 were
resistant, BJragi/is R208 and R212 showed moderate susceptibility,
and B.tragi/is 0423 and 2013E were fully susceptible. The broth
dilution MICs of imipenem, with and without clavulanic acid, are
displayed in Table 5.4.
The impact of the J3-lactamase inhibitor on the MICs of
imipenem for B.tragilis R186, R240, R251, 119, R212 and 0423 was
minimal, the MICs in the presence of inhibitor being equal to or within
one two-fold dilution of the MIC without inhibitor. The negligible effect
of clavulanic acid on the sensitivity of imipenem to B.tragi/is R186,
R240, R251 and 119 was to be expected in view of the resistance of
the enzymes to this inhibitor. The results with the clavulanic acid
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Table 5.4 Broth dllution MICs of imipenem in the presence
and absence of clavulanic acid
Bacterial strain
MICs (mg/l)
imipenem imipenem +
clavulanic acld"
a.fragilis R186 4 4
a.fragi/is R240 4 2
a fragi/is R251 4 4
B.fragilis 119 16 8
B.fragilis R208 2 0.5
a.fragilis R212 4 2
a.fragilis 2013E 2 0.25
a.fragilis 0423 2 1
a.fragilis NCTC 9344+ 0.12 0.06
----------------------
* clavulanic acid at a fixed concentration of 4 mgll
+ control strain
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susceptible enzymes of B.tragi/is R212 and 0423, however, indicated
that ~-Iactamase activity was not responsible for the resistance of
these strains.
The MICs of imipenem in the presence of clavulanic acid for
B.tragi/is R208 and 2013E were between four and eight-fold less
than those of imipenem alone. Enzymes from these strains had
previously shown susceptibility to clavulanic acid, and an increase in
imipenem activity in the presence of this inhibitor suggests some
involvement of ~-Iactamases in the increased resistance to imipenem.
For further investigations into the activities and characterisation
of carbapenemases, enzymes from three additional B.tragi/is strains,
R249, 57 and 97, known or reported to produce imipenem
hydrolysing [3-lactamases, were included. The MIC of imipenem for
B.tragi/is R249 from this study was 1 mgll (section 3:5). B.tragi/is 57
and 97 were clinical isolates described by Eley and Greenwood
(1986a) and the MIC of imipenem for these strains was reported as 8
mg/I and 0.25 mg/I respectively.
5:6 Comparative activity and stability of imipenem and
meropenem
The susceptibility and ~-Iactamase activity of B.fragilis which
showed increased resistance to imipenem were assessed using
meropenem in order to ascertain whether these characteristics
determined with imipenem were common to other carbapenems.
Meropenem and imlpenem were shown generally to have
similar activity against these B.fragi/is strains, MICs of both
compounds being within one dilution for all except three strains,
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B.tragilis R240, R249 and 97, all carbapenemase producers, for
which the MIC of meropenem was four-fold higher than that of
imipenem (Table 5.5).
The degradation of meropenem and imipenem, as measured
by HPLC, by identical samples of concentrated crude cell extracts of
these B.tragi/is strains, is given in Figs. 5.20 and 5.21. Hydrolysis of
the two carbapenems was similar. Extracts of B.tragi/is R186, R240,
R249, R251, 57, 97 and 119 rapidly hydrolysed both meropenem and
imipenem. Hydrolysis of both carbapenems was generally complete
within four hours although a small residue of imipenem was still
detectable after 20 hours of incubation in the case of B.tragilis R186.
5:7 Specific imipenemase activity
The specific imipenemase activity (SIA) was defined as the
number of /l moles imipenem hydrolysed/minlmg of protein in the cell
extract. Hydrolysis of imipenem was determined
.spectrophotometrically by a decrease in absorbance at 299nm and
37oC. Not suprisingly, enzymes from B.fragilis R208, R212, 2013E,
0423 and NCTC 9344, previously shown to be incapable of rapid
hydrolysis of imipenem, showed no or minimal change in absorbance
(SIA = 0). With B.tragi/is strains R186, R240, R249, R251, 57, 97 and
119, the reduction in absorbance was most rapid over the initial five
minute period of exposure of imipenem to the ~-Iactamases. The
specific imipenemase activities of these strains are shown in Table
5.6. The greatest specific activities were obtained with B.tragilis
strains 57 and 119 (0.026 and 0.027 /lmoles/min/mg of protein
respectively). These values are approximately two to ten times greater
than the specific activities of the remaining strains. Of the strains
tested, B.tragi/is 57 and 119 were the least susceptible to imipenem
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Table 5.5 Comparative susceptibilities to imipenem and
meropenem of eleven B.tragi/is test strains.
MIC mg/l
Bacterial strain meropenem imipenem
B.tragi/is R186 4 2
B.fragiJis R240 8 2
B.tragi/is R249 2 0.5
B.fragilis R251 4 2
B.fragilis 57 16 8
B.fragilis 97 2 0.5
B.fragilis 119 32 16
B.fragilis R208 2 2
B.fragilis R212 2 2
B.fragi/is 2013E 2 2
B.fragills 0423 0.5 1
B.fragilis NCTC 9344* 0.12 0.12
* control strain
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Fig. 5.20 Hydrolysis of imipenem by enzyme extracts from B.tragi/is strains
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Fig. 5.21 Hydrolysis of meropenem by enzymes from B.tragi/is strains
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Table 5.6 Specific imipenemase activity of extracts of seven
carbapenemase producing B.fragilis strains that showed
increased resistance to imipenem
Bacterial strain specific imipenemase activity"
----------------------
B.fragilis R186 0.003
B.fragilis R240 0.012
B.fragilis R249 0.004
B.fragilis R251 0.008
B.fragilis 57 0.026
B.fragilis 97 0.008
B.fragilis 119 0.027
It /J moles imipenem hydrolysed/min/mg of protein
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(MIC 8 mgtl and 16 mgtl respectively).
5: 8 Detection of metallo-p-Iactemases
To examine whether the organisms produced zinc dependent
~-Iactamases (metalto-p-lactamases), inhibition of hydrolysis of
imipenem in the presence of the ion chelator EDTA and the
restoration of ~-Iactamase activity with the addition of zinc ions was
investigated. Experiments were also carried out with nitrocefin as
substrate to determine the presence of any non-metallo-
cephalosporinases in addition to metallo-p-lactamases.
(1) With imipenem as substrate
The changes in absorbance at 299 nm and 37oC, representing
hydrolysis of imipenem by concentrated crude extracts of bacteroides
strains with and without EDTA (1 mM) or EDTA and zinc sulphate (1
mM) or zinc sulphate, are shown in Figs. 5.22-5.28. ~-Lactamases
from B.tragilis R186, R240, R249, R251, 57, 97 and 119 hydrolysed
imipenem, although the rate of degradation by B.fragilis R186 and
R249 was slow. EDTA inhibited imipenem hydrolysis by all these
strains, and hydrolysis was restored when zinc sulphate was added.
~-Lactamases from these seven strains, therefore, appeared to be
zinc dependent carbapenemases or metallo-f-lactarnases. There
was a tendency for the addition of zinc sulphate to potentiate
hydrolysis of imipenem in the presence and absence of EDTA,
indicating insufficient zinc ions in the enzymelimipenem test system to
allow full expression of ~-Iactamase activity. This affect was
particularly marked in the case of B.fragilis R251. Enzymes from
B.fragilis R208, R212, 2013E, 0423 and the NCTC 9344 control
produced no change in absorbance with or without EDTA indicating
their inability to hydrolyse imipenem and the absence of metallo-b-
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Fig. 5.22 Spectrophotometric evaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragi/is R186 in the
presence of ethylenediaminetetraacetic acid (EDTA) and zinc
sulphate
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Fig. 5.23 Spectrophotometric. evaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragilis R240 in the
presence of ethylenediaminetetraacetic acid (EDTA) and zinc
sulphate
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Fig. 5.24 Spectrophotometric evaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragilis R249 in the
presence of ethylenediaminetetraacetic acid (EDTA) and zinc
sulphate
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Fig. 5.25 Spectrophotometric evaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragi/is R251 in the
presence of ethylenediaminetetraacetic acid (EDT A) and zinc
sulphate
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Fig. 5.26 Spectrophotometric evaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragilis 57 in the presence
of ethylenediaminetetraacetic acid (EDTA) and zinc sulphate
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Fig. 5.27 Spectrophotometric .eyaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragilis 97 in the presence
of ethylenediaminetetraacetic acid (EDTA) and zinc sulphate
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Fig. 5.28 Spectrophotometric evaluation of the hydrolysis of
imipenem by crude enzyme extracts of B.fragi/is 119 in the
presence of ethylenediaminetetraacetic acid (EDTA) and zinc
sulphate
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lactamases.
(2) With nitrocefin as substrate
The rates of change in absorbance at 482 nm and 370C in
experiments in which nitrocefin was incubated with concentrated
crude cell extracts in the presence of phosphate buffer, EDTA (1 mM),
zinc sulphate (1 mM) or a mixture of EDTA and zinc sulphate, are
shown in Table 5.7. The hydrolysis of nitrocefin by extracts of
B.fragilis R186, R240, R249, R251, 57, 97 and 119 was completely
inhibited by EDTA. With the addition of zinc sulphate, however,
hydrolysis of nitrocefin was restored. The results indicate that these
strains lack cephalosporin hydrolysing non-metallo-f3-lactamases
although they produce zinc dependent metallo-f3-lactamases. In
contrast, non-metallo-cephalosporinases were produced by B.fragi/is
strains R208, R212, 0423 and 2013E, as shown by similar rates of
change in absorbance of nitrocefin in buffer, EDTA, and the mixture of
EDTA and zinc sulphate. In this system, zinc sulphate alone had no
effect on the hydrolysis of nitrocefin by the crude cell extracts tested.
5:9 . Effect of zinc acetate on the imipenem susceptibility
of carbapenemase producing B.fragilis
In order to determine whether the zinc concentration of the
BHIS sensitivity testing medium was a factor in the susceptibility to
imipenem of isolates of B.fragi/is which produce zinc dependent
carbapenemases, MICs were performed in BHIS with and without
supplemented zinc ions. The addition of zinc acetate to the BHIS
broth, which increased the zinc ion content from 75 to 150 J,lmols/l,
had minimal effect on the MICs of imipenem of these B.fragi/is
isolates (Table 5.8). This indicates that the imipenem resistance
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Table 5.7 Effect of EDTA and zinc sulphate, alone and in
combination, on the hydrolysis of nitrocefin by crude
extracts of B.fragilis strains.
Change in absorbance/min (482 nm) of
nitrocefin with crude extract and:
Bacterial strain Buffer EDTA1< ZnS04* 1< *EDTA +ZnS04
-------------------------------------------------------B.fragilis R186 0.03 0 0.03 0.03
B.fragilis R240 0.03 0 0.03 0.03
B.fragilis R249 0.02 0 0.02 0.02
B.fragilis R251 0.03 0 0.03 0.01
B.fragiJis 57 0.04 0 0.04 0.03
B.fragilis 97 0.02 0 0.03 0.02
B.fragilis 119 0.04 0 0.04 0.04
B.fragilis R208 0.09 0.10 0.10 0.09
B.fragilis R212 0.12 0.10 0.10 0.09
B.fragllls 2013E 0.15 0.14 0.12 0.14
B.fragiJis 0423 0.12 0.09 0.10 0.09
1<
at a concentration of 1 mM
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Table 5.8 Minimum inhibitory concentration of imipenem of
carbapenemase producing B.fragilis strains with and without
zinc ion supplemented in BHIS.
MIC mgtl
Bacterial strain no supplement+ zinc added*
B.fragiJis R186 2 2
B.fragiJis R240 2 2
B.fragilis R249 0.5 1
B.fragiJis R251 2 4
B.fragilis 57 16 16
B.fragilis 97 1 0.5
B.fragiJis 119 32 32
B.fragi/is NCTC 9344x 0.12 0.12
x = non-carbapenemase producing control
+ = final zinc concentration 75J.lmolsll
* = " " " t scurnots
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displayed by these strains when tested in BHIS medium was not
artificially low as a result insufficient zinc ions.
5.10 Discussion
Hydrolysis of imipenem was demonstrated by exposure of the
drug to both concentrated crude enzyme extracts and whole cells of
certain strains of B.tragilis. However, the rate of hydrolysis by whole
cells was markedly slower than that by concentrated crude enzyme
extracts, although the degree of imipenem hydrolysis after 18 - 20
hours incubation was similar. This was despite the possible
damaging affects of the sonication process on the intracellular
molecular configuration and activity of the j3-lactamasespresent in the
crude extracts. The increased rate of hydrolysis by crude cell extracts
could be due to the release of the j3-lactamases from the periplasmic
space and concentration of the enzyme extracts.
Microbiological assay proved more sensitive than HPLC for the
measurement of imipenem residues with whole cells and produced
levels which tended to be lower than those obtained by HPLC. It is
possible that some of the imipenem detected by the HPLC system
was not present in a microbiologically active form.
The role of carbapenemases in the resistance to imipenem of
B.tragi/is strains was shown by the inoculum effect observed by
turbidimetry and by their specific imipenemase activities. The
inoculum effect was particularly marked according to the criterion of a
change in the MAC. This effect was minimal with the non-
carbapenemase producers. These findings indicate that, in the case
of carbapenemase producing strains, increased resistance can be
explained entirely by j3-lactamaseactivity. The largest inoculum effect
was seen with B.tragi/is 119; since the MIC of imipenem for this strain
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was at least fourfold higher than for the other carbapenemase
producing strains, an association between increased levels of
carbapenemase and increased resistance to imipenem is implied.
Also, the results of experiments to establish the ~-Iactamase specific
imipenemase activities showed that strains which were the most
resistant to imipenem exhibited the highest specific activity (B.tragilis
57 and 119). Increased carbapenem resistance in B.tragi/is due to
elevated carbapenemase activity has also been reported by
Podglajen et al. (1990). A correlation between the production by
B.tragi/is of other ~-Iactamases and their contribution to
cephalosporin resistance has previously been established (Olsson
et al., 1979; Simpson et al., 1982; Yotsuji et al., 1988; Rogers et
al., 1993).
With nitrocefin as substrate, the low levels of hydrolysis
observed with the metallo-p-Iactarnases was completely inhibited by
EDTA suggesting the absence of 'normal' 2e type ~-Iactamases from
these strains. Single isoelectric points were found by electrophoresis
of extracts of carbapenemase producers including B.tragilis R186
(section 4:3), indicating the presence of one ~-Iactamase type. Yotsuji
et al. (1983), Eley and Greenwood (1986a,b) and Bandoh et al.
(1991) described similar findings. Podglajen et al. (1992a), however,
described metallo-f-lactamase producing B.fragilis strains with two
species of enzyme as shown by isoelectric focusing. The band
remaining after treatment with EDTA, which removed the metallo-p-
lactamase activity, had a pi value of ~4 and is therefore unlikely to
represent 'normal' B.tragilis ~-Iactamases for which the pi is ca. 5.
The strains examined were, in most cases, equally sensitive to
meropenem and imipenem, although three of the seven
carbapenemase producers were marginally less susceptible to
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meropenem. These carbapenerns have been previously shown to
exhibit similar activity against unselected clinical isolates of B.fragiJis
and other Bacteroides species (Edwards et al., 1989; Neu et al.,
1989; Sumita et al., 1989). Enzymes of seven B.tragi/is test strains
hydrolysed the two carbapenems with similar efficiency. Neu et al.
(1989) and Sumita et al. (1989) reported on the stability of
meropenem and imipenem to various ~-Iactamases. They found that
both carbapenems were stable to ~-Iactamases from a variety of
Gram negative 'coliform' organisms, P.aeruginosa, Staph. aureus
and typical B.fragilis strains, although an enzyme from
Xanthomonas ma/tophilia was shown to degrade both meropenem
and imipenem, the rate of hydrolysis of imipenem being slightly
greater than that of meropenem. This ~-Iactamase activity was
associated with carbapenem resistance.
Four strains from the original study and three of the additional
strains were shown to produce zinc dependent metallo-p-lactamases.
Only seven other B.tragi/is strains of this type have been
characterised (Hedberg et a/., 1992; Payne, 1993). The level of
resistance was low: MICs of imipenem were usually at or below the
breakpoint of 4-8 mg/l recommended to designate resistance
(Finegold, 1989; Phillips et a/., 1992) although they were 5 to 10 fold
greater than values for fully sensitive B.tragilis strains. The highest
MIC observed was 16 mg/l, considerably lower than the values
described for most carbapenemase producing B.tragilis strains
examined by other workers. High resistance to imipenem in
B.tragi/is, with MICs >100 mg/l, was reported by Cuchural et al.
(1986b), Ajiki etal. (1991), 8andoh eta/. (1991, 1992) and Hedberg
et al. (1992), although the MIC of imipenem for an isolate presumed
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to produce a metaJlo-B-lactamase described by Yotsuji et al. (1983)
was 12.5 mg/l.
The low MICs of imipenem for zinc dependent metallo-B-
lactamase producing B.tragi/is strains in this study did not appear to
be due to lack of zinc ions in the sensitivity testing medium. When the
MICs of imipenem for these strains were tested in the BHIS broth
medium supplemented with zinc acetate to increase the zinc content
from 75 urnots/l to 150 Jlmols/l, no rise in MICs were detected. Failure
to demonstrate an effect of zinc ions on the imipenem susceptibility
contrasts with the result of experiments with zinc dependent B-
lactamase-producing X. maltophiJia described by Hawkey et al.
(1993).
Bacteroides were considered to display increased resistance
to imipenem if the MIC was ~2 mgll; higher than the MICgO for
imipenem. Two strains, B.tragiJis R249 and 97, have been shown to
possess imipenem hydrolysing metallo-B-Iactamases and yet their
MICs of 0.5 mgll imipenem were within the sensitive range. Shannon
et al. (1986) reported imipenem-hydrolysing activity in Aeromonas
hydrophila which did not confer resistance to the drug. They
speculated that imipenem may saturate the preferred PBP target at
low concentrations so that the B-Iactamase was unable to .givemuch
protection. This present study shows that low carbapenemase activity
is associated with lack of imipenem resistance in B.fragilis.
Similar observations have been made recently by Podglajen
et al. (1992a), who reported four clinical isolates from French
hospitals with MICs of 1 mgll imipenem. These strains carried the
carbapenemase gene and enzyme extracts exhibited specific
imipenemase activities of ca. 3 Jlmols/min/mg. protein. They were
able to produce high resistance to imipenem (MIC >100 mgll) in these
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isolates by one-step mutation on medium containing imipenem at a
concentration of 20 mgt!. Enzymes from these mutants displayed a 41
to 95-fold increase in specific imipenemase activity, associated with
greater expression of the carbapenemase gene. The isolates of
B.tragi/is investigated in the present study appear to differ from those
used by Podglajen et al. (1992a) in that the specific imipenemase
activities of their enzymes were >100-fold higher. The comparison of
specific activities between laboratories can, however, be problematic
as results depend on non standardised technical factors such as the
degree of centrifugation of the sonicated extracts and growth
conditions of bacteria before harvesting (Edwards and Greenwood,
1990).
The effect of clavulanic acid on the activity of imipenem
indicated a possible role of f)-Iactamases other than metallo-p-
lactamases in the resistance of B.tragi/is R20S and 2013E. The
degree and rate of hydrolysis of imipenem by cell extracts and whole
cells of these strains (See sections 5.2 and 5.3) was, however, only
modest. These strains also showed little inoculum effect in
turbidimetric experiments, the MACs of imipenem increasing only by a
factor of two when the inoculum density was increased (See section
5:4). Although clavulanic acid was shown to inhibit the enzymes
produced by these strains, the MICs of imipenem remained above the
normal sensitive range in the presence of the inhibitor, implying the
involvement of resistance mechanisms other than f)-Iactamase. It has
previously been stated that B.fragi/is 2013E produces increased
amounts of the typical B.fragi/is chromosomal f)-Iactamase and
B.fragilis R20S in many ways resembles this strain (See section 4:S).
It is possible, that, in the case of these two organisms, the production
of high levels of 'normal' B.tragi/is f)-Iactamases, which can slowly
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degrade the antibiotic, contributes to reduced bacterial susceptibility.
Livermore (1993) also described trace carbapenemase activity in
some serine ~-Iactamases from P.aeruginosa and Enterobacter
cloacae, which, in association with impermeability, could produce
resistance. These 'weak' carbapenemases can hydrolyse one or two
molecules of carbapenem per minute, but hydrolyse cephalosporins
significantly more rapidly. In contast, metallo-p-tactamases hydrolyse
carbapenems and other ~-Iactams at the rate of several molecules
per minute.
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· GHAPTER 6
PERMEABILITY AS A FACTOR IN THE RESISTANCE OF
B.FRAGILIS TO IMIPENEM
6: 1 Introduction
B.tragi/is R208, R212, 0423 and 2013E displayed reduced
susceptibility to imipenem in the absence of imipenem hydrolysing
metallo-(3-lactamases. Reduction in antibiotic susceptibility can result
from an outer membrane (OM) permeability barrier restricting
antibiotic penetration into the bacterial cell, although this is rarely the
sole factor in resistance (Wexler, 1991; Rasmussen et a/., 1993).
Decreased OM permeability in B.tragi/is has been found in
combination with the production of (3-lactamase or alteration in
penicillin-binding proteins (Cuchural et a/., 1986b; Piddock and
Wise, 1987)
Permeability barriers may be detected indirectly by crypticity
measurements, the ratio of the rate of hydrolysis of a susceptible (3-
lactam by disrupted cells to that of intact cells. High crypticity values
indicate decreased permeability. This assumes that cell bound (3-
lactamases do not behave in a manner markedly differently to that of
free enzyme.
Differences in the OM protein and lipopolysaccharide (LPS)
composition among sensitive and resistant bacteria of the same
species may reflect changes in permeability due to alteration of porin
proteins or hydrophobicity (Godfrey et al., 1984; Piddock and Wise,
1987). In order to establish the OM composition of B.fragilis strains of
normal susceptibility, three clinical isolates (B. tragi/is R116, R135
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and R192) together with a type culture strain (B.tragiJis NCTC 9344),
were investigated. Outer membrane protein and LPS compositions
were compared with those observed in isolates which showed
reduced susceptibility to imipenem.
6: 2 Crypticity measurements
Crypticity values are inversely related to the degree of
permeability and are greater than one when the drug permeation is
the rate limiting step for f3-lactamhydrolysis. Spectrophotometric tests
were carried out and nitrocefin was used as the 13-lactamsubstrate, as
all of the test strains to be compared were capable of hydrolysing this
compound. I3-Lactamase crypticity measurements for eight strains
that exhibited reduced susceptibility to imipenem are given in Table
6.1. Raised crypticity values of 9 and 6 were exhibited by B.tragilis
R212 and 0423 respectively, suggesting the presence of a
permeabilty barrier in these two strains. Low crypticity ratios of 3 and
2 were observed with B.tragilis 119 and R251 respectively. For four
of the strains there was no evidence of any permeability barrier
(crypticity ratio = 1).
6: 3 Outer membrane protein analysis
The OM protein profiles, obtained by SOS PAGE, are shown in
Figs. 6.1. All strains tested possessed a major OM protein of
molecular weight 44 kOa and other prominent bands of 62 kOa, 42
kOa, 38 kOa, 29 kOa and 22 kOa. The OM profiles of B.fragi/is R208,
R212, 0423 and 2013E were similar to those of the sensitive control
strains (B.tragi/is R135 and NCTC 9344). However, differences were
apparent with metallo-I3-lactamase producers B.tragi/is R251, R186,
R240 and 119, these four strains showing an extra band of 40 kDa.
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Table 6.1 s-t.ectamase crypticity values# of B.fragilis
strains with increased resistance to imipenem
MIC (mgll) imipenem
Bacterial strain imipenem hydrolysis Crypticity values
B.fragilis R186 2 + 1
B.fragilis R240 4 + 1
B.fragl/is R251 2 + 2
B.fragilis 119 16 + 3
B.fragiJis R208 4 1
B.fragiJis R212 2 9
B.fragilis 2013E 2 1
B.fragilis 0423 2 6
B.fragilis NCTC 0.12 1
9344*
* control strain
# the ratio of activity of disrupted cells to that of intact
cells
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Fig. 6.1 SDS-polyacrylamide gel electrophoresis of outer
membrane proteins of B.fragilis strains
97 kDa ...... • ..
66 kDa
45 kDa
'11 t
31 kDa
21 kDa
14 kDa
1 2 3 4 5
97 kDa
66 kDa
45 kDa
31 kDa
14 kDa
21 kDa
6 7 8 9 1 0 1 1 12
Lanes: 1 and 6, molecular weight standards; 2, B.fragi/is
R251; 3, B.fragilis R186; 4, B.fragilis R240; 5, B.fragilis
119; 7, B.fragilis R212; 8, B.fragilis 0423; 9, B.fragi/is
R208; 10, B.fragi/ls 2013E; 11, B.fragiJis R135; 12,
B.fragi/is NCTC 9344
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An additional band of 51 kDa was seen in the profile of B.fragi/is
R186. B.fragilis R240 and 1tsshowed a distinctive 16 kDa protein.
6: 4 Lipopolysaccharide analysis
The outer membrane LPS profiles, revealed by silver stained
polyacrylamide gels, are shown in Figs. 6.2. The control strains
B.fragilis R116, R135, R192 and NCTC 9344 displayed an OM LPS
composition similar to that of B.tragi/is R208, R212, 0423 and 2013E,
with a major component (band B) and other bands of higher (band A)
and lower (band C) molecular weights. However, LPS of band A was
not present in B.fragi/is R251, R186, R240 and 119 and band B was
either absent or more diffuse in these strains. All three LPS bands
were present at the base of the ge'ls, adjacent to the low molecular
weight markers, indicating the presence of 'rough' LPS, with short or
absent polysaccharide side chains.
6:5 Discussion
Imipenem appears to be generally highly efficient at
penetrating Gram negative cells. In E.col; K-12, zwitterionic ~-Iactam
compounds,have been shown to penetrate rapidly, and imipenem
showed the highest permeability of these compounds due, in part, to
its compact molecular structure (Yoshimura and Nikaido, 1985).
However, decrease in OM permeability and changes in OM proteins
have been implicated in imipenem resistance in P. aeruginosa and
Enterobacter aerogenes (Buscher et al., 1987; Trias et al., 1989;
Chow and Shlaes, 1991).
Crypticity has been used by Cuchural et al. (1986b) to identify
a barrier to imipenem permeation in two imipenem resistant strains of
B.fragilis which produce ~-Iactamases capable of imipenem
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Fig 6.2 Polyacrylamide gel electrophoresis of
lipopolysaccharide preparations of B.fragilis strains
1 2 3
8 9 1 0
A
B
c
4 5 6 7
A
B
c
1 1 1 2 1 3 14
Lanes: 1 and 8, molecular weight markers; 2, B.tragi/ls R251;
3, B.fragi/is R186; 4, B.fragilis R240; 5, B.fragi/is 119; 6,
B.fragi/is NCTC 9344; 7, B.fragi/is R192; 9, B.fragi/is R212;
10, B.fragilis 0423; 11, B.fragilis R208; 12, B.fragi/is
2013E; 13, B.tragi/is R135; 14, B.tragilis R116
Bands indicated by A, Band C
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hydrolysis. The crypticity values for these two strains, with imipenem
as substrate, were 14 and 18. In the same study, when nitrocefin was
used as substrate, higher crypticity values of 35 and 40 were
observed for these strains. This difference may, in part, be due to the
greater molecular size of nitrocefin resulting in reduced permeation.
Darland and Birnbaum (1977), in a study of cephalosporins, stated
that if ~-Iactamase activity in sonicated extracts increased by a factor
of two or less compared to whole cells, the antibiotics are likely to be
freely accessible to the enzymes in intact cells. In their study, none of
the clinical isolates of B.tragi/is examined showed a permeability
barrier by this criterion. Other studies have correlated crypticity values
with ~-Iactam resistance in B.tragi/is strains with cephaloridine as
substrate. Olsson et al. (1979) found crypticity values of greater than
one in all five highly resistant B.fragilis strains tested; two of these
strains showed high crypticity values of 5.5 and 7.3. Timewell et al.
(1981) reported that almost all B.tragi/is isolates, with sufficient
enzyme for crypticity to be assessed, had a permeability barrier
(crypticity >1). The normal value given was 3.5, and in one strain the
barrier appeared to account for much of the resistance with a crypticity
value of 43.'
Although resistance to imipenem and permeation of the
antibiotic were under consideration in this study, the crypticity values
for nitrocefin, a substrate common to ~-Iactamases of all the test
strains, were assessed to give a crude indication of a general
permeability barrier. The highest crypticity values of 9 and 6 were
shown with B.tragi/is R212 and 0423 respectively. These strains
exhibited a non-enzymic reduction in susceptibility to imipenem and
the results suggest the presence of a permeability barrier which may
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be a factor in increased resistance to imipenem. In contrast to the
findings of Cuchural et al. "(f986b), no high crypticity values were
detected among the metallo-f3-lactamase producers in this study.
However, B.fragi/is 119 gave a crypticity value of 3, possibly
indicating a partial barrier to antibiotic passage, and this may,
together with the production of f3-lactamaseof high specific imipenem
activity, be a factor in the moderate level of resistance of this strain.
Similarly B.fragi/is R251, also a metallo-f3-lactamase producer,
showed a low crypticity value of 2, suggesting minor involvement of a
pemeability barrier in imipenem resistance. In other test strains, the
metallo-f3-lactamase producers B.fragi/is R186 and R240, and the
non-metallo-f3-lactamase producers B.fragi/is R208 and 2013E, no
evidence was found that associated reduced susceptibility to
imipenem with restricted passage of antibiotic into the baoterlal cells.
The effect of EDTA on susceptibility is an additional means of
examining antibiotic penetration into the bacterial cell. EDTA
increases cell permeability and a comparison of sensitivity with and
without EDTA reflects antibiotic permeation (Malouin and Lamothe,
1987). This method was considered unsuitable for the examination of
B.fragilis strains in this study as EDTA also has the ability to remove
zinc ions, and this would restrict the activity of the mstallo-p-
lactamases affecting bacterial susceptibility. Low zinc concentrations
in sensitivity testing media has been shown by Hawkey et al. (1993)
to result in increased susceptibility of metallo-f3-lactamase producing
X.maltophilia strains to imipenem. Zinc is also known to affect the
imipenem sensitivity of non-metallo-f3-lactamase producing
P.aeruginosa (Cooper et al., 1993). These workers speculated that
zinc could alter the interaction of impenem with penicillin binding
proteins. Therefore, the affect of EDTA on bacterial sensitivities may
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not be due solely to increased permeability.
Paxton and Brown (1979) found that the OM and 'associated
proteins' of several strains of B.tragi/is were similar to each other yet
distinct from those of several other species of Bacteroides. The OM
protein profiles obtained with the sensitive B.tragi/is strains tested,
including the B.tragi/is NCTC 9344 control, appeared similar to that
of the sensitive B.fragi/is ATCC 25285 strain described by Oiedrich
and Martin (1981), which had a major protein band of 43 kOa.
The similarity in OM protein profiles between the non-metallo-
(3-lactamaseproducing resistant strains and the sensitive strains does
not implicate differences in the porin proteins in increased resistance
to imipenem. These findings are in contrast to those of Piddock and
Wise (1987), who described a B.tragi/is isotate resistant to cefoxitin
(not due to (3-lactamases) in which a protein of 49 kDa, found in the
sensitive NCTC type strain, was absent. They presented this as
evidence for cefoxitin resistance due to altered porin proteins. The
highly cefoxitin resistant B.fragills R212 (MIC 128 mg/l, See section
3.5) examined in the present study, which produced (3-lactamases
capable of rapid hydrolysis of cefoxitin (See section 4.5), showed no
loss of OM proteins compared to the sensitive strains, despite a high
crypticity value.
In this study, the metalto-p-Iactamase producing B.tragi/is
isolates surprisingly displayed an additional 40 kOa band that was
not present in the sensitive strains or the non-metallo-(3-lactamase
producers with increased imipenem resistance. It is possible that this
band represents (3-lactamase,but this could not be confirmed since
the (3-lactamase enzyme was likely to have been denatured by the
SOS-PAGE procedure. However, the majority of reports of the
molecular mass of metalto-p-lactarnases gave values between 25
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kDa and 33 kDa (Hedberg et al., 1992; Payne, 1993), with the
exception of Cuchural et al. (1986) whose estimate was 44 kDa.
Interestingly, Podglajen et al. (1992a) also found that the OM protein
composition of imipenem metallo-tHactamase producing resistant
mutants differed from that of their sensitive parental strains, and from
that of a sensitive reference strain. A decrease in the amount of a 47
kOa OM protein was observed in the imipenem resistant strains, with
an increase of a protein with slightly lower molecular weight in the
mutant strains. The association between these OM protein changes
and antibiotic permeation is unknown.
LPS analysis of B.fragi/is carried out by Weintraub et al.
(1985) revealed that most strains have similar, if not identical, LPS of
the 'rough' type with one major and one minor band of relatively short
polysaccharide chains. In the present study, the B.fragilis NCTC
control and clinical isolates of normal sensitivity showed three bands,
all of low molecular weight. These were identical to the LPS profiles
of the B.fragilis strains in which decreased susceptibility to imipenem
was not enzyme mediated. These results suggest that the LPS
composition, or associated hydrophobicity, are not features
contributing to the resistance of these strains. Curiously, as with the
OM proteins, the metallo-(3-lactamase producers differed from the
other test strains in their LPS content, as shown by the absence of the
higher molecular weight band. This may represent differences in 0
side chains indicating a different serotype. Different serotypes of
Salmonella have been shown to exhibit distinct banding patterns on
silver-stained gels (Luk and Lindberg, 1991). Similar observations
have been made with different serotypes of Pasteurella multocida
(Rimier, 1990). Another possibility is that these structural differences
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indicate that metallo-(3-lactamase producing strains of B.fragilis
belong to a distinct phenotypio sub-group.
Evidence, from the crypticity studies and OM profiles, of a
permeability barrier in B.fragi/is strains that exhibit increased
resistance to imipenem in the absence of metallo-(3-lactamaseactivity
is, therefore, conflicting. Crypticity studies showed clearly raised
crypticity values for two of these strains, but no difference in OM
composition was apparent between these and the sensitive strains. It
is possible that hydrophobicity is not a feature of imipenem
permeation, and examination of gross OM protein content may not
have revealed the alteration of porins which was responsible for
changes in the efficiency of passage of imipenem.
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CHAPTER 7
CHANGES IN PENICILLIN BINDING PROTEINS AS A
MECHANISM OF INCREASED RESISTANCE TO IMIPENEM
IN B.FRAGILIS
7: 1 Introduction
In addition to B-Iactamase activity and reduced permeability,
antibiotic resistance may be due to altered binding to essential PBPs.
Since PBPs represent the target site for B-Iactam antibiotics, changes
in these proteins may lead to a decrease in effectiveness of B-Iactam
agents against the microorganism. Alterations in susceptibility may
reflect the number of different PBPs present in the cytoplasmic
membrane or modification of the affinity of the PBPs for a particular B~
lactam antibiotic. Imipenem resistance has been shown to be
associated with modifications of PBPs in Acinetobacter baumanii. A
comparison of a clinical isolate with an imipenem resistant mutant that
was derived from it showed the mutant to have diminished labelling of
all but one lower molecular weight PBP (Gehrlein et al., 1991).
Five previous reports have described the number and
molecular sizes of PBPs in B.fragi/is (Botta et al., 1983;
Georgopapadakou et al., 1983; Piddock and Wise, 1986; Yotsuji et
al., 1988; Wexler and Halebian, 1990). The findings of these studies
are conflicting. An investigation of the PBPs of typical, fully sensitive
B.fragilis strains (B.fragi/is R116, R135, R192 and NCTC 9344) was
therefore carried out to clarify the situation and to provide a basis for
comparison with the PBPs of imipenem resistant non-carbapenemase
producers.
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PBP-associated resistance to cefoxitin attributable to
decreased affinity for the PBP1 complex or PBP2 has been reported
in laboratory mutants and clinical isolates of B.tragi/is (Piddock and
Wise, 1986; Wexler and Halebian, 1990). Also, resistance to
cephalothin and other cephalosporins has been ascribed to reduced
binding to PBP3 (Yotsuji et a/., 1988). In an attempt to detect any
involvement of PBPs in imipenem resistance of B.tragi/is isolates
from this study, the PBPs of strains in which resistance to imipenem
was not due to metallo-B-Iactamase (B. tragi/is R208, R212, 0423 and
2013E) were investigated.
Cell membrane proteins of B.tragi/is strains exposed to 3H-
benzylpenicillin were separated on SOS PAGE gels. The radioactive
benzylpenicillin, bound to the PBPs, was detected by scintillation
counts of discrete gel segments, covering arbitrarily defined
molecular weight ranges, or by the more sensitive technique of
fluorography (see Section 2.20).
The affinity of various concentrations of imipenem for PBPs of
molecular weights greater than or less than 60 kOa from fully
sensitive and imipenem resistant B.tragi/is strains was also
measured in competition assays with radiolabelled benzylpenicillin to
determine the main regions of imipenem binding.
7:2 Scintillation counts of gel segments
Scintillation counts of proteins in the gel segments were
initially measured to ensure the presence of sufficient bound
radioactive benzylpenicillin before the lengthy process of
fluorography. It became apparent, however, that this method was also
useful as a rapid and simple measure of radioactive binding to
proteins in gel segments of known molecular weight ranges.
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(a) Sensitive a.fragilis strains
Scintillation counts of' gel segments containing proteins of
molecular weights 100 kOa to 60 kOa and 60 kOa to 20 kOa from
experiments in which 5 ).11 of 3H-benzylpenicillin was used in PBP
assays with cell membrane proteins from the four fully sensitive
a.tragi/is strains are given in Table 7.1. The major binding of
benzylpenicillin was to proteins of molecular weights from 100 kOa to
60 kOa; between 83% and 91% of the total bound labelled penicillin
was present in this gel segment. The proteins of molecular weights
between 60 kOa and 20 kOa were associated with a maximum of
17% of the total bound 3H-benzylpenicillin.
To examine these binding sites in more detail, the SOS-PAGE
gel resulting from a PBP assay with a.tragi/is NCTC 9344 was
divided up into five segments covering the approximate molecular
weight ranges >100 kOa, 100 kOa-75 kOa, 75 kOa-50 kOa, 50 kOa-
25 kOa, <25 kOa. The scintillation counts of these segments are
shown in Table 7.2. Most of the 3H-benzylpenicillin was associated
with the high molecular weight proteins, particularly those between
100 kOa and 75 kOa to which 76% of the labelled benzylpenicillin
bound.
A competition assay was performed with imipenem and
B.tragi/is R135 to ascertain the degree and site of imipenem binding
to cell membrane proteins of this sensitive strain. A high degree of
binding of imipenem was seen with proteins of molecular mass 100
kOa to 60 kOa (Table 7.3). Labelled benzylpenicillin in this segment
was reduced generally in proportion to the concentration of imipenem
used in the assay, imipenem in the range of 0.015 mg/l to 0.25 mg/l
resulting in a decrease of 3H-benzylpenicillin binding to these
proteins from 72% to 18% of the total 3H-benzylpenicillin bound in the
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Table 7.1 Scintillation counts of gel segments of cell
membrane proteins from sensitive B. tragilis strains exposed
to 5 JlI 3H-benzylpenicillin.
Bacterial strains Scintillation counts+ in gel segments
containing proteins of mol. wt. (kOa)
100-60 60-20
B.tragilis R116 1200(83) 250(17)
B.tragilis R135 1373(91 ) 141 (9)
B.fragilis R192 1200(86) 195(14)
B.tragi/is 1715(92) 154(8)
NCTC 9344 '"
'" control strain
Figures in brackets represent the percentage of radioactive
label detected in each segment of gel.
+ counts per minute above the background count
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Table 7.2 Scintillation counts of gel segments
..
containing cell membrane proteins from B.fragi/is NCTC
9344 exposed to 5 III 3H-benzylpenicillin.
Gel segments containing
proteins of mol. wt. (kOa)
Scintillation counts+
> 100 51 (3)
100-75 1501 (76)
75-50 264(14)
50-25 94(5)
< 25 25(2)
Figures in brackets represent the percentage of
radioactive label detected in each segment of gel.
+ counts per minute above the background count
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Table 7.3 Scintillation counts of gel segments containing
cell membrane proteins from B.fragilis R135 in PBP
competition assay with imipenem.
Scintillation counts+ of gel
Imipenem conc. (mg/l) segments containing proteins
'"of mol. wt. :
100-60 kOa 60-20 kOa
o 1417 (96) 63 (4)
0.015 1059 (72) 45 (3)
0.03 562 (38) 39 (3)
0.06 389 (26) 31 (2)
0.12 432 (29) 29 (2)
0.25 263 (18) 59 (4)
'" figure in brackets show the percentage of total labelled
penicillin bound in absence of imipenem
+ counts per minute above the background count
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absence of imipenem. The degree of binding of labelled
benzylpenicillin to proteins of molecular weights 60 kDa - 20 kDa was
again minor (4% of total bound labelled penicillin). The decrease in
bound 3H-benzylpenicillin correlated with the presence of increasing
amounts of imipenem in the assay, with the exception of an anomaly
with 0.25 mgJl imipenem. The lowest level of binding was seen with
0.12 mgJl imipenem, at which concentration 46% of the binding of 3H-
benzylpenicillin, without imipenem, to these segment proteins was
observed.
(b) B.fragi/is strains in which reduced susceptibility to imipenem was
not associated with metallo-fj-/actamase
PBP assays in which B.fragi/is strains were exposed to 5 III
and 15 III of 3H-benzylpenicillin were carried out to investigate the
location of the major penicillin binding sites in the strains exhibiting
reduced susceptibility to imipenem and to determine whether the
increase in amount of 3H-benzylpenicillin would be reflected in
increased binding of radioactive benzylpenicillin.
The scintillation counts obtained with gel segments containing
proteins of molecular weights 100 kDa - 60 kOa and 60 kOa - 20 kDa
in these experiments are given in Table 7.4. These results were
markedly different from those obtained with the sensitive strains. The
total counts were reduced on average by a factor of five in
experiments with 5 III 3H-benzylpenicillin (See table 7.1), and were
concentrated in the segments containing proteins of molecular
weights 60 kOa to 20 kOa.
A threefold increase in the amount of 3H-benzylpenicillin used
in the PBP assay resulted in a less than twofold increase in binding to
proteins of 60 kDa - 20 kDa for all four test strains and the NCTC
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Table 7.4 Scintillation counts of gel segments from PBP
assays in which cell membranes of B.fragilis strains with
non-f3-lactamase mediated increased resistance to imipenem
were exposed to 5 IJI and 15 IJI 3H-benzylpenicillin
Gel segments Scintillation counts+ in
containing assays in which the amount
Bacterial proteins of of 3H-benzylpenicillin was:
strains mol. wt. (kOa) 51JI 15,..11
--------------------------
B.fragilis R208 100-60 146 195
60-20 165 249
B.fragilis R212 100-60 142 191
60-20 167 242
B.fragilis 0423 100-60 160 155
60-20 184 244
B.fragilis '2013E 100-60 141 289
60-20 215 370
B.fragilis 100-60 1550 2218
NCTC 9344* 60-20 135 162
+ counts per minute above the background count
* control strain
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control. Increase in binding to proteins in the 100 kOa - 60 kOa region
was even more modest although a twofold increase was observed
with BJragilis 2013E.
Competition by imipenem for the binding of 3H-benzylpenicillin
was examined in a resistant B.tragilis strain (B. tragi/is R212). The
results of these experiments are given in Table 7.5. The impact of
imipenem on the binding of labelled benzylpenicillin was overall less
than that of the sensitive strain. The reduction in scintillation counts
correlated with an increase in the imipenem concentration present in
the PBP assay and, in contast with the sensitive strain (See table 7.3),
was generally more apparent in the gel segment containing proteins
of molecular weights less than 60 kOa.
7:3 Fluorography
(e) Sensitive B.tragilis strains
The PBPs of the fully sensitive B.fragi/is strains R116, R135,
R192 and NCTC 9344 were resolved by fluorography in experiments
in which 5 III 3H-benzylpenicillin was used. Their molecular weights
varied slightly between, but not within, four duplicate experiments
(Table 7.6). A typical fluorograph is shown in Fig. 7.1. Three important
penicillin binding sites were detected with mean molecular weights of
91 kDa, 80 kDa and 69 kDa (designated PBPs 1, 2 and 3
respectively); these bands were found in all four sensitive strains on
all four occasions. In one experiment fainter bands representing two
additional PBPs with low molecular weights were detected: B.tragi/is
R135 and NCTC 9344 appeared to possess a 63 kOa protein
(designated PBP 4) and B.fragi/is R135 yielded an additional diffuse
band of ca. 47 kDa (designated PBP 5).
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Table 7.5 Scintillation counts of gel segments containing
cell membrane proteins from B.fragilis R212 in PBP
competition assay with imipenem.
Scintillation counts+ of gel
lmipenem conc. (mg/l) segments containing proteins
1<
of mol. wt. :
100-60 kOa 60-20 kOa
o 144(49) 148(51)
0.12 152(52) 134(46)
0.25 108(37) 155(53)
0.5 143(49) 93(32)
1 102(35) 102(35)
2 120(41) 85(29)
1<
figure in brackets show the percentage of total labelled
penicillin bound in absence of imipenem
+ counts per minute above background count
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Table 7.6 Molecular weights of PBPs of 4 fully sensitive
B.tragi/is strains (inctuding B.tragi/is NCTC 9344)
determined in 4 separate experiments with 5 ,.d 3H-
benzylpenicillin
Molecular weight+ (kDa) in
experiment
PBP 1 2 3 4 mean
---------------------------
1 90 90 90 92 91x
2 79 79 79 83 80x
3 66 70 69 73 69x
4 63 * 63
5 47# I\[) NJ 47
ND - Not Detected
+ Molecular weights for each PBP determined in each
experiment were identical
x PBPs 1, 2 and 3 detected in all four test strains on each
occation
* Detected in B.tragi/is R135 and NCTC 9344
# Detected in B.tragilis R135 only as a diffuse band
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Fig. 7.1 A typical fluorograph showing PBPs of fully sensltive
B. fragilis strains
PBP
3- • !!8'
4-
1-
2-
5-
1 2 3 4
Lanes: 1, B.fragiJis NCTC 9344; 2, B.fragiJis R116; 3, B.fragi/is
R192; 4, B.fragi/is R135
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(b) B.fragiJis with increased resistance to imipenem which was not
associated with metallo-f}-/aCtamase
No PBPs were seen with B.tragi/is R208, R212, 0423 and
2013E, in experiments in which 5 J.11 3H-benzylpenicillin was used.
However, with 15 J.11 of labelled benzylpenicillin present in the PBP
assay, PBPs were visualised as listed in Table 7.7 and illustrated in
Fig. 7.2. A PBP of 40 kDa (designated PBP 6), which had not been
observed in experiments with fully sensitive strains, was detected in
all four resistant isolates but not in the B.tragilis NCTC sensitive
control. B.tragi/is 2013E also possessed each of the PBPs found in
the sensitive strains, including a 62 kDa and 48 kDa protein. The 48
kDa band was also present in B.tragilis 0423, but higher molecular
weights bands were not detected in this strain. The 40 kOa band was
the only PBP detected in B.fragilis R208 and R212 .
These strains were originally selected on the basis of elevated
~-Iactamase production. Low penicillinase levels persisted in their
cell membrane preparations which were used in PBP assays despite
washing five times in buffer (See section 2.20). This is in contrast to
the sensitive strains, in which no penicillinase activity was detected in
the washed membrane preparations. The hydrolysis of 3H-
benzylpenicillin by ~-Iactamases during the PBP assay may,
therefore, have been responsible for the low numbers of PBPs
resolved by these strains. Five general methods were considered in
order to overcome the presence of ~-Iactamase in the PBP assays:
removal, inactivation, separation or inhibition of the enzyme and
addition of excess 3H-benzylpenicillin (Table 7.8). Repeated washing
(10 times) of the cell membrane preparations in phosphate buffer
failed to remove all penicillinase activity. Complete inactivation of the
~-Iactamases was not achieved when the cell membrane
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Table 7.7 Molecular weights of PBPs of B.fragilis strains
showing non-p-lactarnase 'mediated resistance to imipenem
detected in experiments with 15 JlI 3H-benzylpenicillin
Molecular weight (kDa) of
PBP
Bacterial strain 1 2 3 4 5 6
B.fragilis R208 NJ 40
B.fragilis R212 40
B.fragilis 0423 NJ NJ 48* 40
B.fragilis 2013E 90 79 70 62 48* 40
B.fragilis 90 79 70
NCTC 9344+
NO - Not Detected
* diffuse band
+ control strain
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Fig. 7.2 Fluorograph showing PBPs of imipenem resistant non-
metallo-p-Iactamase producing B.fragi/is strains' from
experiments with 15 III 3H-benzylpenicillin
PBP
1 2 3 4 5
Lanes: 1, B.fragilis NCTC 9344 (sensitive control strain); 2,
B.fragilis 2013E; 3, B.fragills 0423; 4, B.fragilis R212; 5,
B.fragi/is R208
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Table 7.8 Possible methods to overcome presence of ~-
lactamases in cell membrane preparation used in PBP assays
Removal
Repeated washing (x10) in phosphate buffer
Inhibition with:
clavulanic acid
sulbactam
p-chloromercuribenzoate
N-ethylmaleinide
Inactivation
temperature 4°C
" 65°C for 10 minutes
sodium azide
Separation
lso-electr!c focusing
SOS-PAGE
electroelution
Adding excess 3H-benzylpenicillin
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preparations were malntained at 40C or exposed to the enzyme
poison, sodium azide (10mM). The ~-Iactamases were totally
inactivated as a result of heating the cell membranes at 650C for 10
minutes, but these conditions were found to prevent binding of
radiolabelled benzylpeniciilin to the PBPs. Physical separation of the
~-Iactamases from the PBPs was not attempted because of the
likelihood of PBP damage by the techniques involved. In the
presence of the inhibitors pcmb (1mM) and N-ethylmaleinide (5mM),
cell membrane penicillinase activity persisted, whereas with
clavulanic acid (5 mgtl) and sulbactam (10 mgtl) the penicillinase
reaction showed very weak or negligible activity.
Therefore, in an attempt to resolve the PBPs of these a.tragi/is
strains, the volume of labelled benzylpenicillin used in the PBP assay
was further increased to 30 III and, in other experiments, ~-Iactamase
inhibitors were used. Also, to aid visualisation of weak PBP bands,
the exposure time of the radioactive gel with the film at -70oC was
increased from three to seven weeks.
With 30 III 3H-benzylpenicillin present in the PBP assay, three
bands were visualised for a.tragi/is R208 and 0423, corresponding
to proteins of molecular weights 76 kOa, 67 kOa and 37 kOa. Results
with a.fragilis 2013E were similar to those achieved with 15 III 3H-
benzylpenicillin, with six proteins showing of 87 kDa, 76 kOa, 67 kOa,
60 kOa, 45 kOa and 37 kOa. With a.fragilis R212, only the 37 kDa
protein was observed (Table 7.9, Fig. 7.3).
The PBP assays with 10 III 3H-benzylpenicillin were repeated
in the presence of the ~-Iactamase inhibitors clavulanic acid (5 mgtl)
and sulbactam (10 mgtl) (Table 7.10, Fig. 7.4). All four strains now
showed PBPs of 88 kDa, 78 kOa and 68 kDa in the presence of
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Table 7.9 Molecular weights of PBPs of B.fragi/is strains
showing non-p-Iactamase ·mediated resistance to imipenem
detected in experiments with 30 III 3H-benzylpenicillin
Molecular weight (kDa) of
Bacterial strain PBP
1 2 3 4 5 6
-------------------------
B.fragi/is R208 f\D 76 67'" t-..c f\D 37
B.fragi/is R212 N) ro 37
B.fragi/is 0423 76 67 37
B.fragi/is 2013E 87 76 67 60'" 45 37
B.fragilis+ 87 76 67 f\D
NCTC 9344
NO not detected
'" faint band
+ control strain
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Fig. 7.3 Fluorograph showing PBPs of imipenem resistant, non-
metallo-p-Iactamase producing B.fragi/is strains' r from
experiments with 30 III 3H-benzylpenicillin
PBP
I
1-1
2-
3-
4-
-_,..-
-
I'
5-
6- -
1 2 3 4 5
Lanes: 1, B.fragilis 2013E; 2, B.fragilis NCTC 9344 (sensitive
control strain); 3, B.fragilis 0423; 4, B.tragi/is R208; 5,
B.fragilis R212
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Table 7.10Molecular weights of P8Ps of B.fragilis strains
detected in experiments with '0 III 3H-benzylpenicillin in the
presence of clavulanic acid or sulbactam.
Molecular weight (kDa) of
Bacterial strain P8P
, 2 3 4 5 6
B.fragi/is R208 CA 88 78 68 N) I'D 37
58 88 78 68 N) N) 37
B.fragiJis R212 CA 88 78* 68* N) N) 37
58 N) N) N) NJ N) 37
B.fragilis 0423 CA 88 78 68 62* 45 37
58 88 78 68 t-£) 45 37
B.fragilis 2013E CA 88 78 68 N) N) N)
58 NT NT NT NT NT NT
B.fragilis+ CA 88 78 68 N) N) N)
NCTC 9344 58 NT NT NT NT NT NT
CA with clavulanic acid (5 mg/l)
58 with sulbactam (10mg/l)
ND not detected
NT not tested
* faint band
+ control strain
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Fig. 7.4 Fluorograph showing PBPs of imipenem resistant non-
metatlo-p-lactarnase producing B.fragi/is strains " from
experiments carried out in the presence of clavulanic acid and
sulbactam
PBP
4-
-
1 2 3 4 5 6 7
Lanes: 1-4 with clavulanic acid (5 mg/l) 1, B.fragilis R212; 2,
B.tragiJis R208; 3, B.tragiJis 0423; 4, B.tragiJis 2013E
Lanes 5-7 with sulbactam (10 mg/l) 5, B.fragi/is 0423; 6,
B.fragiJis R212; 7, B.fragilis R208
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clavulanic acid, although the latter two bands only appeared faintly in
B.tragilis R212. These three PBPs, however, were not detected in
B.tragi/is R212 in the presence of sulbactam. B.tragilis 0423 was the
only strain tested to show bands of 62 kDa and 45 kDa. A 37 kDa PBP
was present in all the strains tested with both f)-Iactamase inhibitors,
except for B.tragilis 2013E and the NCTC 9344 sensitive control.
7:4 Discussion
The demonstration of PBPs and the assessment of the
molecular size depend on the method used to prepare the cell
membrane, on the exact method of electrophoresis and on the
techniques used to calculate the molecular weights.
In the study, the PBPs of B.fragi/is showing normal
susceptibility to f)-Iactam agents were revealed by fluorography after
preliminary investigation of gel segments. Three important binding
sites were apparent, comprising proteins with molecular weight
exceeding 60 kDa.
Previous workers have provided conflicting accounts of the
number and molecular weights of B.fragilis PBPs. Generally five
PBPs with molecular weights ranging from 100 kDa to 32 kDa have
been described. Botta et al. (1983) used 14[C)-cefotaxime to
investigate the PBP profile of two strains of B.tragi/is, and found only
three PBPs with molecular weights of 76 kDa, 56 kDa and 53 kDa.
The validity of using labelled cefotaxime as a PBP probe was
questioned by Piddock and Wise (1983) who emphasised the poor
affinity between the antibiotic and PBP 4,5 and 6 of E.coli K-12. They
suggested that the low number of PBPs observed by Botta et al.
(1983) was due to poor binding of cefotaxime and insufficient
antibiotic in the assay. Georgopapadakou et al. (1983) examined
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eight strains of B.tragi/is and found three PBPs with molecular
weights of 100 kDa, 86 kDa arid 65 kDa which showed high affinity for
imipenem. Occasionally, additional PBPs of 78 kDa and 32 kDa were
seen. In 1986, Piddock and Wise investigated the PBPs of B.tragi/is
and three other Bacteroides species. In B.tragi/is they demonstrated
a PBP 1 complex with molecular weights ranging from 82 kDa to 78
kDa; two other PBPs of 75 kDa and 70 kDa were also present. Yotsuji
et al. (1988) described PBPs of molecular weights 94 kDa-88 kDa
(PBP 1 complex), 82 kDa (PBP 2) and 72 kDa (PBP 3). Wexler and
Halebian (1990) reported similar results for B.tragi/is ATCC 25285:
high molecular weight PBPs of 91 kDa (PBP 1), 83 k Da (PBP 2) and
69 kDa (PBP 3). However, two additional low molecular weight PBPs,
of 64 kDa (PBP 4) and 40 kDa (PBP 5) were also reported for this
strain in addition to bands of 55 kDa and 33 kDa which were
described as 'regions of non-specific binding'. In two clinical isolates
of B.tragi/is examined by these workers, one of which was resistant
to cefoxitin, PBPs 2 and 4 could not be detected. The resistant isolate
also possessed PBPs of 50 kDa, 39 kDa and 29 kDa. These previous
reports are summarised in Table 7.11.
The results of the present study with sensitive B.fragilis strains
broadly agree with those described for two B.tragilis isolates by
Yotsuji et al. (1988) and B.fragilis ATCC 25285 reported by Wexler
and Halebian (1990). The PBPs of 91 kDa, 80 kDa and 69 kDa which
were found consistently for all four sensitive strains tested correspond
closely to the PBPs with molecular weights of PBP 1, 2 and 3
described by these authors. In addition, a PBP of 63 kDa was
occasionally detected in two of the four sensitive B.tragilis strains
examined. This presumably corresponds to Wexler and Halebian's
PBP 4 of 64 kDa. The protein of 47 kDa that was seen as a diffuse
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Table 7.11 Molecular weights (kOa) of PBPs of B.fragilis
reported in the literature .
Botta Georgopapadakou Piddockand Yotsuji Wexler and Present
et al. et al. Wise et al. Halebian study
(1983) (1983) (1986) (1988) (1990)
+ S R
1OO(1)
94(1 a)
90(1b) 91 (1) 91 (1 )
86(2) 88(1c) 86(1 )
82(1a) 82(2) 83(2) 80(2)
80(1 b) 80(1 )
78f 78(1c)
76( 1) 75(2)
65(3) 70(3) 72(3) 69(3) 66(3) 69(3)
64(4) 64(3) 63(4)*
56(2)
53(3)
50(5) 47(5) **
40(5) 39 40(6)§
. 32f 29
The designated PBP are in parentheses
f occasionally detected
+ B.fragi/is ATCC 25285
S Cefoxitin sensitive isolate
R Cefoxitin resistant isolate
§ found in imipenem resistant strains only
'" found in B.fragilis R135 and NCTC 9344 only
"'* found in B.fragilis R135 only as a diffuse band
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band in B.tragi/is R135 in on~ experiment may correspond to the 50
kOa PBP of the cefoxitin resistant isolate examined by Wexler and
Halebian (1990).
The molecular sizes determined for the individual PBPs in the
study were uniform within experiments for the four sensitive strains
tested, although between experiments the value for the same PBP
varied by a maximum of 7 kOa. Georgopapadakou et al. (1983) and
Wexler and Halebian (1990), who stated the molecular weights of
PBPs of individual B.tragi/is strains, showed greater ranges of 14
kDa and 11 kOa respectively. The resolution of constituent bands of
PBP 1 reported by some authors (Piddock and Wise, 1986; Yotsuji et
a/., 1988) was not achieved in this study, possibly due to the size of
gel employed.
Scintillation counts of SOS-PAGE gels of membrane proteins
from B.tragi/is NCTC 9344 indicated that the major binding region for
benzylpenicillin lay in the part of the gel containing proteins with
molecular weight between 100 kDa and 75 kDa, that is PBPs 1 and 2.
The low level of binding to proteins of less than 50 kOa proved
insufficient to produce bands on the fluorograph.
In an attempt to increase the level of bound radioactivity in
order to study the PBPs of the imipenem resistant strains, the volume
of 3H-benzylpenicillin in the PBP assay was increased three-fold to
15 J.11. In these experiments, a low molecular weight band of 40 kDa
was revealed for all four resistant strains, but not for the sensitive
control. Wexler and Halebian (1990) found a 40 kOa PBP in a fully
sensitive B.tragi/is ATCC strain and a 39 kOa PBP in a cefoxitin
resistant clinical isolate. Scintillation counts of SOS-PAGE gel
seqments reflected the results obtained by fluorography; the increase
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in binding to lower molecular weight proteins (60 kOa-20 kOa) was
greater for the resistant strains than for the sensitive B.tragi/is NCTC
control.
These results raise the possibility that the hydrolysed
radioactive benzylpenicillin binds, in the form of radioactive
fragments, to non-specific binding regions comprising low molecular
weight cell membrane proteins of less than 60 kOa which do not
exclusively bind intact 13-lactammolecules. Wexler and Halebian
(1990) described bands from a fluorograph of B.tragi/is representing
proteins below 60 kOa as non-specific binding sites. low molecular
weight PBPs have been described as non-essential and associated
with carboxypeptidase and weak penicillinase production in
B.tragi/is and P.aeruginosa (Georgopapadakou et al. 1983;
livermore, 1987). The low molecular weight (40 kOa) PBP 6 may
represent 13-lactamase which binds to 3H-benzylpenicillin.
Georgopapadakou et al. (1983) reported 32 kOa PBPs in three out of
eight B.tragi/is strains studied, including one strain which was
resistant to 13-lactamantibiotics. Interestingly, binding to this PBP was
found to be inhibited by clavulanic acid.
The greatest increase in binding to proteins of molecular
weight above 60 kOa of the four resistant strains, as measured by
scintillation counts of gel segments and the appearance of PBP
bands by fluorography, was seen with B.fragi/is 2013E. With this
strain, the 3H-benzylpenicillin present may have saturated the 13-
lactamase leaving more of the drug to bind to the major PBPs.
However, the specific activity of B.tragi/is 2013E 13-lactamasewith
nitrocefin as substrate was higher than that of enzymes from the other
three resistant test strains (Eley and Greenwood, 1986b; see also
section 4.2), although a comparison of penicillinase activities would
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be more relevant.
In order to further resolve the PBPs of the non-carbapenemase
producing imipenem-resistant strains, attempts were made to prevent
penicillinase activity during the PBP assay so that increased amounts
of labelled benzylpenicillin were available for binding to target
proteins. Other workers have used a variety of ways to try to remove
tJ-lactamases from the cell membranes in PBP assays. Botta et al.
(1983) suspended the cell membrane preparations in buffer
containing p-hydroxy mercuribenzoate (phmb), a tJ-lactamase
inhibitor. There is conflicting evidence whether or not phmb interacts
with PBPs. Spratt (1977a) showed that phmb did not alter the PBP
profile of E.coli. However, Curtis and Strominger (1978) and later
Broome-Smith and Spratt (1984) reported interaction between p-
chloromercuribenzoate (pcmb), a tJ-lactamase inhibitor closely
related to phmb, and PBP 5 of E.coli. The tJ-lactamases from the four
test strains in this study were in any case resistant to inhibition by
pcmb (section 4.4; See also Eley and Greenwood, 1986b). Piddock
and Wise (1986, 1987) and Yotsuji et al. (1988) used cell envelope
preparations from bacterial cultures in the late logarithmic phase
which, they believed, produced reduced levels of tJ-lactamases. If,
after thorough washing, tJ-lactamase was still detected, the
preparation was discarded. However, substantial tJ-lactamaseactivity
may be present up to, and sometimes including, the stationary phase
of growth (Edwards and Greenwood, 1990) particularly in strains of
bacteroides that produce increased amounts of enzyme (Eley and
Greenwood, 1985). More recently, Wexler and Halebian (1990)
performed PBP assays with cell membrane preparations exhibiting tJ-
lactamase activity in the presence of sulbactam (2 mg/I) to achieve
visualization of the PBPs. A solution to this problem of hydrolysis of
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the 3H-benzylpenicillin durinQ the PBP assay would have been the
use of radioactive imipenem as a direct measure of affinity of the
antibiotic. Unfortunately, radio-labelled imipenem is not currently
commercially available.
The modifications to the PBP assay method that were chosen
to combat the presence of B-Iactamases in the cell membrane
preparations were: further increasing the concentration of radioactive
benzylpenicillin from 15 III to 30 III in an attempt to saturate the B-
lactamase or including the B-Iactamase inhibitors clavulanic acid and
sulbactam.
By doubling the volume of 3H-benzylpenicillin used from 15 lJl
to 30 ul, additional PBP bands were seen with B.tragi/is R208 and
0423. Both these strains showed 76 kOa and 67 kOa proteins, likely
to correspond to the PBP 2 and PBP 3, previously detected with the
sensitive strains and B.fragi/is 2013E. The higher molecular weight
protein of 87 kOa (PBP1) was not detected with these two strains.
PBP 2 was, therefore, labelled in preference to PBP 1 with B.tragi/is
R208 and 0423, supporting the findings of Piddock and Wise (1986)
that most B-Iactam compounds, including benzylpenlclllln, bind
preferentially to PBP 2 in B.fragilis. Again, PBP 6 was found in the
four resistant strains but not in the sensitive control, possibly reflecting
the presence of B-Iactamases within the cell membrane of resistant
strains during the PBP assay.
In the presence of clavulanic acid, PBPs 1, 2 and 3,
corresponding to those found with the sensitive B.tragilis strains,
were seen in all four resistant strains. PBP 5 (45 kOa) was visible only
with B.tragi/is 0423, which also yielded a faint band of 62 kOa,
presumably PBP 4. These findings confirm that the previous failure to
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demonstrate binding of 3H-benzylpenicillin with these strains was due
to hydrolysis by f3-lactamaseS.PBP 6 has previously been shown to
be associated with f3-lactamase activity, being consistantly observed
in imipenem resistant non-metallo-f3-lactamase producing strains
which produced elevated amounts of f3-lactamase, and not found in
sensitive B.tragi/is strains with low levels of f3-lactamase activity.
Unexpectedly, PBP 6 was demonstrated in all strains, except
B.tragi/is 2013E, despite the presence of f3-lactamase inhibitor. It is
tempting to speculate that this low molecular weight PBP is
associated with non-f3-lactamase mediated imipenem resistance,
although Wexler and Halebian (1990) observed a 40 kOa PBP in the
sensitive B.tragi/is ATCC 25285 strain.
In the case of B.tragi/is R212, PBPs 1, 2 and 3 were absent in
tests carried out in the presence of sulbactam, as was PBP 4 of
B.tragilis 0423. Failure to detect PBPs in the presence of sulbactam
may represent the competitive affect of the f3-lactamase inhibitor or
the activity of f3-lactamasesdespite the presence of sulbactam.
The effect of the f3-lactamase inhibitors was more marked for
B.fragi/is 0423 and 2013E than for B.tragi/is R208 and R212 and
corresponds to the sensitivity of the enzymes to the f3-lactamase
inhibitors as demonstrated by the inhibition studies (section 4.4; See
also Eley and Greenwood, 1986b). This was indicated by the
appearance of additional PBP bands with B.tragi/is 0423, and the
absence of PBP 6, which appears be associated with f3-lactamases,
with B.fragi/is 2013E.
Competition assays with a sensitive B.fragi/is strain indicated
that the greatest binding of imipenem was to the higher molecular
weight PBPs of more than 60 kOa. This is in agreement with the
findings of Piddock and Wise (1986) who reported that imipenem
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binds initially to PBP 3, then to PBP 2, and, at concentrations close to
the MIC, to PBP 1. In the imipenem resistant strain, the degree of
imipenem binding appeared to be reduced and favoured the low
molecular weight proteins. It is possible that this apparent reduced
affinity of imipenem, particularly to those PBPs of high molecular
weight with lethal functions, may playa part in resistance. However,
the situation is complicated by the presence of 13-lactamasesin the
PBP competition assay of resistant strains which governed the
amount of 3H-benzylpenici"in available for binding and may
themselves be inhibited by imipenem. The possibility that imipenem
could act as a 13-lactamaseinhibitor in the competition assay with the
resistant strain B.tragi/is R212 was supported by the 13-lactamase
inhibition profile of this strain which indicated susceptibility of the
enzyme to imipenem (See section 4.4). Therefore, any reduction in
penicillin binding resulting from the competitive action of imipenem
may be offset by reduced hydrolysis of 3H-benzylpenicillin due to 13-
lactamase inhibition by imipenem.
Both sensitive B.tragi/is and strains with increased resistance
to imipenem (in the presence 13-lactamase inhibitors) have been
shown to possess the three major penicillin binding proteins PBPs 1,
2 and 3. Imipenem showed a high degree of binding to these higher
molecular weight PBPs of sensitive strains. The affinity of PBPs of the
resistant strains for benzylpenicillin or imipenem was difficult to
determine due to the presence of 13-lactamasesand the competitive
action of 13-lactamase inhibitors. Low molecular weight PBPs were
detected in the imipenem resistant non-carbapenemase producers
and in some of the sensitive strains. Some of these PBPs may
represent non-specific binding sites. The lowest molecular weight
PBP (ea. 40 kOa) was only present in the imipenem resistant strains
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and was associated with ~-Iactamase activity or possibly non-enzymic
resistance.
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DISCUSSION OF RESISTANCE MECHANISMS
Of 108 clinically significant bacteroides isolates collected for
this study, 21 produced elevated amounts of (3-lactamaseas judged
by enhanced hydrolysis of nitrocefin. This group of isolates contained
all the strains which showed increased resistance to benzylpenicillin,
latamoxef and imipenem, and nine of the twelve strains that showed
increased resisitance to cefoxitin. This reinforces the importance of (3-
lactamases in the resistance of bacteroides to (3-lactam antibiotics
(Nord and Hedberg, 1990) and indicates that the vast majority of
strains did not possess unusual permeability barriers or alterations in
the target proteins. Clinical isolates of (3-lactamase-negative
bacteroides, in particular, B.distasonis, that were resistant to many (3-
lactam agents have been reported (Finegold, 1989). Interestingly, two
out of the three bacteroides isolated in this study that exhibited
increased resistance to cefoxitin and which did not produce elevated
(3-lactamase levels, were identified as B.distasonis.
Bacteroides with increased resistance to the test (3-lactam
antibiotics were, therefore, largely restricted to the 21 strains which
produced raised levels of (3-lactamase.
Benzylpenicillin
Fourteen of the 21 strains that exhibited enhanced (3-lactamase
activity were resistant to benzylpenicillin (MIC ~32 mg/l). Clavulanic
acid (4 mg/l) failed to restore full sensitivity (MIC ~1 mgll) in only two
of these strains (B.fragilis R212 and B.thetaiotaomicron R233),
although a sixteen-fold and four-fold reduction in MIC of
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benzylpenicillin respectively was observed. (3-Lactamases from both
of these strains were moderately sensitive to clavulanic acid as
shown by inhibition of hydroysis of nitrocefin (ICsos 1 J..lM),although
pardoxically the inhibitor (clavulanic acid 4 mgll, equivalent to 20 J..lM)
failed to prevent rapid and complete hydrolysis of benzylpenicillin in
studies with crude cell extracts or whole cells. Three of the 14
benzylpenicillin resistant bacteroides, B.distasonis R118, B.fragi/is
R208, and B.ovatus R215, appeared susceptible to benzylpenicillin
in the presence of clavulanic acid although enzymes from these
strains were only moderately sensitive to inhibition by clavulanic acid
(ICsos 1, 10 and 1 J..lMrespectively), and slow breakdown of
benzylpenicillin by crude cell extracts was observed in the presence
of the inhibitor. The remaining isolates with MICs of ~32 mgll
benzylpenicillin, as expected, possessed enzymes that were fully
sensitive to clavulanic acid in inhibitor studies (ICsos <0.1 J..lM)and
failed to hydrolyse benzypenicillin in the presence of the inhibitor.
Cefoxitin
Nine of the 21 isolates that produced high levels of (3-
lactamasa were shown to exhibit increased resistance to cefoxitin
(MIC ~32 mgll), and these also displayed reduced susceptibility to
latamoxef or imipenem or both. Crude cell extracts of seven of these
strains were capable of some hydrolysis of cefoxitin, although whole
cells from all nine resistant strains reduced the activity of the antibiotic
to some extent after 22 hours' incubation. Extracts and whole cells of
B.fragi/is R212 and B.thetaiotaomicron R233 completly hydrolysed
cefoxitin and this was associated with a high degree of resistance to
cefoxitin (MICs ~128 mgll). High level resistance to cefoxitin in these
strains seems clearly (3-lactamasemediated. Crude cell extracts from
B.ovatus R102, B.distasonis R118 and B.fragi/is R208, which
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showed low-level resistance to cefoxitin (MICs 32 mgtl), caused no, or
in the case of a.tragi/is R20a,·minimal, hydrolysis the antibiotic. With
whole cells of these strains, more than 70% of the antibiotic control
remained. Results obtained with these strains, which hydrolysed the
antibiotic feebly, suggested that other resistance factors may have
been operating. The moderate degree of degradation of cefoxitin
shown with a.tragi/is R186, R215, R240 and R251 by crude cell
extracts and whole cells was reflected in the relatively modest levels
of resistance of these strains (MICs 32-64 mg/l). Interestingly, crude
cell extracts of a.fragi/is R249 showed modest hydrolysis of cefoxitin
although the strain was judged sensitive (MIC 16 mgll cefoxitin).
Latamoxef
Five isolates of bacteroides were resistant to latamoxef (MIC
~32 mg/l). Four, a.tragilis R208 and R212, B.ovatus R215 and
B.thetaiotaomicron R233 were highly resistant (MIC >128 mg/l).
Crude cell extracts and whole cells of two of these strains, B.tragi/is
R212 and B.ovatus R215, completely hydrolysed latamoxef, clearly
implicating ~-Iactamases in the resistance. In the case of
B.thetaiotaomicron R233, the efficient hydrolysis achieved by crude
extracts was not seen in experiments with whole cells. The
discrepancy in these results may have been due to the concentration
of the ~-Iactamases present in the crude cell extracts. With a.tragi/is
R208, only modest hydrolysis of the antibiotic was observed in
experiments with crude cell extracts or whole cells, suggesting a role
for non-p-lactarnase mediated resistance. Also, as with cefoxitin,
crude cell extracts of B.ovatus R102 failed to degrade latamoxef, yet
this strain showed modestly increased resistance (MIC 32 mg/l
latarnoxet). In experiments with whole cells of this strain only slight
decay of the antibiotic was observed. These results again suggest
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that non-enzymic mechanisms may be responsible for the decreased
susceptibility of this strain.
Curiously, crude cell extracts from B.tragi/is R186, R240, R249
and R251 completely hydrolysed latamoxef after 20 hours' incubation,
yet these strains were found to be sensitive to the drug. Unfortunately,
breakdown of latamoxef by whole cells of these strains could not be
tested as sub-MIC concentrations were below the detection limit of the
microbiological assay system.
Imipenem
No bacteroides strain that was highly resistant to imipenem
was encountered in the study. However, isolates for which the MIC of
imipenem was 2 mg/l or more, at least 16-times greater than the MICs
for 'normal' sensitive B.tragi/is, were considered to show increased
resistance. Seven isolates, five B.tragi/is together with B.distasonis
R118 and B.thetaiotaomicron R233, showed increased resistance to
imipenem by this criterion. In all seven cases the MIC of imipenem
was equal to or below the breakpoint of 4-8 mg/l that is usually cited
as indicating resistance to imipenem in bacteroides (Finegold, 1989;
Phillips et al., 1992). Niether crude extracts nor whole cell
preparations of the two non-B.tragi/is strains markedly hydrolysed
imipenem, so that resistance factors other than fj-Iactamase appeared
to be involved in these strains. However, because of constraints of
time, mechanisms of increased resistance to imipenem were
investigated futher only in isolates of B.fragilis.
Imipenem owes its high antibacterial activity to several unique
features. It has a compact structure (molecular weight 299 kDa) and is
a zwitterion, both of these characteristics normally facilitate rapid
penetration across the E.coli outer membranes (Yoshimura and
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Nikaido, 1985). It is also highly stable to most types of B-Iactamases
(Neu and Labthavikul, 1982) and has been shown to have high
affinity for critical PBPs in Gram negative pathogens
(Georgopapadakou et al., 1983; Hashizume et al., 1984).
In order to try to elucidate the resistance mechanisms in
B.tragi/is strains showing reduced susceptibility to imipenem, the five
carbapenem resistant isolates were considered together with three
additional B.tragilis strains that had been found in earlier studies
(Eley and Greenwood, 1986b). The characteristics of these strains are
summarised in Table 8.1.
Metallo-B-/actamase mediated increased resistance
Rapid hydrolysis of imipenem (and meropenem) was shown by
crude cell extracts and whole cell preparations of four of the eight
resistant strains: B.tragi/is R186, R240, R251 and 119. These strains
all produced metallo-B-Iactamases, and displayed a marked inoculum
effect; their increased carbapenem resistance was undoubtedly B-
lactamase mediated.
There appeared to be a relationship between the degree of
imipenem resistance and the specific imipenemase activities,
indicating that higher resistance resulted from greater activity or
production of metallo-B-Iactamases.Therefore, the relatively low MICs
of imipenem of the metallo-B-Iactamase producing test strains
appeared to be related to the low imipenemase activity of these
enzymes. This was typified by two other B.tragi/is isolates, R249 and
97, which appeared fully sensitive to imipenem in MIC titratitions
despite their production of metallo-B-Iactamases. Enzymes from these
strains exhibited low specific activities and this may explain the lack of
resistance with imipenem.
These observations indicate the presence, in the B.tragi/is
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Table 8.1. Summary of characteristics of imipenem resistant
B.fragi/is strains indicating likely resistant mechanisms
Characteristic
B. fragilis strain
R186 R240 R251 119 R212 0423 R208 2013E
MIC (mg/l) 2 4 2 16 2 2 4 2
p-Lactamase type 1 1 1 1 2 2 3 4
% imipenem remaining
after 20 hrs
incubation with
crude cell extracts
5 <5 <5 <5 90 55 72 83
Inoculum effect Yes Yes Yes Yes No Slight Slight
Reduction of MIC
of imipenem by
clavulanic acid
No No Yes Yes
Crypticity factor 1 1 2 396 1 1
OMchangeS Yes Yes Yes Yes No No No No
Presence of
PBPs 1,2,3 and 6
NT NT NT NT Yes Yes Yes Yes
~~~~~~------J-----~~;;;P~--------l-;e~~~;b~;;l-~~;~~a~~-
:~:~~~~~------- ~~~~~~~:~-------~:~~~~--:::::~~-
NT = Not Tested
!J. = clavulanic acid does not inhibit metallo-p-lactarnases
+ = B.fragi/is R251 and 119 are also possibly associated with a permeability
barrier
* = toqetner with other unknown resistance factors
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population, of strains which produce metallo-f3-lactamases, have low
specific carbapenemase actlvlty and show low level carbapenem
resistance. In the study, four strains of this type were encountered out
of 69 B.tragi/is isolates (6%), while highly resistant carbapenemase
producers were not found. Podglajen et al. (1992b) reported, in a
French study, that the incidence of B.tragilis carrying a 'silent' ctiA
gene showing low resistance to carbapenems is twice as high as
highly carbapenem resistant strains which express the gene. The in
vitro one-step mutation to high-level carbapenem resistance of
B.tragilis strains carrying 'silent' carbapenemase genes, described
by Podglajen et al. (1992a), highlights the potential for development
of carbapenem resistance among B.fragilis.
A striking feature of the metallo-f3-lactamase producers
examined in the study was their distinctive OM protein and LPS
composition. This may simply reflect a specific biotype since
permeability barriers appeared not to be a major feature as
demonstrated by the low crypticity values generally found for these
strains (See section 6.2). However, in the case of B.tragi/is 119,
crypticity experiments indicated a partial permeability barrier which
may be an additional factor in this strain's moderately high resistance
to imipenem. Also, the slightly raised crypticity value shown by
B.tragi/is R251 may be relevant.
Increased resistance not associated with metallo-f3-lactamases
B.tragi/is strains R208, R212, 0423 and 2013E clearly had
imipenem resistance mechanisms that were different to those of the
strains previously described. They did not produce metallo-p-
lactamases and did not rapidly hydrolyse carbapenems. All four
stralns produced f3-lactamases that caused only a slow loss of
imipenem. Paradoxically, these strains exhibited OM and LPS profiles
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similar to those of fully sensitlve B.tragi/is.
B.fragi/is R212 and 0423 possessed ~-Iactamases of a similar
type, type 2 as defined by this study (See section 4.7). Although these
enzymes seemed moderately sensitive to clavulanic acid, the ~-
lactamase inhibitor had no effect on imipenem susceptibility. Also, no
inoculum effect was shown in turbidimetric experiments with these
strains. ~-Lactamases, therefore, did not appear to play any part in the
imipenem resistance. However, crypticity tests indicated that these
strains possessed substantial permeability barriers, although this was
not reflected in their OM protein and LPS composition. Permeability,
therefore, appeared to be a factor in the increased resistance of
B.tragilis R212 and 0423 to imipenem and other ~-Iactam antibiotics,
but the nature of the permeability change remains obscure.
There was no indication of a permeability barrier with B.tragi/is
R208 and 2013E. Evidence has been presented that B.tragi/is 2013E
is a high producer of normal type 4 ~-Iactamases, and BJragi/is R208
produced elevated amounts of type 3 enzyme (See section 4.7).
These two enzyme types display certain similarities. Both B.fragilis
R208 and 2013E showed a slight inoculum effect and, more
importantly, some increase in imipenem sensitivity was seen in the
presence of clavulanic acid. These findings suggest that the ~-
lactamases of BJragilis R208 and 2013E, although incapable of the
rapid efficient hydrolysis of imipenem displayed by the metalto-p-
lactamases, showed weak carbapenemase activity which may have
played a part in the increased imipenem resistance of these strains.
Other resistance factors are suggested for these strains by the
inability of clavulanic acid to fully restore sensitivity to imipenem.
Similar observations were described by Livermore and Yang (1987)
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who reported slow hydrolysis of imipenem, mediated by chromosomal
ncn-metallo-p-lactarnases in P.aeruginosa, which protected the
bacteria, although insufficiently to cause clinical resistance. Imipenem
resistance in a B.distasonis strain has been reported by Hurlbut et
al. (1990) to be associated with a combination of impermeability and
the activity of a non-metallo-p-lactarnase susceptible to clavulanic
acid. Not surprisingly, the enzyme from this B.distasonis strain
differed from the [3-lactamasesof B.tragilis 2013E and R208 in that it
hydroysed cefoxitin and had a pI value of 6.9.
The possibility exists that lack of binding of imipenem to
essential PBPs could result in resistance of these strains. However, it
has been shown that, in the presence of fl-Iactamase inhibitors, the
four imipenem resistant strains in which metallo-fl-Iactamases were
not found, possessed the three major PBPs (1, 2 and 3) which were
present in sensitive B.tragi/is isolates. The presence of fl-Iactamase
in the cell membrane of the resistant strains proved to be an obstacle
to the assessment of the affinity of imipenem to the PBPs. However,
the lowest molecular weight PBP detected, PBP 6, was present in
imipenem resistant B.tragi/is strains and absent from sensitive
isolates. Although this PBP appeared to be associated with fl-
lactamase activity, it was also possibly involved in non-enzymic
resistance.
Clinical significance
This study revealed the presence of bacteroides strains with
susceptibilities to fl-Iactam antibiotics below the conventional break-
points determined in vitro which possessed a variety of resistance
mechanisms. The therapeutic implications of these isolates with
reduced susceptibility to fl-Iactam agents remain unclear and require
investigation. Conversion of these strains, particularly those which
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produce rnetallo-p-lactamases, to higher resistance levels during
therapy is a possible threat. .
The proportion of bacteroides showing resistance or reduced
susceptibility to '~-Iactamase stable' antibiotics was low and
appeared unchanged over a five year period, with the possible
exception of a rise in cefoxitin resistance. High level resistance to
latamoxef and cefoxitin (MIC >64 mg/l) appeared marginally more
common. Future monitoring is required to detect any changes in the
degree resistance of Bacteroides spp. to these antibiotics.
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on the specific activity of ,8-lactamases of Bacteroides spp. JoUl7llJlof Applied Bacte-
riology 69, 421-425.
The inftuences of growth conditions and cold storage on the specific activity of
,8-lactamases of four strains of BacteroUks !pp. was studied. Interbatch variation
was observed in extracts prepared in an identical way on separate oc:casions but
less variation was observed in extracts prepared Crom bacteria grown on Brain
Heart Infusion apr supplemented with yeast extract, haemin and menadione, than
in similar extracts of bacteria grown in broth or on other solid media. The loss of
enzyme activity seen during the stationary phase oC growth oC some strains in broth
was minimal during incubation Cor48 h on apr. Storage oC enzyme extracts at 4°C
was associated with 1011 of enzyme activity, but activity was retained during storage
at - 700C Cor up to 32 days. Freezing and thawing had little effect on enzyme
activity.
Bacteroides spp. are commonly responsible for
anaerobic infections in man and are often resist-
ant to Jl-Iactam antibiotics (Dornbusch et al.
1975; Sutter & Finegold 1976). An important
cause of this resistance is the production of JI-
lactamases (Anderson & Sykes 1973; Britz &
Wilkinson 1978; Del Bene & Farrar 1973), for
the characterization of which quantitative deter-
minations have been extensively used (Eley &
Greenwood 1986a, b; Simpson et al. 1982).
Production of Jl-Iactamase by some strains of
Bacteroides spp. is known to vary throughout
the growth cycle (Darland & Birnbaum 1977;
Eley & Greenwood 1985). Moreover, medium
composition appears to affect Jl-Iactamase pro-
duction, making comparisons between different
studies difficult (Olsson et al. 1976; Simpson et
al.1982).
We have investigated the specific activities of
Jl-Iactamases produced by selected strains of
Bacteroides spp. under various conditions of
growth and have explored the effect of storage
conditions on the stability of the enzymes in
crude extracts.
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Materials aacI Methods
BACTBIUAL STRAINS
Four representatives of the Bacteroides fragilis
group were studied: B.fragilis 2013E, B. thetaio-
taomicron 0456 and B. distasonis R939 were
used in an earlier study of the effect of growth
phase on Jl-Iactamase production (Eley &
Greenwood 1985); B. Ollarus RE2 was a fresh
clinical strain obtained in Nottingham Public
Health Laboratory.
EXTRACTION OF /J-LACTAMASES
Bacteria were harvested from solid media with a
cotton wool swab, or from broth by centrifu-
gation. The organisms were suspended in 4 mI
of phosphate-buffered saline (0·02 mol/l; pH 7)
in a beaker of iced water. The bacterial suspen-
sions were then subjected to six 30 s bursts of
sonication under ice in a Soniprep 150 ultra-
sonicator (MSE Scientific Instruments). The
extracts were centrifuged at 4000 rev/min for 30
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Fig. 1. Specific activities {JIIIl nitrocefin hydrolysed/min/rug protein) of p-lactamases derived from (a) Bacteroides
fragilis 20!3E; (b) B. thetaiotaomicron 0456; (c) B. distasonis R939; (d) B. ovatus RE2 harvested from supplemented
Brain Heart Infusion broth and agar (BHIS broth and BHIS), BHIS agar with 7% horse blood (BHISB) and
Blood Agar Base with 7% horse blood (BABB) after various times of incubation. Results shown are from three
independent experiments. M. mid-logarithmic phase; L,late logarithmic phase; S, stationary phase of growth.
min at 4°C (Coolspin; MSE). Each supernatant
fluid (crude extract) was divided into two por-
tions and stored at -70°C for not more than 14
days.
DETERMINA TION OF SPECIFIC ACTIVITY
The method used was that of O'Callaghan et al.
(1972). The rate of hydrolysis of 1·9ml of nitro-
cefin (51·6 mg/l solution in phosphate buffer at
pH 7) by 0·1 ml of crude enzyme extract was
measured over 3 min at 37°C and 482 nm in
a spectrophotometer (UY-160A; Shimadzu).
Extracts achieving maximum hydrolysis in
under 3 min were diluted appropriately in phos-
pate buffer and retested.
The total soluble protein content of the crude
extracts was measured with the Sigma Protein
Assay ki].
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Specific activity was calculated according to
the formula:
~O.D./min N
total ~O.D. x protein content (mg/ml)
x enzyme dilution
where N = pmoles nitrocefin present in the
cuvette.
EFFECT OF GROWTH CONDITIONS
The test strains were grown at 37°C in Brain
Heart Infusion broth (Oxoid) supplemented
with yeast extract 5 g/l, haemin 5 mg/l and
menadione 1 mg/1 (BHIS) in the anaerobic
turbidimeter described by O'Grady & Eley
(1983). Bacteria were harvested during the
middle and late logarithmic (pre-stationary)
ap-Lactamases of Bacteroides spp.
b
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Fig. 2. Specific activities (pm nitrocefin hydrolysed/rnin/rng protein) of p-lactamases from (a) Bacteroides jragilis
20tJE; (b) B. theraioraomicron 0456; (c) B. distasonis R939; (d) B. ovatus RE2 before and after various cold storage
regimens. m. -70°C; r2i1. -20°C; • • +4°C.
phases of growth and after 24 h of incubation
(stationary phase).
In experiments with solid media three types
were used: BHIS solidified with 1% agar (BHIS
agar), BHIS agar with 7% horse blood (BHISB)
and Blood Agar Base (Oxoid) with 7% horse
blood (BABB). All media were pre-reduced
overnight in an anaerobic cabinet. Specific
activity was determined on extracts of bacteria
harvested after incubation for 7, 24 and 48 h in
an anaerobic cabinet at 37°C.
Growth and extraction procedures were
carried out on three separate occasions for each
condition of growth.
To assess intrabatch reproducibility, one
extract of each strain was tested for specific
activity three times on the same day.
EFFECT OF STORAGE
The specific activities of extracts of the test
strains grown on BABB were determined imme-
diately after preparation of the crude extract.
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Each extract was then divided into nine por-
tions and stored in batches of three at 4°C,
- 20°C and - 70°C. Specific activity was deter-
mined after 7, 17 and 32 days in each storage
condition.
EFFECT OF FREEZING AND THAWING
Further crude extracts were made of strains
B. Jragilis 2013E and B. thetaiotaomicron 0456
grown in BHIS. The specific activity of these
extracts was immediately determined. Portions
of the extracts were then frozen (at - 20°C and
-70°C) and thawed three times over a period of
4 h and the specific activities measured on each
occasion.
Results
INTRABA TCH REPRODUCIBILITY
The maximum deviation from the mean of spe-
cific activity values of one extract analysed three
times on the same day was 10%.
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EFFECT OF GROWTH CONDITIONS
Specific activities of p-Iactamases derived from
bacteria harvested from broth or three types of
solid medium are given in Fig. 1, in which the
results of three separate experiments are shown.
Specific activities of p..lactamases of B. fragilis
2013E and B. ovatus RE2 increased during the
late logarithmic (pre-stationary) phase of
growth in broth and declined dramatically
during the stationary phase. Such loss of activ-
ity on prolonged incubation was absent or
much less marked during growth of these
strains on solid media for up to 48 h.
Specific activities of the p..lactamases of B.
thetaiotaomicron 0456 and B. distasonis R939
were vastly different. However, the activities of
both enzymes were retained in the stationary
phase of growth in broth and during incubation
for 48 h on solid media.
Growth on BABB yielded greater specific
activity than that observed after growth on BHIS
or BHISB agars. This was particularly marked
for B. fragilis 2013E and B. ovatus RE2. Con-
siderable variation in specific activity was
observed among samples processed in an identi-
cal manner on three separate occasions. In
some, values recorded varied by a factor of two
or three.
EFFECT OF STORAGE
The impact of cold storage on the p-lactamase
activity of extracts of the test strains is shown in
Fig. 2. Stability of the enzyme varied somewhat
from strain to strain, but marked loss of activity
occurred during storage at 4°C with all strains.
For three of the four extracts, enzyme activity
was retained more completely during storage at
- 70°C than at - 200C.
EFFECT OF FREEZING AND THAWING
Freezing at - 700C and subsequent thawing
had .little or no effect on p..lactamase activity,
but m experiments in which freezing was carried
out at - 20°C, a small loss of activity was
observed, particularly with B.fragilis 2013E.
Discussioa
Comparison of the results of studies of p..
lactamases is often difficult, because of the
possjbility that methodological differences
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might influence the findings. This is a particular
problem in studies of Bacteroides spp., in some
strains of which p-lactamase production is
known to vary with the phase of growth
(Darland & Birnbaum, 1977; Eley & Green-
wood 1985). In this study we have attempted to
define the optimum conditions of growth and
storage for the characterization of p-lactarnases
of species of Bacteroides within the B. fragilis
group. To this end we have evaluated the inter-
batch and intra batch reproducibility of assays
of specific activity and examined the effects of
storage and freezing and thawing on enzyme
activity. .
Not surprisingly, intrabatch reproducibility
proved to be very good (± 10%), but the inter-
batch variation observed was much greater.
Thus, when specific activity was measured on
samples prepared in an identical fashion on
three different occasions, twofold differences in
specific activity were commonly found and
larger differences were occasionally encoun-
tered. Such biological variation in enzyme activ-
ity appeared somewhat less marked in samples
prepared from bacteria grown on BHIS agar for
24 or 48 h.
In general, the highest yield of p-lactamase
activity was obtained on BABB. Whether this
effect is attributable to the presence of the horse
blood is doubtful, since such a stimulatory effect
was not uniformly achieved by addition of horse
blood to BHIS agar.
Overall, these results suggest that BHIS agar
(without blood) provides a reliably reproducible
growth medium for p..1actamase studies of Bac-
teroida spp. Growth on agar seems preferable
to that in broth since this obviates, or much
reduces the inftuence of growth phase on
enzyme production and therefore renders the
time of harvest much less critical. BHIS also has
the virtue of providing luxuriant growth of mor-
phologically normal cells of Bacteroides spp.
(Eley et al. 1985). Some other commonly used
anaerobic media, such as Schaedler broth,
Wilkins-Chalgren broth and thioglycoUate
broth are less satisfactory in this regard (Eley et
al. 1985) and were, for this reason, not tested in
this study.
Investigation of the stability of p-lactamases
during storage revealed considerable loss of
activity when extracts were held at 4°C, but
almost complete retention of activity during
storage at - 70°C for up to 32 days. There was
p-Lactamases of Bacteroides spp. 425
little evidence of loss of activity by repeated
freezing and thawing.
Loss of activity at 4°C was greatest in those
strains in which loss of p-lactamase activity was
observed during the stationary phase of growth
in broth. Loss of activity is without doubt
associated with proteolytic breakdown of pre-
formed enzyme, an effect which evidently con-
tinues during storage at 4°C.
We have previously suggested (Eley & Green-
wood 1986a,b) that it might be useful to cate-
gorize the p-lactamases of clinical strains of
Bacteroides spp. on the basis of their specific
activities. The present results highlight the
necessity to define the conditions of growth and
storage if specific activity is to be used in this
way.
On the basis of the present findings, we
recommend that BHIS agar should be used for
the growth of Bacteroides spp. and that sonicat-
ed extracts, prepared according to a stan-
dardized protocol. should be stored at -70ac
for not longer than 3 weeks before the estima-
tion of specific activity or use in other enzyme
studies.
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Extended abstract
An investigation of f3-lactamase-mediated imipenem
resistance in clinical isolates of Bacteroides spp.
R. Edwards and D. Greenwood
Department of Microbiology and PHLS Laboratory,
Queen's Medical Centre, Nottingham, NG 7 2UH.
Imipenem is used in the treatment of anaerobic infections
and has excellent antimicrobial activity which is due, in
part, to f3-lactamase stability. We have determined the
degree of resistance to imipenem amongst clinically
significant bacteroides isolates. The role of f3-lactamases
in this resistance was studied by examining imipenem
stability to crude enzyme extracts and whole cells, and by
investigating the affect of clavulanic acid, a f3-lactamase
inhibitor, on imipenem activity.
Of 116 clinical bacteroides isolates, seven (6%) were
found to be imipenem resistant (MIC >2mgll). These strains
comprised 5 a.fragi/is (R186, R208, R212, R240, R251), 1
a.distasonis (R118) and 1 a.thetaiotaomicron (R233). MICs
were determined in supplemented Brain Heart Infusion
(S.H.I.) agar with 48 hours of incubation.
f3....Lactamase activity was investigated by exposing crude
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enzyme extracts, obtained by sonication of bacterial cells,
to imipenem (50mgll). The mixture was incubated at 370C
and the residual imipenem assayed by HPLC after 2, 4 and
22 hours. The r3-lactamase activity of whole cells was
examined using strains grown in supplemented S.H.1. broth
containing rmipenem (O.25mgll). After 22 hours of
incubation, the residual imipenem was measured by
microbiological assay. In addition, the MIC and the
breakdown of imipenem by whole cells were tested in the
presence of clavulanic acid for those strains whose r3-
lactamases were known to be affected by this inhibitor.
Enzyme extracts from three B.fragilis strains (R186,
R240 and R251) were capable of rapid hydrolysis of
imipenem. With whole cells, imipenem was detected after
incubation with only one strain, B.fragilis R212. In
previous experiments with penicillin, the ability of
clavulanic acid to inhibit these r3-lactamases was observed
with only two strains, B.fragilis R208 and B.distasonis
R118. In the presence of clavulanic acid, sensitivity to
imipenem .was restored for both these strains and residual
imipenem was detected after incubation with whole cells.
The results suggest that r3-lactamases were a factor in
the resistance to imipenem for six of the seven bacteroides
strains tested. These six strains appeared to break down
imipenem in growing cultures, although only three strains
demonstrated degradation with crude enzyme extracts. This
difference may be due to alteration of the enzymes during
the extraction process or to the different imipenem
concentrations used in the two experiments. The non-p-
258
lactamase-mediated resistance of the one strain is
presumably associated with low permeability or lack of
affinity to the P.B.P.s.
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An investigation of p-Iactamases. from clinical isolates of
Bacteroides species
R. EDWARDS and D. GREENWOOD
Dep,rtment of Microbiology and PHLS L,boratory, University Hospital, Queen's Medic,1 Centre, Nottingh,m
NG72UH
Summary. Among a group of 116 clinically significant isolates of Bacteroides spp., 24
exhibited p-lactamase activity greater than the basal level characteristic of most Bacteroides
strains. Investigation of specific enzyme activity, iso-electric point and enzyme inhibition
profiles revealed that the p-lactamases involved could be divided into four groups, some
showing similarity to those described in previous studies. Seven of the enzymes were able to
hydrolyse cefoxitin, latamoxef or imipenem, and eight enzymes degraded penicillin in the
presence of ciavulanic acid. Five strains showed reduced susceptibility to cefoxitin, latamoxef
or imipenem which was not associated with p-lactamase activity.
Introduction
The production of p-lactamase is the major factor
in the resistance of Bacteroides spp. to p-lactam
antibiotics. Most Bacteroides strains exhibit low-level
chromosomally mediated p-lactamase activity that
affects benzylpenicillin and many other penicillins,
although the enzyme preferentially hydrolyses cepha-
losporins. I A substantial number of clinical isolates
show raised levels of p-lactamase activity.l-4 Some of
these enzymes inactivate p-lactamase-stable com-
pounds, including cefoxitin.Iatamoxef and imipenem,
and are insusceptible to inhibition by P-lactamase
inhibiton, such as clavulanic acid or sulbactam.4-8
Attempts have been made to classify the P-
lactamases produced by Bacteroides spp. according to
their substrate profiles, susceptibility to various en-
zyme inhibitors, iso-electric point, specific enzyme
activity and rate of hydrolysis of susceptible sub-
strates. l. 7 In a previous communication. 4 we used
such methods to examine the p-lactamases of a group
of Bacteroides strains isolated from clinical specimens
in Nottingham, and suggested that those strains
exhibiting enhanced levels of enzyme activity could
be grouped according to their specific cephalosporin-
ase activity.
We have now examined a further group of clinical
isolates to assess the prevalence of the various enzyme
types and to try to shed further light on the
characterisation of these enzymes.
Materials and methods
Bacterial strains
One hundred and sixteen clinically significant
isolates of Bacteroides spp, were collected randomly
Received 20 March 1991; accepted 21 May 1991.
from specimens submitted to Nottingham Public
Health Laboratory and maintained in skimmed milk
at - 700C. They were identified by carbohydrate
fermentation tests and, if these tests yielded equivocal
results. by the ATB 32A system (API Products,
Basingstoke, Hants), B.fragilis NCTC 9344 was used
as a control strain.
Antibiotics
Solutions of benzylpenicillin (Glaxo laboratories
Ltd), clavulanic acid (Beecham Research laboratories
Ltd), cefoxitin (Merck, Sharp and Dohme ltd) and
latamoxef'(Eli Lilly and Co. Ltd) were freshly prepared
as required in sterile distilled water, Appropriate
concentrations of imipenem (Merck, Sharp and
Dohme Ltd) were dissolved in O'Obl phosphate buffer,
pH 7'0, according to the manufacturer's instructions.
Antibiotic titrations
Minimum inhibitory concentrations (MICs) were
determined by the agar incorporation method. Anti-
biotics in suitable two-fold serial concentrations were
incorporated in Brain Heart Infusion Agar supple-
mented with yeast extract 5 giL, haemin 5 mg/L,
menadione 1mg/l and lysed horse blood 5%. An
inoculum of c. 106 organisms was delivered on to the
agar surface with a multipoint inoculator (Denley
Instruments, Billingshunt, Sussex). The lowest anti-
biotic concentration that completely inhibited growth
after incubation for 48 h at 37°C, in an anaerobic
cabinet, was taken as the MIC.
Semi-quantification of fJ-lactamase in intact
bacteria
Penicillinase. The method of Escamilla? was used.
In this test, a pH change occurring as a result of
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hydrolysis of benzylpenicillin is assessed by a colour
change in a phenol red indicator.
Cephalosporinase. The hydrolysis of nitrocefin
(250 mg.L), which results in a colour change from
yellow to red, was used as described by Aldridge et
al."
In both tests, several colonies from overnight
cultures of organisms grown on supplemented Brain-
Heart infusion agar were used and the results were
assessed visually over a l-h period.
Preparation of crude fJ-lactamase extracts
Bacterial growth was harvested from Blood Agar
plate cultures (Blood Agar Base, Oxoid. with horse
blood 7'YO>after incubation for 48 h in an anaerobic
cabinet. The bacteria were suspended in a tube
containing 4 ml of phosphate buffer (0·02 M; pH 7·0)
in a beaker of iced water. The bacterial suspensions
were then subjected to six 3O-Sbursts of sonication, on
ice. in a Soniprep 1SO ultrasonicator (MSE Scientific
Instruments, Crawley, Sussex). The extracts were
centrifuged at 4000 rpm for 30 min at 4°C (Coolspin;
MSE) and the supernate (crude extract) was divided
into four portions and stored at - 70°C. II
Determination of specific activity
The method used was based on that of O'Callaghan
et al. 12 The rate of hydrolysis of nitrocefin (1·9 ml of a
SI·6 mgjL solution in phosphate buffer, pH 7·0) by
0·1 ml of crude enzyme extract was measured over
3 min at 37°C and 482 nm in a spectrophotometer
(UV-16OA; Shimadzu, Kyoto, Japan). Extracts
achieving maximum hydrolysis in under 3 min were
diluted appropriately in phosphate buffer and re-
tested. The total soluble protein content of the crude
extracts was measured by the Sigma Protein Assay
Kit. Specific enzyme activity was calculated as the
amount (pmol) of nitrocefin hydrolysedlminlmg of
protein.
Iso-electric focusing
Iso-electric focusing of crude Jl-lactamase extracts
was done on cellulose acetate membranes as previously
described.13
Inhibition profiles
Enzyme inhibition analysis was performed in a
centrifugal fast analyser (Centrifichem 400; Union
Carbide, Terrytown, New York, USA) by following
the colour change induced in nitrocefin in the presence
of serial IG-fold concentrations (range 0·1-100 pM) of
imipenem, latamoxef, cefoxitin, clavulanic acid, sul-
bactam (Pfizer Ltd), cloxacillin (Beecham Research
Laboratories Ltd.) and p-chloromercuribenzoate
(pCMB) (Sigma) as described by Eley and Green-
wood. ~-The activities of the crude Jl-lactamase extracts
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were standardised before testing by appropriate
dilution with 0·02 M phosphate buffer.
High pressure liquid chromatography ( HP Le)
The kinetics of hydrolysis of latamoxef, cefoxiun,
imipenem and the combination of benzylpenicillin
and clavulanic acid (4 mg/L) was investigated by
HPLC; 0·2 ml of enzyme extract, concentrated five
times by freeze drying, was mixed with 0·8 ml of
antibiotic solution to give a final concentration of
SO mg/L and incubated at 37°C. Samples were re-
moved for HPLC analysis at 0, 2, 4 and 20 h. Antibiotic
controls, in which phosphate buffer was substituted
for enzyme extract, were examined in parallel. A
Hypersil SODS column (HPLC Technology, Maccles-
field, Cheshire) was used. The mobile phase for
analysis of benzylpenicillin and cefoxitin was metha-
nol:water 40:60 with detection at wavelengths of
227 run and 23Srun, respectively. For latamoxef,
methanol :water 2S: 7S was used with detection at
250 run, and for imipenem, methanol: water 20: 80
with detection at 300 run. Phosphoric acid 1% was
included as a mobile phase modifier throughout these
experiments.
Results
Identification of isolates
The 116 isolates were identified as: B. fragilis (69),
B. distasonis (16), B. ovatus (13), B. thetaiotaomicron
(6), B. melaninogenicus (4), B. vulgatus (4), B. bivius (3)
and B. buccae (1).
Semi-qutlnlification of enzyme activity
Of the 116 isolates, 28 failed to induce a colour
change in nitrocefin within I h, 64 produced a weak
reaction. and 24caused a complete colour change. The
latter strains (14 B. fragiJis, S B. ovatus, 2 B. bivius, I
B. thetaibtaomicron, 1 B. distasonis and I B. buccae)
were selected for further characterisation of their Jl-
lactamases. Fifteen of the 24 strains that produced
enhanced levels of cephalosporinase also gave positi ve
reactions in the Escamilla test for penicillinase.
Antibiotic titrations
MICs of the antibiotics for all 116 test strains are
shown in table I. Imipenem and the combination of
benzylpenicillin with clavulanic acid were more active
than cefoxitin, latamoxef or benzylpenicillin alone.
Eleven of the 24 strains with raised Jl-lactamase levels
exhibited increased resistance to benzylpenicillin
(MIC> 32 mgjL). Clavulanic acid 4 mgjL reduced the
MIC of benzylpenicillin more than two-fold with all
but three of the 24 test strains; in all but six cases the
susceptibility to benzylpenicillin was reduced to
Table I. Susceptibilities of Bacteroides strains to selected p-
lactam antibiotics
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Minimum inhibitory concentration
Antibiotic (mill)
Range MIC50 MIC90
Benzylpenicillin O·S->64 16 32
Benzylpenicillin + 0·06-16 0·15 2
cia vulanic ac:id
Cefoxitin 0·15-> 128 16 32
Latamoxef 0·25-> 118 I 16
lmipenem 0·03-4 o-s 2
MICSO and MIC90, concentrations inhibiting 50"1. and ~~ of
strains. respectively.
<2 mg/l in the presence of clavulanic acid 4 mgil
(table II). The strains displayed a wide range of
susceptibilities to the other test antibiotics. Four
strains, B.fragi/is R:!11 and R208, B. Ol'utus R21S and
B. thetaiotaomicron R133 exhibited markedly reduced
susceptibility to cefoxitin, latamoxef and imipenem.
Specific enzyme actit'ity
Specific cephalosporinase activity (prool of nitroce-
fin degraded/min/mg of protein) of the crude enzyme
extracts ranged from 0·0I to 1·33 (table III). All the
strains for which the specific activi ty was ;;t 0·1
exhibited high penicillinase activity as determined by
the whole-cell semi-quantitative test, whereas many
of the p-lactamases with lower specific activity lacked
penicillinase activity.
Iso-electric focusing
Crude extracts of B.fragi/is isolates yielded a single
iso-electric point between 4·9 and S·3 (table III). No
band was detected by iso-electric focusing of extracts
of three other D. fragi/is strains (R240, R249, R2S1)
despite repeated testing. Enzymes from the five B.
ovatus strains displayed a wide range of pI values (4·S-
6·7). The two B. bivius strains displayed high pl values
(>6·0).
Inhibition profiles
Only five of the 24 strains (D. fragilis RI06, R216
and R226, B. ooatus Rill and R112) produced fJ-
lactamases that were at least partially susceptible to
all the inhibitors tested; a further seven were suscep-
tible to all but pCMB (table IV). The concentrations
of inhibitors required to achieve inhibition of the
individual enzymes varied considerably. The fJ-lacta-
mase from D. fragilis R 186 was not inhibited by any
of the agents tested and three D. fragi/is strains (R240,
R:!49 and R251) displayed very low levels of inhibition
(table IV). There were only three profiles common to
more than one strain: those shown by B. fragi/is R130
and RlS2; D. buccee R147 and B. bicius Rl60; and B.
ovatus R137 and B.fragi/is Rl41.
Table II, Antibiotic susceptibility (MIC mg, L) of 24 strains of Bacteroides that exhibited increased fJ-lactamase activity
Minimum inhibitory concenualion (mgJL)
Bacterial strait)
benzyl benzylpenicillin
penicillin +clavulanic acid cefoainn Iatamoxef imipenem
B./ra,lIu RI06 32 O-S 16 I o-S
B./ra,lIu RIJO 32 O-S 8 I 0-25
B./ra,lIu R249 4 2 16 O·S I
B./ragilu R251 16 2 32 4 2
B./ragilu RI86 8 4 32 I 2
B./ra,lIu R140 8 4 32 I 4
B. buccQl RI47 16 <0·12 <0·5 0-5 <0·03
B.o.allU RI37 16 0·5 8 I 0·5
B._nu Rill 16 0·2S 4 I O·S
B.blriu.r RI60 4 <0·12 4 4 0·06
B. dUllUOIIU R118 32 I 32 16 2
B./ra,lIu R208 >64 1 32 >128 4
B./rallilu RI41 16 0·25 16 0·5 0·06
B. biriu.r RI;!3 16 0·25 4 4 0·03
B./rallilis RI16 >64 I 16 16 O·S
B.Ot:anu R21S >64 O·S 64 > 128 I
B./ra,ilu RIS2 >64 <0-12 8 8 0·12
B.oranu R1I2 >64 0·25 16 16 O-S
B./ragilu R226 >64 O·S 8 16 I
B./ra,ilu R216 >64 I 8 8 1
B. ovanu RI02 >64 I 32 32 0-5
B./ragIlU R212 >64 4 128 >128 2
B./ra,iIU RI34 >64 0·25 16 16 (}25
B.IMlaiolaonUt:rrm R233 >64 16 >128 > 128 4
B./ra,ilu NCTC9344· 16 0·2S 8 0·25 (}12
• Data from reference 7. included for comparison.
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Table III. Characterisation of iJ-lactamases from 24 strains of Bacteroides that exhibited increased p-Iactamase activity
p-Idctamase activity
Bacterial strain Specific acuvity" lso-electric point
cephalosponnase penicillinase
B./ralll/is RI06 .....+ 0·01 S'3
B. t,a,,/is RI30 ++ 0·01 S'O
B. /,all'/is R~49 ++ 0,'11 NO
B. Irugrlis R~S I ...+ 0·01 NO
B./ragl/is RI86 +++ 0'02 4-9
B. l'ra.fli/is R:-IO ++ ...... 0,'12 NO
B !)!M:ca,RI47 ..... 0,'13 S.2
B.• ,'unu RI37 ++ ...... 1}03 4·S
B. oranu Rill +++ + O·OS 4-8
B. bi.,us RI60 ......+ I}OS 6'1
B. JistasonU RI18 ++ + 0·07 4-6. S'O
B..Ira,i/ir R:08 ++ 0,')8 S·O
B.J'ragriis RI41 ++ 1}09 S-O
B. bi.,us RI43 +++ +++ 0·10 6-4
B.f,a.fli/is RI:6 + ...+ +++ O-IS S-O
B. oJt'OnuR:IS ++ +...+ 0-16 5-0. b-7
B.fragrlir Rl52 + ...+ +-+ 0·21 S-2
B. uvatus RI12 +++ +++ 0-44 H
B. !ruri/is R:26 + ..+ ++ ... 0·{)8 4-9
B.tragl/is R:16 +++ ......+ 0·71 4·9
B. OVIUUSRI02 ....... + ...+ 0'S7 5-0
B.lragi/ir R212 ++ .. ... .+ 0'S8 S-I
B./,afli/ir RI34 +++ +++ 0-93 4-9
B.IMtuiolaomicran R233 ++ .. + ...+ 1·33 4·6
B'/,agi/ir NCTC9344 ± 0·03 H
...- + + +.arbitrary levels of enzyme activity assessed visually accordinlto tbe speed and completeness of the colour chaase. Isolates that
exhibited basal levels of cephalosporinase aeuviry, scored as ± after lb. arc omiued from th.s table (results for B. jratri/is !'ICTC 9344'
included for comparison) .
• !'Iilrocefin,.. mol delraded;minlml of protein.
NO. not detected.
Table IV. Inhibitor profiles of ,8-lactamases of strains listed in tables II and III
ICso (pM)
Bacterial strain
clavulanicpcmb imipenem Iatamoxef cefoxitin
acid sulbactam cloxacillin
B.jragilir RI06 10 <0·1 <I}I <0·1 <0·1 <0·1 10
B.lragi/is RI30 >100 <0·1 <I}I <0·1 <0·1 I 100
B.jragi/is R249 10 >100 >100 >100 >100 >100 lOO
B./ragrlis R2S1 100 >100 >100 >100 >100 >100 100
B.lragi/ir RI86 >100 >100 >100 >100 >100 >100 >100
B.jratri/is R240 100 >100 >100 >100 >100 >100 >100
B.but:cu RI47 >100 <0·1 <0·1 <0·1 <0·1 1 >100
B. ooatus R137 >100 <0·1 <0·1 <0·1 <o-I <0·1 lOO
B. ovatus Rill 10 <0·1 <0·1 <O-I <0·1 <0·1 100
B. bwUlS RI60 >100 <0·1 <0·1 <0·1 <0·1 I >100
R. disttutNlis R118 >100 <I}I <0-1 <0·1 I 10 >100
B. J'ragi/is R208 >100 <0·1 100 I 10 10 >100
B./ratti/is RI41 >100 <0-1 <0'1 <0·1 <O-I <0·1 100
B. bil1ius RI43 >100 <I}I 100 1 <0·1 10 >100
B.lragi/ir RIl6 >100 <0·1 I <0·1 <0'1 <0·1 100
B.tJfJQtus R2IS >\00 <I}I 10 I I I 100
B./,agi/is RIS2 >100 <0-1 <0·\ <0·1 <I}I 1 lOO
B. ovanu Rill 100 <0·1 <0·1 <o-t <1}1 <0·1 lOO
B.lragi/is R226 I <0·1 <I}I <0·1 <0·1 <0·1 10
B.lragi/is R216 I <I}I <0·1 <o-t <0-1 <0·1 I
B. ovalUS RI02 100 <o-I <o-t <0'1 <0·1 >100 >100
B./'agi/ir R212 >100 <0·1 100 I I I >100
B.lragi/ir RI34 >100 <o-I <0·1 I <I}I <0·1 100
B. tMtalotaomicrtm R233 >100 <0·1 100 I I 10 >100
IC,o.lowest concentrauon of inhibitor producinl > w,~inhibition: pcmb. p-chloromercuribenzoate.
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Figs. 1-4 show the rates of hydrolysis of benzylpen-
icillin (in the presence of clavulanic acid). cefoxitin,
latamoxef and imipenem for those strains in which
breakdown was detected by HPLC. In the presence of
cia vulanic acid. benzylpenicillin was rapidly degraded
by enzymes from B.fragi/is strains R186. R212. R:40.
R249 and R2S I and Buhetatataomicron R233: enzymes
from B. bioius RI43 and B. ovatus R21S hydrolysed
penicillin more slowly (fig. I). All these strains. with
the exception of B. bioius R143. also broke down
cefoxitin and latamoxef (figs. 2 and 3): latamoxef was
hydrolysed more rapidly than cefoxitin in all cases.
Only four of the test strains. R186. R240. R249 and
R2S1. were active against imipenem; all hydrolysed
the antibiotic rapidly, but a small amount of the
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F1a.4. Hydrolysis of imipenem by enzyme extracll from 8oc_ides
strains; -0-. control; -0-. R249; -.-. R186; --0--.
R240; --e--. R2S1.
compound was still detectable after overnight incu-
bation (fig. 4).
Discussion
Some unusual properties of the p-Iactamases of
Bacteroides spp. have been revealed in previous
studies. J.-'. 7 but the characterisation and classification
of these enzymes remain ill-defined.
In the present study of 116 clinically significant
isolates of Bacteroides. 24 produced levels of cephalo-
sporinase activity greater than the basal level typical
of most Bacteroides strains. and two-thirds of these
also exhibited the capacity to hydrolyse penicillinase
as judged by the phenol red test.? Fourteen of these 24
strains were identified as B. /ragilis, and six of the
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seven strains that failed to give a positive result in the
test for penicillinase activity belonged to this species.
In contrast to a previous study of 78 clinical isolates of
the B.fragi/is group, in which all but one of 13 "high
p-Iactamase" producers were identified as B. fragi/is
sensu stricto," seven isolates were identified as other
members of the B. fragi/is group, including five B.
ocatus strains.
As in the earlier study," imipenem and the combi-
nation of benzylpenicillin with clavulanic acid were
much more active than cefoxitin, Iatamoxef or
benzylpenicillin alone. asjudged by conventional MIC
titration. The overall level of resistance remained low,
although there seems to have been a slight increase in
the prevalence of resistance to cefoxitin and imipenem
in the intervening 5 years: for nine strains (8~~, the
MIC of cefoxitin was ~ 32 mg/L; five of these strains
W;,) were also resistant to latamoxef (MIC ~ 32 mgl
L). A total of seven strains (6~;,)displayed reduced
susceptibility to imipenem (MIC ~ 2 mg/L), The pro-
portions of strains in the previous study exhibiting
this level of resistance were cefoxitin (4~;,),latamoxef
(6'YJ and imipenem (4~. Among the present strains,
seven (6~-Owere able to hydrolyse cefoxitin.latamoxef
or imipenem; 4~~ of strains in the earlier study
displayed this property.
The categorisation of the I1-lactamases of Bacter-
oides spp. is problematic. Thus, enzymes classified on
the basis of their differential ability to hydrolyse 11-
lactamase-stable compounds such as cefoxitin, lata-
moxef, imipenem and clavulanic acid often exhibit
heterogeneous properties according to other measures
of activity, such as inhibition profiles and specific
enzyme activity.
Use of specific activity as a differential feature
presents particular problems, because the conditions
of growth of the organisms. as well as the methods
used for preparation. concentration and storage of the
enzyme extracts, may profoundly affect the results. II
These factors were carefully standardised in the
present investigation. but variability originating in
methodological differences makes comparison with
the results of other studies difficult.
Despite the problem of reconciling so many hetero-
geneous properties, certain tentative groupings can be
perceived among the strains described in the present
study and others previously reported (table V) ...•7
In the first group are the enzymes produced by B.
fragilis strains R186. R240, R249 and R251. which
appear to have broadly similar characteristics: low
specific activity; insusceptibility to inhibition by fJ-
lactamase inhibitors. including clavulanic acid; rela-
tive resistance to imipenem; and the ability to degrade
imipenem, latamoxef and. more slowly. cefoxitin.
These properties are similar to those previously
described in B. fragi/is strains. 57. 97 and 119,'"7
although the failure to detect iso-electric focusing
bands in B. fragi/is strains R240, R249 and R25l is
anomalous.
The second group is represented by B.fragi/is R212.
B. ollatus R215 and B. thetawtaomicron RZ33. all of
which exhibited resistance to benzylpenicillin. cefox-
itin and latamoxef and reduced susceptibility to
imipenem; they also displayed intermediate. or high
speCific activity. Enzymes from these strains showed
similar (but not identical) inhibition profiles and
hydrolysed /1-lactamase-stable compounds other than
imipenem. These enzymes are clearly not identical.
since their iso-electric points are diverse as would be
expected of enzymes from these different species. The
overall behaviour is similar to that of enzymes
produced by B. thetaiotaomicron 0456 and B. distaJOnis
R939. described previously."
A third group, represented by two strains. B.
distasonis Rl18 and B.jragi/is R208. exhibited reduced
susceptibility to cefoxitin, latamoxef and imipenern,
but did not hydrolyse these antibiotics as judged by
HPLC. The enzymes displayed variable inhibition
profiles and intermediate levels of specific activity.
Other strains have been described that appear to be
resistant to I1-lactamase-stable compounds although
they do not hydrolyse them. Such strains seem to
belong to a heterogeneous group which may possess
other mechanisms of resistance I" and these will be the
subject of further study.
Most of the strains encountered in this. and a
previous study," retain a high degree of susceptibility
to cefoxitin, latamoxef and imipenem. Generally, the
enzymes are fully susceptible to p-lactamase inhibitors
and clavulanic acid fully restores the activity of
benzylpenicillin. These strains produce enzymes with
a wide range of specific activities that have no
hydrolytic activity against I1-lactamase-stable com-
pounds. These strains were identified as enhanced 11-
Table V. Characteristics of four types of p-lactamasesfrom 24Bacteroides strains
MIC (mill) of Activity of Hydrolysis of
Type InhibilOB of benzylpeniciUin
benzyl latamoxef i~!:-
P-Iactamase rcstoredby benzyl Iata- imipe-
penicillin cefoxitin clavulanic acid peniciUin' ccfoxitin moxef nem
Type I 4-16 16-32 0·5-4 1-4 Reaistant No Yea Yes Yes Yes
(slow)
Type2 >64 >32 >128 1-4 Intennediate Partial Yes Yes Yes No
Type3 >16 32 >8 2-4 Variable Yes No No No No
Type4 4->64 4-32 0·5-32 "I Susceptible Yes No No No No
• In the presence of clavulanic acid.
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lactamase-producers by the nitrocefin screening pro-
cedure and it is probable that they are strains that
produce greater than normal amounts of the cephalo-
sporinase that most B.fragilis group strains are known
to produce.
The enzyme produced by B. bicius Rl43 did not
conform to any of the categories described above,
notably by slowly hydrolysing benzylpenicillin in the
presence of clavulanic acid. In other respects its
behaviour was similar to that of the other B. bit'ius
strain RI60. although it was considerably less suscep-
tible to inhibitors of p-lactamase activity.
The strains that we have examined were selected on
References
I. Tally FP. Ma1amy MH. Antimicrobial resistance and resistance
transfer in anaerobic bacteria. A review. Sctmd JGas_
InoII984; 19Supp191: 21-30.
2. Olsson B. Dornbusch K. Nord CEo Susceptibility to beta-Iactam
antibiotics and productionofbeta-Iactamasc in &Jcluoida
j;al/tlu . .'tfftl Mk:robIoIl...-noI1977 .163: 183-194.
3. Tajima M, Saw. K. Watanabe K. Ueno K. The ,B-Iactamases
of aenus &Jcluoida. J Anlibiol 1983; 36: 423-428.
4. Eley A. Greenwood O. Cbaracterization of ,B-Iactamases in
clinical isolateS of 8tM:lm>kIa. J .~nttmicrob CMmotire,
1986: 18: 325-333.
S. Cucbural GJ. Tally FP. Jacobus NV. Marcb PK. Maybelli' IW.
Cefoxitin inactivation by &Jclm>kl~! frafilu. Anllmicrob
Arm,. Clwmolirer 1983: lA: 936-940.
6. MaskellIP. Nasu M. Williams 10. Cephalosporin-resistance
in Ibe &cl~rouJe$ fraril" poup and tbe effect of clavulamc
acid. J Anllmicrob Clrmrolirer 1984; 13: 23-30.
7. Eley A. Greenwood O. 8eta-lacumases of type cullUre strains
of the &JclnoiU![rogil" poup and of strains that bydrolyse
cefoxitin.latamoxef and imipenem. J Mftl Mit:robiol1986;
11: ~9-S7.
8. Aldridge KE. Henderberi A. Sanden CV. Enhanced antimi-
crobial activity of old and new ,B-Iac:tamsapinst cefoxitin-
resiStant &JckmuJa frarilu poup isolateS by ,B-Iactamase
inbibitorS. J AntImicrob Clrmrolirer 1990; 15: 873-17S.
9. Escamilla 1.Susceptibility of H_,lriIru In/fwruuto ampi-
cillin as determined by use of a modi&ecl. one-minute beta-
lactamase teSt. Antlmicrob Apnt! CIrmroIIwr 1976; 9: 196-
198.
the grounds of their involvement in some pathogenic
process and most of the species encountered belonged
to the B. fragilis group. Others have described
p-Iactamases with heterogeneous properties from non-
B. fragilis group species" and it is clear that the P-
lactamases of anaerobic gram-negative rods are much
more variable than those of enterobacteria.!" I'
Fortunately, the number of strains that exhibit
enzymic or other mechanisms of resistance to p-Iactam
antibiotics appears presently to be quite small. but
there is no guarantee that this situation will continue
to prevail under the selective pressure of antibiotic
usage.
10. Aldridge KE. Sanders CV • Lewis AC. Marier RL. Susceptibility
of anaerobic bacteria to beta-Iac:tam antibiotics and beta-
lactamase production. J •..,ftl Mit:robiol1983; t6: 1S-82.
II. Edwards R. Greenwood O. Effect of growth conditions and
storaaaon the specific ac:tivityof,B-lactamasesof&Jcteroida
spp. J Appl BaclmoIl990: 69: 421-125.
12. O'Callqllan CH. Morris A. Kirby SM. SbinaJer AH. Novel
method for detection of ,B-Iac:tamucs by usinl a chromo-
lenic: cephalosporin substrata. Antlmicrob Apnu CMmolMr
1971; I: 283-288.
13. Eley A. Ambler J. Greenwood O. IIoeIec:tric focusinl of ,B-
lactamucs on cellulose acetate metnbranes. J Antimicrob
CIrmroIIwr 1983; 11: 193-196.
14. Wexler HM. Halebian S. Alterations to the penicillin-bindinl
proteins in the Bat:luouJ~! [,agil" poup: a mechanism for
non-,B-Iac:tamasc mediated cefoxitin resistance. J Anttmicrob
CM_,M, 1990:!AI: 7-20.
IS. Appelbaum PC, Pbilippon A, Iacobs MR. Spangler SK.
Gutmann L. Cbaracterization of ,B-Iactamases from non-
&Jc1~rouJe! frarilu IrouP il«luoilh! spp. belonainl to
seven species and their role in ,B-Iactam resistance.
AnllmicrobA,."uClwmolM, 1990; 34: 2169-2176.
16. Simpson IN. Harper PB. O'Calla,ban CH. Principal ,B-
lactamalel responsible for resistance to,B-1ac:tamantibiotics
in urinary tract infections. AIrllmicrob AftIIU CIrmroIIwr
1980; 17: 929-936.
17. Cooksey R. Swenson 1. Clark N. Gay E. Thornsberry C.
Patterns and mechanisms of ,B-lac:tam resistance amonl
isolateS of &chukltiD coil from hospitals in the United
States . .4nltmit:rob Ag~! eiremoliN, 1990; 34: 739-745.
266
VIII International Symposium of the Society for Anaerobic Microbiology,
Cambridge, July 1993.
Extended abstract
OUTER MEMBRANE ANALVSIS OF B.FRAGILIS STRAINSWITH
REDUCED SUSCEPTIBILITYTO IMIPENEM
R. Edwards and D. Greenwood, Dept. of Microbiology and PHLS
Laboratory, Queen's Medical Centre, Nottingham, UK
Imipenem is normally highly active against B.tragi/is (MIC $;0.12
mgll), but a minority of strains (about 6%) display reduced susceptibility
(MIC ~2 mgll). Some of these strains produce imipenem-hydrolysing
metallo-f-lactamases" but in others the reduction in susceptibility does
not appear to be associated with enzymatic activity2. To ascertain the
role of other resistance factors, such as reduced antibiotic penetration
into the cell, the outer membrane (OM) protein composition (which
reflects the porin content) and OM lipopolysaccharide (LPS) (which
contributes to bacterial hydrophobicity) were examined. The OM
compositions of 8 B.tragi/is strains with reduced susceptibility to
imipenem, 4 of which produced metallo-(3-lactamases (R186, R240,
R251 and 119) and 4 which were not metallo-(3-lactamase producers
(R208, R212, 0423 and 2013E) were compared to 2 fully sensitive
B.tragi/is strains (R135 and NCTC 9344) by SOS-PAGE.
All strains possessed a major OM protein of molecular weight 44
kDa and other main bands of 62 kDa, 42 kDa, 38 kOa, 29 kDa and 22
kDa. The profiles of metallo-(3-lactamase producing B.tragi/is were
distinctive with an extra band of 40 kDa (figure 1). An additional band of
51 kDa was seen in the profile of B.tragilis R186. Also, B.tragi/is R240
267
and 119 possessed an extra 16 kDa protein. The LPS compositions of
the fully sensitive B.tragi/is strains and of those resistant strains that did
not produce metallo-(3-lactamasewere similar, with a major component
(band B) and additional bands of larger (band A) and smaller (band C)
molecular size. LPS of band A was not present in strains that produced
metallo-(3-lactamases and band B was either absent or more diffuse in
these strains.
B.tragi/is strains with reduced susceptibility to imipenem, but which
do not produce imipenem hydrolysing metallo-(3-lactamases appeared
to possess OM protein and LPS profiles that were similar to those of fully
sensitive strains. As the OM represents a permeability barrier, these
findings suggest that antibiotic penetration into the cell is not
responsible for the increase in resistance of these strains. A reduction in
the affinity of imipenem for the penicillin-binding proteins of these strains
may account for their reduced sensitivity and this is being investigated.
Suprisingly, the metallo-(3-lactamase-producing B.tragi/is strains
showed OM protein and LPS profiles that differed from those of the non-
metallo-(3-lactamaseproducers. Their additional protein band of 40 kDa
may represent metallo-(3-lactamase. The distinctive LPS profile of the
strains that produce metallo-(3-lactamases may simply represent
differences in 0 side chains indicating differences in serotype.
1) Hedberg M., Edlund C., Lindqvist L., Rylander M. and Nord C.E.
Purification and characterisation of an imipenem hydrolysing metallo-(3-
lactamase from Bacteroides tragilis. J. Antimicrob. Chemother. (1992)
29, 105-113.
2) Edwards R. and Greenwood D. An investigation of (3-lactamasesfrom
clinical isolates of Bacteroides species. J. Med. Microbiol. 36 (1992)
89-95.
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Abstract
The activity of meropenem was similar to that of imipenem
against 88 clinical isolates of Bacteroides spp .• including 28non-
fragilis strains. Four of the isolates were able to hydrolyse ce-
phamycins or pen ems. Investigation of p-lactamases from
these strains and 10 laboratory stock culture Bacteroides
showed that meropenem and imipenem were degraded at a
similar rate by cell-free preparations of these enzymes. Some
of these strains were able to completely hydrolyse the carbape-
nems within 2 h. Despite this rapid hydrolysis, MICs of mero-
penem and imipenem for some of the strains remained within
the susceptible range as judged by agar dilution titration .
.................
Introduction
Meropenem is a new carbapenem with
broad-spectrum activity and stability to most
p-Iactamases [1-4]. Most clinical isolates of
Bacteroides spp. are unable to hydrolyse car-
bapenems or cephamycins, but potent p-lacta-
mases that degrade cefoxitin and imipenem
are occasionally encountered and are associ-
ated with a reduction in antibiotic susceptibil-
ity [5-8]. In this study, the in vitro activity of
meropenem was compared with that of four
other anti-anaerobe p-lactam agents against
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clinical isolates of Bacteroides spp. The com-
parative stability to enzymes from these and
other strains capable of hydrolysing carbape-
nems and cephamycins was examined.
Materials and Methods
Eighty-eight clinically significant isolates of Bacte-
roides spp. were collected from specimens submitted
to Nottingham Public Health Laboratory. and main-
tained in skimmed milk at-70°C. They were identified
by standard methods. Ten laboratory stock cultures of
Bacteroides which have been shown to hydrolyse carba-
R. Edwards
Dcpanmenl uf Microbiul"l)' and
PHLS Laborau)I'Y. Universiry Hospilal
Queen's Medical Ccnlre
NOllinsham NG7 !UH (UK)
CI993
S. Karger AG. Basel
Il()(JI}-31S71931
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Meropencm, imipenem and cluvulanic acid were
gifts from the manufacturers: standard pharmaceutical Antibiotic
preparations of cefoxitin. piperacillin and benzylpen-
icillin were used. MICs were determined by the agar di-
lution method with brain heart infusion agar supple-
mented with yeast extract S gl, haemin S mgtl and me-
nadione 1 mg/l, Inocula of about 10·and 10"c.f.u.'spot
were delivered onto the agar surface with a multipoint
inOC'.1iatingdevice. Results were recorded after ineu-
bation for -'8 h at 37'C in an anaerobic cabinet.
Crude !3-lactamllSe extr.lcts were obtained by soni-
c::ltion of bacterial suspensions freshly prepared as de-
scribed elsewhere [9). For high-pressure liquid ehro-
mato~phy (HPLC) 0.2 ml of enzyme extract was
mixed with 0.8 ml of antibiotic solution to give a final
ccncemration of 50 mgtl and incubated at 37·C. Sam-
ples were introduced into a Hypc:rsil SODS HPLC col-
umn after O. ! "and ~ h. The HPLC conditions ~or
imipenem. ceroxitin and penicillin have been previ-
ously described [7]; for meropenem the mobile phase
was methanol: water (:5 :75) with spectrophotometric
detection at 300 nm.
penerns or cepharnycins in previous investigations
(5-7) were also used. B. frayrlis :-.iCTC93·B was used JS
a control strain.
Results and Discussion
Of the 88 clinical isolates of Bacteroides. 60
were identified as B. fragilis. 13as B. distasonis.
8 as B. ovarus. 4 as B. thetaiotaomicron and 3 as
B. vulgatus. Overall, meropenem and imipe-
nem were the most active of the antibiotics
tested, with MIC9I,s of0.5-1 mg/l (table 1).The
combination of benzylpenicillin and c1avu-
lanic acid showed activity similar to that of the
carbapenems against B. fragi/is isolates, but
less activity against the non-fragi/is strains
(MI~ of 4 mgll). Cefoxitin and piperacillin
were less active than the carbapenems or clav-
ulanate-potentiated penicillin against these
strains. Inoculum effects were small or absent
in all cases. These findings are in broad agree-
ment with other studies [1-41.
Four of the clinical isolates (B. fragi/is R186
and R212. B. IhetaiolU()micron R233 and
B. ovatus R215). representing 5% of the strains
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Table 1. Antihiotic susceptibilities of Bacteroides
frllgilis and non-fragilis strains to selected ~-l:1ctam an-
tibiotics (inoculum 10" c.f.u.'spot)
MIC. mg/l
range xic, ~1I~
B. fragilis (n - (0)
Meropenem 0.06-4 0.:5 0.5
Imipenem 0.06-2 o ~< 0.5._
Piperacillin 0.5-> 1:8 4 64
Cefoxitin "'2-1:8 S 16
Penicillin with
clavulanic acid· ",0.015-16 0.:5 1
Other Bacteroides spp. (n - 28)
~(eropenem 025-4 0.5 0.5
Imipenem 0.1:-4 0.5 1
Pipencillin "-> 1:8 16 64
Cefoxitin "'1-> 1:8 16 16
Penicillin with
clavulanic acid· "'0.015-16 0.25
"
• Clavulanic acid: ~ mgtl•
studied. showed reduced susceptibility to the
carbapenems or cefoxitin and possessed ~-Iac-
tamases which hydrolysed these compounds,
Investigation of these 4 isolates together
with 10 laboratory stock culture strains pos-
sessing ~-Iactamases capable of hydrolysing
'carbapenerns or cephamycins showed that
imipenem was 2- to 4-fold more active than
meropenem for 7 of these strains (table 1).
HPLC analysis revealed that 6 of these 7 iso-
lates (and 1other. B. fragi/is 119,which was re-
sistant to both imipenem and meropenem)
were able to hydrolyse meropenem com-
pletely within 2 h. With 1 of these strains
(B. fragi/is Rl86), complete hydrolysis of imi-
penem was not observed even after incubation
for 20 h (table 3). These penem-degrading
~-Iactamases are metallo-enzymes [10]and, as
expected. clavulanic acid did not protect ben-
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Table 2. Antibiotic
susceptibilities of 14 Bacteroides Strain MIC. mg/l
strains with ~-Iactamases capable rnero- irni- cdo- peni-
of hydrolysing carbapenems or penem pcncrn xitin cillin'
ccpharnycins (inoculum 1O~
c.I.u.rspot) B. fragilis R240 8 2 -, 4-'_
B. fragilis R:5 1 4 2 32 2
B. fragilis R249 2 0.5 16 4
B. fragi/is R 186 4 ., -? 8... -'_
B. fragilis 97 2 0.5 16 8
B. fragilis 57 >8 8 32 >8
B. fragilis 119 >8 >8 64 >8
B. fragilis 107 0.5 0.5 32 1
B. fragi/is 04:3 0.5 1 32 1
B. fragilis R:12 2 2 128 4
B. thetaiotaomicron R:33 4 4 > 128 16
B. thetaiotaomicron 0456 4 2 >64 4
B. o~'atuS R215 1 1 64 0.5
B. diuasonis R939 0.5 1 32 >8
B. fragilis NCfC93.t3b 0.12 0.12 4 0.12
, Tested in the presence of 4 mg'1 clavulanic acid.
b Control strain.
Table 3. Degradation of penicillin in the presence of clavulanic acid (4 mg/l), ccfoxitin. imipenem and mero-
penem by ~-Iactamases from 14 strains of Bacteroides spp.
Strain Antibiotic remaining. %'
meropenem imipenem cefoxitin penicillin
2h 4h lOh 2h 4h 20 h Zh 4h lOh 2h 4h lOh
B. fragilis R240 0 0 0 0 0 0 68 49 31 0 0 0
B. fragilis R:5 1 0 0 0 0 0 0 64 41 11 0 0 0
B. fragi/is R249 0 0 0 8 0 0 81 i2 58 0 0 0
B. fragilis R186 0 0 0 20 15 6 81 .,., 64 0 0 0
B. fragi/is 97 0 0 0 6 0 0 75 68 58 0 0 0
B. fragilis 57 0 0 0 0 0 0 21 9 0 0 0 0
B. fragilis 119 0 0 0 0 0 0 2R 11 0 0 0 0
B. fragilis 107 100 100 62 92 87 16 8<} 87 83 78 71 0
B. fragi/is 0423 97 97 24 84 78 10 83 81 72 0 0 0
B. fragilis R2l2 98 98 41 92 98 61 0 U 0 0 0 0
B. thetaiotaomicron R233 98 98 59 88 95 39 0 0 0 0 0 0
B. thetaiotaomicron 0456 IlX> 100 27 94 97 4 30 23 0 0 0 0
B. ovatuS R215 98 98 8 92 98 61 79 65 65 4 0 0
B. distasonis R939 100 100 22 94 89 4 83 79 67 4 0 0
B. fragi/is NCfC9343b 100 100 95 100 100 95 ILKl 98 95 100 95 90
, Percentage relative to the organism-free control value after incubation at 37°C for the time indicated.
b Control strain.
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zylpenicillin from hydrolysis: as reported pre-
viously [11. 12] cefoxitin was more stable: than
carbapenern compounds to these enzymes.
Despite the rapid hydrolysis of meropenem
and imipenem by crude cell-free extracts of
certain strains of Bacteroides spp., MICs of
these compounds were not always raised
above 4 mg/l, These isolates would be re-
garded as susceptible according to conven-
tional criteria [13]. but the MICs of carbape-
nems for these strains were about lO-fold
higher than those seen with fully sensitive Bac-
teroides strains.
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